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ABSTRACT 
Intraindividual Variability as a Predictor of Cognitive Decline in Elderly 
by 
Wendy S. Ramratan 
 
Advisor: Dr. Laura A. Rabin 
 Mild cognitive impairment (MCI) is conceptualized as a transitional state between 
normal aging and fully developed clinical features of dementia. The literature on MCI is notable 
for varied measurement approaches and lack of stability in the diagnostic entity, with many 
individuals remaining stable or reverting to normal cognitive status.  Researchers agree that 
multiple neuropsychological domains should be assessed to enhance the assessment and 
prediction of cognitive decline.  In addition, within-person assessments capture trajectories of 
decline, which are better suited for understanding individual change than simple comparison to 
group norms.  The current study investigated the ability of within-person change on novel 
experimental cognitive tasks, referred to as intraindividual variability (IIV), to enhance 
characterization and prediction of MCI compared to traditional neuropsychological measures. 
 Participants were 426 older adults from the Einstein Aging Study, a longitudinal 
community-based study, who were classified as healthy controls (HC) with no cognitive or 
functional impairment at a baseline assessment (mean age=79.89, SD=5.05).  Participants 
completed a two-day testing battery that included standard (Free and Cued Selective Reminding 
Task, Trail Making Test Part A, Trail Making Test Part B) and experimental (Cued-Recall 
Retrieval Speed Task, Number Match Task, N-Back 2 Task) tests of episodic memory, 
processing speed and executive function.  For standard tasks we recorded the number of items 
correct and/or time to task completion.  For experimental tasks we recorded reaction time IIV 
v 
 
and accuracy IIV. The outcome of interest was MCI, which was defined by two classification 
approaches to prevent diagnostic circularity.  Participant cognitive status was assessed annually 
for up to 10 years following initial baseline testing.   
 Within-domain analyses aimed at characterizing future MCI status revealed that 
participants who transitioned to MCI performed worse at baseline on the episodic memory 
standard task and all experimental tasks; they also exhibited greater IIV on the episodic memory 
experimental task.  Within-domain analyses aimed at predicting future MCI status revealed that 
baseline performance on the episodic memory standard task predicted future incident MCI and 
baseline performance for the episodic memory experimental task predicted future incident MCI 
when utilizing the alternate MCI criteria.  Across-domain analyses aimed at predicting future 
MCI status revealed that episodic memory and executive function standard tasks predicted 
incident MCI better than experimental tasks.  Across-domain time-dependent analyses revealed 
that the episodic memory standard and experimental tasks and the executive function standard 
task distinguished between individuals who transitioned to MCI within three years and HC.  
However, this analysis was unable to distinguish between participants who transitioned to MCI 
four or more years after initial testing.   
 Overall, results revealed that baseline differences on cognitive tasks present up to 10 
years before MCI diagnosis.  Episodic memory IIV classified transition of MCI for both 
diagnostic MCI definitions.  In addition, incident MCI can be predicted from baseline 
performance on episodic memory standard and experimental tasks and on an executive function 
standard task.  These measures could be considered an early detection approach and should be 
further examined to facilitate early diagnosis of MCI and related preclinical conditions.  
Keywords: Intraindividual variability, mild cognitive impairment, aging, prediction of MCI 
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Introduction 
Cognitive Decline and the Elderly 
 Cognitive changes are a normal part of the aging process, though the trajectory of decline 
differs for those with non-normative cognitive decline resulting from a neurodegenerative 
process such as dementia.  Alzheimer’s disease (AD) is the most common type of dementia 
among the elderly, accounting for approximately 60-80% of all cases.  The pathology of AD is 
believed to begin many years before a clinical diagnosis leading to research focused on detecting 
cognitive decline at its earliest stage.  Studies have utilized multiple methodologies to examine 
the prodromal stage of AD – mild cognitive impairment (MCI) – and the transition to AD.  
Unfortunately, at the MCI stage, impairment may be too progressed to treat and researchers have 
thus focused on healthy elderly to determine when non-normative changes first become evident. 
The assessment of within-person cognitive change over time may be a specific and sensitive 
marker of non-normative cognitive change, though research on this topic is inconclusive due, in 
part, to the multiple methodologies and varying tests used to assess intra-individual change.  At 
present the field lacks consensus about how best to assess within-person change over time and 
how to utilize this methodological approach to predict which cognitively healthy elderly 
individuals will transition to MCI and AD. The current study addresses these important issues 
through the assessment of within-person change using novel experimental cognitive tasks that 
capture intraindividual variability in reaction time and task accuracy.  
 
Alzheimer’s Disease Prevalence and Risk Factors 
 AD, the most common form of dementia, is the sixth leading cause of all deaths in the 
United States and the fifth leading cause of death of those aged 65 and older (Alzheimer’s 
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Association, 2016).  One in every nine adults aged 65 or older carries a diagnosis of AD and the 
estimated lifetime risk for developing AD ranges from 13-16% as age increases beyond 65 
(Alzheimer’s Association, 2016).  By the end of 2016 there will be approximately 5.7 million 
older adults with AD (Alzheimer’s Association, 2016).  Barring any monumental breakthroughs 
in disease prevention or cure, it is estimated that within the next 10 years there will be 7.1 
million people aged 65 or older with AD in the United States, representing a 37% increase in 
prevalence compared to current rates (Alzheimer’s Association, 2016).   Globally, there is an 
estimated 46.7 million people aged 60 or older with dementia (Alzheimer’s Disease 
International, 2015).  Within 15 years, this value is predicted to have a 63% increase in 
prevalence, so that by 2030, there will be an estimated 75 million people worldwide with 
dementia (Alzheimer’s Disease International, 2015).   
 The greatest risk factor for developing AD is advancing age. Individuals between the 
ages of 65 to 74 comprise 15% of the AD population compared to individuals ages 75 to 84 and 
85 and older, who comprise roughly 44% and 37% of the AD population, respectively.  Women 
comprise approximately 63% of those with AD, which is likely due to the fact that on average, 
women live longer than men and as previously noted, older age is the greatest risk factor for AD.  
African-American and Hispanic individuals are more likely than Caucasian individuals to have 
AD.  Health conditions, such as cardiovascular disease and diabetes, which are associated with 
an increased risk for AD, and are more prevalent within African-American and Hispanic 
individuals, likely account for differences between ethnic groups.  Globally, 58% of all people 
with dementia have a lower socioeconomic status therefore indicating a higher risk of dementia 
for those with a lower income.  In addition, genetic factors increase the risk of developing AD—
for example, 40-65% of those diagnosed with AD carry one or two copies of the APOE 4 gene, 
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indicating that while inheriting the gene increases the risk of AD, it does not guarantee that an 
individual will develop AD (Alzheimer’s Association, 2016). 
 
AD Diagnostic Criteria 
 The National Institute on Aging and the Alzheimer’s Association (NIA-AA) provide 
recommendations for the clinical diagnosis (criteria) of all-cause dementia, which includes 
cognitive or behavioral symptoms that interfere with daily activities, represent a decline from 
previous functioning, and are not explained by delirium or major psychiatric disorder.  Cognitive 
impairment is detected and diagnosed through historical reports from patient and knowledgeable 
informant(s) and objective cognitive assessment through bedside mental status examination or 
neuropsychological tests.  Cognitive and behavioral impairment must be present in at least two 
of the following domains: acquisition and recall of new information, reasoning and handling of 
new tasks, visuospatial abilities, language functions and changes in personality, behavior or 
comportment (McKhann et al., 2011).   
 The NIA-AA also specifies criteria for the diagnosis of AD dementia including possible 
AD dementia, which occurs when the clinical criteria for cognitive deficits (see above) are met 
and there is a sudden onset of cognitive impairment or demonstrates insufficient objective 
documentation of cognitive decline.  A diagnosis of possible AD dementia can also be made 
when there is a mixed etiological presentation that meets the clinical criteria of AD dementia but 
also has evidence of features of other neurological on non-neurological medical issues that could 
have a substantial effect on cognition.  A diagnosis of possible AD dementia with 
pathophysiological evidence does not eliminate the likelihood that other pathophysiological 
conditions are also present (McKhann et al., 2011).  The diagnosis for probable AD dementia 
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includes the aforementioned criteria for dementia and also insidious onset, history of worsening 
condition, the most prominent cognitive deficits have an amnestic or non-amnestic presentation, 
and there is no evidence of any other medical or neurological disorder that could have an effect 
on cognition (McKhann et al., 2011).  A diagnosis of probable AD dementia is supported by the 
presence of a causative genetic mutation (amyloid precursor protein, presenilin 1, or presenilin 
2).  Presence of biomarkers (total tau, phosphorylated tau or amyloid-β) may also increase 
certainty of the probable AD dementia diagnosis, but are not advocated due to limited access and 
information on the utility of these markers (McKhann et al., 2011).  The criteria for diagnosis of 
definite AD dementia include the clinical and cognitive criteria for AD dementia and 
histopathological evidence obtained from a biopsy or autopsy (McKhann et al., 2011). 
 More recently, the Diagnosis and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-V) characterized major neurocognitive disorder due to probable/possible AD (also 
commonly referred to as Alzheimer's Dementia) where there is evidence of causative AD genetic 
mutation from family history or genetic testing and/or decline in memory/learning and one other 
cognitive domain; steadily progressive, gradual decline in cognition and absence of other 
etiologies.  Mild neurocognitive disorder due to probable AD is diagnosed if there is evidence of 
causative AD genetic mutation from family history or genetic testing; mild neurocognitive 
disorder due to possible AD is diagnosed if there is no evidence of causative AD genetic 
mutation but there is decline in memory/learning; steadily progressive, gradual decline in 
cognition and no evidence of mixed etiology (American Psychiatric Association, 2013).   
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AD Neuropathology 
 The AD brain is characterized by the presence of extracellular amyloid plaques and 
intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed 
filaments (Alzheimer’s Association, 2016; Bloom, 2014). The soluble building blocks of these 
structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.  The behavioral symptoms 
of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence 
of the destruction of synapses that mediate memory and cognition (Bloom, 2014).  Synaptic loss 
can be caused by the failure of neurons to maintain functional axons and dendrites or by neuronal 
death (Blumenfeld, 2002; Kolb & Whishaw, 2009; Petersen et al., 2001).  Because soluble toxic 
aggregates of Aβ and tau self-propagate and spread throughout the brain, therapeutic intervention 
for AD requires early detection before plaques, tangles, and cognitive impairment become 
evident (Bloom, 2014).  
 Jack and colleagues (2010) proposed a biomarker model of AD that suggests a temporal 
cascade of onset AD pathology and clinical symptoms across the trajectory of cognitively normal 
to MCI to AD (Figure 1).  According to the model, as the clinical stage of the disease advances, 
the presentation of biomarkers increase, with each biomarker presenting at different stages.  
Therefore, AD can be viewed as an evolving process in which pathological changes in the brain 
can present years before the onset of overt clinical symptoms.  Biomarkers can be divided into 
two categories: brain amyloid β plaque formation and neurodegeneration.  Amyloid β (Aβ) 
plaque formation can be measured by decreased cerebrospinal fluid levels of Aβ42 and by brain 
PET Aβ imaging.  Neurodegeneration is noted by neuronal damage (increased cerebrospinal 
fluid tau), reduced brain metabolism (decreased Fluorodeoxyglucose uptake on PET) and 
cerebral atrophy (Jack et al., 2010).  According to Jack and colleagues (2010), the amyloid 
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cascade hypothesis of AD states that AD begins with abnormal processing of the amyloid 
precursor protein, which then leads to excessive production or reduced clearance, and 
consequently plaque formation of Aβ in the brain.  Recent research has led to an updated model 
(Figure 2), which introduces differing profiles for low-risk versus high-risk individuals (Jack et 
al., 2013).   
 Jack and colleagues (2013) observed that individuals who are high-risk differ along the 
spectrum from those at low-risk.  Individuals who are at high risk for cognitive impairment due 
to AD pathophysiology may have more genetic risk alleles, lower cognitive reserve, or other co-
morbid brain pathologies, while low-risk individuals present with a protective genetic profile, 
high cognitive reserve, and the absence of co-morbid brain pathologies; these individuals can 
have substantial AD pathophysiology while still maintaining normal cognitive function (Jack et 
al., 2013).  Therefore, at a specific time point, individuals can present with the same AD 
pathological burden, but because of their risk-status, display different cognitive profiles. 
Specifically, a high-risk individual may display cognitive impairment while a low-risk individual 
(examined at the same time) may present with normal cognition (Jack et al., 2013).  It is 
therefore imperative to utilize measures that detect subtle, cognitive impairment in order to 
correctly classify all types of at-risk individuals.       
 
Conceptualization and Characterization of Mild Cognitive Impairment 
 AD progresses slowly and begins years before the clinical manifestation of symptoms 
(Alzheimer’s Association, 2016; McKhann et al., 2011). Brain changes associated with AD may 
begin as early as 20 years before clinical symptoms actually appear.  As noted above, AD is 
characterized by deterioration in memory and other cognitive abilities (e.g., executive function, 
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language) and changes in personality and behavior as a result of the neurodegenerative changes 
(Alzheimer’s Association, 2016; Chantal, LaBelle, Bouchard, Braun, & Boulanger, 2002; 
McKhann et al., 2011).  As neuronal damage increases, individuals demonstrate increasing 
cognitive decline, which eventually compromises every cognitive domain and all activities of 
daily living (Alzheimer’s Association, 2016).   
 The prodromal phase of AD, which is characterized by a gradually progressive cognitive 
decline, is believed to be the result of accumulation of AD pathology within the brain.  Multiple 
studies have examined this stage of AD, often referred to as mild cognitive impairment (MCI).  
MCI is conceptualized as a transitional state between the cognitive changes of normal aging and 
the fully developed clinical features of dementia (Morris, 2006; Petersen, 2007; Petersen et al., 
2014).  But, the point at which the onset of decline begins is difficult to identify and therefore the 
transition points from asymptomatic to symptomatic pre-dementia to dementia onset are also 
difficult to distinguish.  As a result, The NIA-AA introduced “mild cognitive impairment due to 
AD” to characterize individuals along the MCI spectrum with primarily underlying AD 
pathology.  They recognized the need for core clinical criteria that would be broadly used by 
healthcare professionals without the need for specialized tests or procedures as well as clinical 
research criteria that incorporated the use of biomarkers for use in research settings.   
 According to Petersen (2007) and Albert and colleagues (2011), diagnosis of MCI is 
made in individuals who are not demented, who have a cognitive complaint, cognitive 
decline/impairment not normal for their age, and preservation of independence in functional 
abilities.  A combination of clinical, physiological, and neuropsychological measures may be 
used to diagnose MCI, including a complete medical history, self-report assessment of daily 
living activities, information from a close friend or relative, examination by a neurologist, mood 
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evaluation, neuropsychological assessment, blood work, and in some cases neuroimaging (Albert 
et al., 2011; Blumenfeld, 2002). 
 Studies of MCI have determined that there are multiple domains of cognition that can be 
impaired (Albert et al., 2011).  Petersen (2004) characterized subtypes based on the cognitive 
domains of impairment (e.g., impairment in memory alone was characterized as amnestic MCI-
single domain). Individuals with amnestic MCI (aMCI) have a higher conversion rate to AD (18-
19%) compared to other non-amnestic MCI (naMCI) subtypes (5-10%) (Damien et al., 2013; 
Fischer et al., 2007; Jungwirth, Zehetmayer, Hinterberger, Tragl & Fischer, 2012; Mitchell & 
Shiri-Feshki, 2009; Tifratene, Robert, Metelkina, Pradier & Dartigues, 2015).  Impairment in 
memory and non-memory domains is characterized as amnestic MCI-multiple domain.  
Individuals with this subtype have a higher likelihood of progressing to AD in addition to 
vascular dementia (Petersen, 2004).  Impairment in a single domain, which is not memory, is 
characterized as non-amnestic MCI-single domain.  Individuals with this subtype have a higher 
likelihood of progressing to frontotemporal dementia and dementia with Lewy bodies.  
Impairment in more than one non-memory domain is characterized as non-amnestic MCI-
multiple domain.  Individuals within this subtype have a higher likelihood of progressing to 
dementia with Lewy bodies and vascular dementia (Petersen, 2004).   
 Research criteria for MCI incorporate the presence of biomarkers (as mentioned 
previously) associated with AD pathology.  Albert and colleagues (2011) proposed a 
hypothetical framework in which biomarkers may be used to increase diagnostic accuracy.  Their 
framework consisted of four levels in relation to biomarker presence/absence: high likelihood, 
intermediate likelihood, low likelihood and uninformative.  A high likelihood of MCI due to AD 
requires the biomarker presence of Aβ and neuronal injury.  An intermediate likelihood of MCI 
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due to AD requires the biomarker presence of Aβ or neuronal injury.  A low likelihood of MCI 
due to AD requires the absence of Aβ and neuronal injury biomarkers.  An uninformative 
situation of MCI due to AD usually occurs when obtained biomarker information is 
indeterminate, such that biomarker absence/presence is inconclusive.  Interestingly, individuals 
that fall within this category have the typical presentation of individuals who are at an increased 
risk of progressing to AD.  An uninformative situation of MCI due to AD also includes cases 
where biomarkers were not tested such as in the core clinical criteria – which is still consistent 
with the possibility that individuals with MCI have underlying AD pathology (Albert et al., 
2011).  Recently, Vos and colleagues (2015) examined the proposed biomarker framework to 
determine how accurately it assessed and predicted progression from MCI to AD and found the 
refined model to have a greater sensitivity and specificity compared to prior criteria and therefore 
recommend the implementation of such in clinical settings. 
 Mitchell and Shiri-Feshki (2009) found that in specialty settings (clinics, hospitals), rates 
of conversion from MCI to dementia were 39.2%, and in the general population samples rates of 
conversion were 21.9%.  A review by Ward and colleagues (2012) found that the prevalence of 
MCI ranged from 3% to 42% among international studies.  Sachdev and colleagues (2015) 
argued that this wide variation may be due to differences in the definition and methodology of 
identifying MCI (e.g., studies vary widely in how they define and quantify objective cognitive 
impairment on neuropsychological assessment).  Sachdev and colleagues (2015) aimed to apply 
a uniform diagnostic criterion, to produce more reliable estimations of MCI prevalence across 
different geographical and ethnocultural regions.  By applying more uniform criteria, which 
utilized a broad spectrum of neuropsychological tests, they found that the prevalence of MCI 
ranged from 6%-12%, which was greatly reduced from prior assessments.  Moreover, prevalence 
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of MCI increased with age but was unaffected by sex and prevalence of aMCI and naMCI was 
2.0% and 3.9%, respectively.  These values are more closely aligned with the worldwide 
prevalence rates of AD and suggest that use of a full neuropsychological test battery leads to 
more accurate diagnosis of MCI.  
 
Neuropsychological Assessment 
 Here we focus on the core clinical criteria for MCI, which do not depend on the inclusion 
of biomarker testing.  MCI is typically diagnosed following neuropsychological assessment, 
which involves an in-person evaluation of specific cognitive abilities such as episodic memory, 
executive functioning, language/verbal ability, visuospatial skills, attention and processing speed 
(Weintraub et al., 2012) and applying a cutoff (usually 1.5 or more standard deviations below 
normative means on at least one measure.  Episodic memory tasks generally tap how new 
information is learned, stored, and retrieved (Derby et al., 2012; Weintraub et al., 2012).  
Commonly used measures include list-learning tests such as the Free and Cued Selective 
Reminding Task (Grober & Buschke, 1987) or story memory such as the Logical Memory 
Subtests of the Wechsler Memory Scale (WMS–IV; Wechsler, 2009).  Tests of executive 
functioning tap higher-level cognitive abilities such as executing complex mental tasks that 
require initiation, planning, sequencing, set-shifting, flexibility, sustained attention, resistance to 
interference, and the manipulation of new information (Chan, Shum, Toulopoulou, & Chen, 
2008; Weintraub et al., 2012).  Commonly used tests include the Wisconsin Card Sort Test 
(Heaton, Chelune, Talley, Kay, & Curtiss, 1993), Stroop Color-Word Test (Golden, 1978) and 
Trail Making Test Part B (Army Individual Test Battery, 1944).  Neuropsychological tests of 
language and verbal ability tap general knowledge of facts, concepts, and the ability to name or 
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report the meaning of words (Lezak, Howieson, Bigler, & Tranel, 2012; Weintraub et al., 2012).  
The Boston Naming Test (Kaplan, Goodglass & Weintraub, 1983), for example, measures 
confrontational word retrieval while category (Monsch et al., 1992) and letter fluency (Benton & 
Hamsher, 1989) tests assess the ability to produce words under specific phonemic or semantic 
constraints.  Visuospatial tasks tap visual information processing skills (Weintraub et al., 2012) 
such as the ability to draw a clock from memory and set the time correctly (i.e., Clock Drawing 
Test, Shulman & Gold, 1993) or hands-on block assembly with provision of a visual model (e.g., 
Block Design, Wechsler, 2008).  Tests of attention and processing speed tap into the ability to 
focus and sustain attention and capture the time it takes to perceive information (typically 
through visual and auditory channels), process information and/or formulate or enact a response 
(Weintraub et al., 2012).  Commonly used measures of attention and processing speed include 
the Digit Span (auditory) and Digit Coding (visual) subtests from the Wechsler Adult 
Intelligence Scale (WAIS–IV; Wechsler, 2008) and the Trail Making Test Part A (Army 
Individual Test Battery, 1944).  
 The above neuropsychological tests are generally administered under standardized 
laboratory conditions and require varying amounts of time to administer and score (Lezak et al., 
2012).  As an alternative to lengthy evaluations that enable the characterization of specific 
patterns of cognitive strengths and weaknesses, clinicians sometimes use brief assessment tools 
such as the Mini Mental State Exam (MMSE; Folstein, Folstein & McHugh, 1975) and the 
Blessed Information–Memory-Concentration test (BIMC; Blessed, Tomlinson & Roth, 1968) to 
screen for cognitive disorders.  The MMSE is a 30-item test that assesses orientation, registration 
and recall of three words, attention and calculation, language, and constructional praxis and takes 
about 10 minutes to administer.  The BIMC is a 33-item test that assesses orientation, long-term 
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memory (by assessing the ability to recollect information of both personal and non-personal 
significance), recall, and concentration and also takes about 10 minutes to administer. Not 
surprisingly, as measures of global cognition, the MMSE and BIMC are highly correlated (Thal, 
Grundman & Golden, 1986). 
 The literature on MCI is notable for varied measurement approaches in terms of the way 
objective and subjective memory are assessed and operationalized (including cutoffs for 
impairment) and lack of stability in the diagnostic entity itself.  In fact, research on MCI has 
generally concluded that there is no “gold standard” test battery.  Many individuals diagnosed 
with MCI remain stable or revert to normal cognitive status on longitudinal follow-up (Baerresen 
et al., 2015; Belleville, Gauthier, Lepage, Kergoat & Gilbert, 2014; Bondi et al., 2014; Bondi & 
Smith, 2014; Forlenza, Diniz, Stella, Teixeira & Gattaz, 2013; Klekociuk, Summers, Vickers & 
Summers, 2014; Petersen et al., 2014; Roberts et al., 2014).  Moreover, due to the complex 
nature of correctly classifying MCI, predicting the transition from normal cognitive function is 
also difficult. Generally, researchers agree that multiple cognitive domains should be assessed to 
enhance prediction of decline.  As discussed in detail below, within-person change over time also 
can be utilized to identify trajectories of decline as opposed to simple comparisons to group 
norms (Baerresen et al., 2015; Belleville et al., 2014; Bondi et al., 2014; Bondi & Smith, 2014; 
Forlenza et al., 2013; Klekociuk et al., 2014).  
 
Preclinical AD 
 Bondi and colleagues (2008) described a preclinical AD condition that may be a stage 
prior to MCI, which is characterized by subtle cognitive decline but not necessarily impairment.  
They reviewed 91 studies of neuropsychological functioning and neuroimaging and found 
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preclinical AD to be characterized by subtle deficits in a broad range of neuropsychological 
domains (learning and memory, executive functioning, processing speed, attention and semantic 
knowledge).  A meta-analysis of 47 studies by Backman and colleagues (2005) found preclinical 
deficits in global cognition, episodic memory, perceptual speed and executive function best 
discriminated subjects who developed AD from those who remained non-demented.  They 
concluded that it would be beneficial to use a broad range of tests to improve the stability and 
reliability of diagnosis.  In addition, a study by Bennett and colleagues (2006) examining autopsy 
results showed that MCI patients exhibit substantial AD pathology but preclinical AD patients 
exhibit only minor AD pathology.  This suggests that individuals with MCI may be closer to AD 
than previously thought and that it may be beneficial to assess cognition even before clinical 
manifestation of impairment at MCI develops.  And, there may exist several potential markers of 
a prodromal period of AD, in which specific cognitive and biomarker changes precede the 
clinical manifestations (Bondi et al., 2008) 
 Chao and colleagues (2010) further investigated the possible preclinical AD stage 
through examination of volumetric and metabolite differences in individuals characterized as 
cognitively healthy, pre-MCI and MCI.  Despite significant structural MRI differences that 
differentiated between cognitively healthy and pre-MCI, there were no significant verbal 
episodic memory, visual memory, semantic memory, executive function or MMSE differences 
between pre-MCI and cognitively healthy subjects.  Although the sample sizes for each group 
were small, these findings lend support to the theory that changes in brain pathology can exist 
before symptomatic/measurable cognitive changes are present (Chao et al., 2010).   
 Sperling and colleagues (2011) observed that individuals who had evidence of amyloid 
accumulation on PET scans in early AD but who did not meet clinical criteria for MCI were at 
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risk for progression to AD.  These individuals demonstrated very subtle decline but did not meet 
standardized criteria for MCI diagnosis and might be classified as “Not normal, not MCI” 
(though they warrant inclusion under the rubric of preclinical AD). It is imperative to further 
study these preclinical/prodromal stages of AD because they represent the initial emergence of 
clinical impairment when individuals could benefit most from early intervention (Sperling et al., 
2011).   
 The NIA-AA recognized preclinical AD (pre-MCI) as an asymptomatic phase in which 
individuals are classified as cognitively normal but have biomarkers associated with AD and 
possible subtle cognitive decline which has not been quantified (Sperling et al., 2011).  Edmonds 
and colleagues (2015) aimed to define “subtle cognitive decline” and the association to 
biomarker abnormalities.  Within a group of cognitively normal participants, subtle cognitive 
decline was defined as impaired scores in two out of the six neuropsychological measures (in 
different domains) administered.  Of the participants that displayed subtle cognitive decline, 75% 
showed evidence for biomarker abnormalities (amyloidosis and/or neurodegeneration).  
Interestingly, biomarker evidence of amyloidosis plus neurodegeneration or neurodegeneration 
alone were the most common among individuals with subtle cognitive decline.  These findings 
suggest that most individuals did not follow the amyloid cascade hypothesis, which presents as 
amyloidosis, followed by neurodegeneration, followed by subtle cognitive decline (Jack et al., 
2010; Jack et al., 2013).  Instead, Edmonds and colleagues (2015) showed that 
neurodegeneration and subtle cognitive decline can present concurrently without amyloidosis 
and there are also individuals with subtle cognitive decline that have no biomarker presence but 
still transition to MCI.  Traditionally, subtle cognitive decline has been viewed as the last marker 
to be affected in preclinical AD but that may be a result of insensitive measures that are unable to 
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detect slight variations in cognition.  More sensitive measures may be able to capture subtle 
cognitive change and thus enhance the ability to fully characterize the preclinical stage of AD 
and better predict transitions to MCI and AD.   
 
Trajectory of Cognitive Decline 
 It is imperative to delineate the neuropsychological trajectory from normal cognitive 
aging to MCI to dementia and variables that influence progression.  Forlenza and colleagues 
(2013) observed that impairments in memory (amnestic MCI-single domain) emerged as the 
most common path to AD followed by impairments in memory and executive function (amnestic 
MCI-multiple domain).  Bondi and colleagues (2014) examined the diagnostic progression of 
participants with MCI using conventional techniques and cluster analysis.  Within the MCI 
group, three impaired domains emerged from the cluster analyses: amnestic, dysexecutive/mixed 
and language deficits.  Using the development of AD as the external referent, 30.3% of MCI 
participants progressed to AD and 4.2% reverted to cognitively normal.  Using subgroups 
defined by cluster analysis, 49% of the MCI group progressed to AD and less than 1% reverted 
to cognitively normal, which indicates that groups defined by cluster analysis were classified 
better than using conventional techniques.   Although Bondi and colleagues (2014) had a group 
of cognitively normal participants, they did not assess the outcomes of these individuals, such as 
transitioning to MCI or remaining normal (i.e. stable).  Therefore, we are unable to determine 
how reliable the cluster analysis approach is when examining the progression from healthy to 
MCI to AD, and how early impairment within those clusters manifest.  Research examining 
impairment in specific domains could lead to a more reliable, stable and possible earlier 
diagnosis of MCI.   
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 Klekociuk and colleagues (2014) aimed to reduce false positive MCI diagnoses over 
time.  Participants were assessed at three different time points using varying neuropsychological 
tests across different domains and were classified as either MCI or unimpaired.  MCI and 
unimpaired participants were monitored over time to assess whether they remained stable (i.e. 
MCI to MCI or unimpaired to unimpaired) in their classification or changed classification (i.e. 
MCI to unimpaired or unimpaired to MCI).  Results showed that 80% of MCI and 88% of 
unimpaired were correctly classified and the groups remained stable over time.  These findings 
suggest that tapping multiple cognitive domains is beneficial when attempting to reliably classify 
and differentiate between MCI and unimpaired older adults (Klekociuk et al., 2014). 
 Tarnanas, Tsolaki, Nef, Müri, and Mosimann (2014) examined cognition using a virtual-
reality computer-based simulation that assessed executive function, prospective memory, and 
reasoning.  Computerized tests offer many advantages such as standardized formatting as well as 
precise recording of accuracy and speed of responses.  The authors utilized a computerized task 
in addition to standard neuropsychological assessment to predict the progression of MCI to AD.  
The computerized task strongly discriminated between MCI-progressor and MCI-stable and also 
between MCI-progressor and healthy elderly; specifically MCI-progressor and MCI-stable 
exhibited poorer executive function task performance compared to healthy elderly (Tarnanas et 
al., 2014).  The authors failed to utilize a time component in their study thus not allowing for 
information about processing speed to be addressed.  Using a computer-based 
neuropsychological test in addition to speed of performance could optimize the early diagnosis 
of AD compared to other techniques. 
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Within-Person Assessments 
 Storandt, Grant, Miller and Morris (2006) examined individuals with MCI and preclinical 
MCI (participants who were insufficiently impaired to meet MCI classification) across multiple 
cognitive domains at different time periods to compare the rate of cognitive decline between 
groups.  They found that the rate of decline for the MCI group was faster than for the pre-MCI 
group across all domains.  Storandt and colleagues (2006) further proposed that individuals with 
MCI represent an early stage of AD and those with preclinical MCI have subtle cognitive 
changes detected through within-person (intraindividual) differences (accounting for why the 
pre-MCI group declined slower than the MCI group).  Perhaps the combination of early 
biomarkers and clinical measures of cognitive decline over time may aid in diagnosing 
progression to AD at the early onset of decline (Storandt, Grant, Miller, & Morris, 2006). 
 Serial evaluations that examine change over time can be used to establish whether 
cognitive performance is impaired beyond what is expected for an individual given his or her 
demographic characteristics (Albert et al., 2011).  Within-person or intraindividual assessments 
can be made over various time periods.  Longitudinal studies often assess individuals annually.  
At the other extreme, multiple assessments can be made during one testing session.  By assessing 
within person cognitive change, it may be possible to identify even earlier stages of cognitive 
decline (Tarawneh & Holtzman, 2012).  Intraindividual variability has been used to characterize 
cognitive impairment in the elderly but has not been fully explored for its diagnostic capabilities.   
 
Intraindividual Variability 
 Variability in one’s performance over short periods of time could indicate neural 
dysfunction not typically assessed with traditional testing methods. Inconsistency in 
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performance, for example, could be an early marker of loss of neural integrity, which is 
represented by compromised regulation and coordination of neural networks (Macdonald, Li & 
Backman, 2009).  Exploring measures of intraindividual variability (IIV) in reaction time tasks 
of sufficient complexity may facilitate identification of subclinical cognitive impairment before 
decline across a broad range of cognitive domains become apparent.  MacDonald and colleagues 
(2009) proposed that increased IIV could reflect endogenous neural changes underlying 
cognitive deficits.  IIV measured over short time intervals, such as block-to-block fluctuations in 
reaction time tasks, may represent endogenous sources that underlie cognitive variability and 
therefore may capture aspects of neural functioning such as changes in the efficiency of 
neurotransmitters previously concealed.  Reduction in neurotransmitters may give rise to 
increased neural noise and present as increased IIV in cognitive performance.  In addition, 
increased fluctuation in performance could indicate diminished stability of performance over 
time resulting in maladaptive outcomes (MacDonald et al., 2009).   
 IIV can be defined as the variability or inconsistency of performance of a single person 
across repeated blocks of a task during a single testing occasion (Gorus, De Raedt, Lambert, 
Lemper, & Mets, 2008; Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000).  IIV 
has also been characterized as variability of performance of a single person across different tasks 
within a single testing session (Tractenberg & Pietrzak, 2011).  There are multiple methods for 
measuring IIV: (1) intraindividual standard deviation (i.e., computed standard deviation for items 
or for standardized test scores per person; ISD), (2) coefficient of variation (i.e., standard 
deviation divided by mean, either over all items or over standardized test scores; ICV), and (3) 
level-independent variation (i.e., variability independent of an individual’s predicted mean score; 
LIV) (Tractenberg & Pietrzak, 2011).  These methods of measuring IIV are primarily used in the 
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context of reaction time tasks that measure speed of performance as opposed to accuracy of 
performance.  IIV has shown some utility in differentiating between diagnostic groups (within 
elderly populations), more so than conventional measures of accuracy alone (Bielak, Hultsch, 
Strauss, MacDonald & Hunter, 2010a; Dixon et al., 2007; Ramratan et al., 2012).  However, to 
date, no single method of measuring IIV has been established as the optimal approach for 
examining cognitive dysfunction within the elderly population (Bielak et al., 2010a; Dixon et al., 
2007; Ramratan et al., 2012; Tractenberg & Pietrzak, 2011). 
 Tractenberg and Pietrzak (2011) compared effect sizes on three different measures of IIV 
(listed above) for the MMSE and Clock Drawing Test to effect sizes for the total score of these 
tests.  Effect sizes were based on 500 simulated observations for individuals characterized as 
normal, MCI, or AD.  For all group comparisons, there were greater IIV effect sizes for the 
MMSE than the Clock Drawing test.  In addition, stronger ISD effect sizes were present for the 
Clock Drawing test while stronger ICV effect sizes for the MMSE were present.  IIV was also 
indicated to be a stronger predictor of change in Clinical Dementia Rating (a global clinical 
measure that assesses overall cognitive functioning) scores.  Stronger effect sizes were present 
when evaluating IIV in the MMSE and Clock Drawing tests, indicating that IIV measures were 
useful as an alternative performance summary (compared to total test scores).  While this study 
provided preliminary evidence that IIV measures can be used to provide information on test 
performance, it did not specifically evaluate IIV measures for their ability to correctly classify 
diagnostic group membership.  Also, the tests used were not reaction time tasks; rather, they 
were estimates of global cognition, a method not typically used in IIV assessment. 
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IIV used to Distinguish Cognitive Outcome 
 Researchers commonly examine IIV using simple and complex multi-block reaction time 
tasks among participants in various stages of cognitive decline, including multiple subtypes of 
MCI, and mild dementia (Christensen et al., 2005; Dixon et al., 2007; Gorus et al., 2008; Hultsch 
et al., 2000).  In general, individuals with mild dementia or MCI (with or without amnestic 
impairment) have displayed poorer accuracy, higher reaction times, and increased IIV on simple 
and complex multi-block reaction time tasks (Christensen et al., 2005; Dixon et al., 2007; Gorus 
et al., 2008; Hultsch et al., 2000).  Researchers have also suggested that IIV on reaction time 
tasks may enhance diagnostic accuracy or the ability to detect neuropathological changes before 
rapid change across a range of cognitive domains becomes apparent (Christensen et al., 2005; 
Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000).   
 Christensen et al. (2005) examined older adults (aged 60-64) who were cognitively 
impaired compared to healthy older adults without cognitive impairment.  The authors calculated 
the mean independent variability for reaction time tasks and found greater IIV in the cognitively 
impaired group compared to healthy controls, but increased IIV did not uniquely contribute to 
diagnostic status.  Also, group differences in reaction time tasks were more pronounced for the 
simple task rather than the complex task, which was an unexpected finding given that increased 
complexity typically correlates with poorer performance (Christensen et al., 2005).  The complex 
task was a slight variation of the simple task and thus may not have tapped into higher-order 
functioning normally reserved for complex tasks.  Therefore, performance in the simple task 
would generate larger variability than the complex task due to the initial novelty of the task.    
 Dixon and colleagues (2007) further investigated levels of cognitive impairment (mild 
versus moderate), assessing speed across five separate occasions utilizing three multi-block 
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reaction time tasks.  Cognitively impaired groups were slower and more variable (greater ISD) 
than the non-impaired groups, with MCI-moderate more so than the MCI-mild subgroup.  
Further, the researchers were able to use these measures to distinguish between the MCI and 
non-impaired groups.  The authors concluded that neurocognitive resources may be 
compromised during the transition from normal aging to mild impairment and that greater IIV 
may be indicative of compromised cognition (Dixon et al., 2007). 
 Gorus and colleagues (2008) found that individuals with AD had greater ICV compared 
to aMCI and healthy controls regardless of task complexity, and those with aMCI had greater 
ICV only when performing complex tasks—as compared to healthy elderly controls.  This may 
indicate that task complexity influences performance beyond simple reaction time measurements 
(as noted in Christensen et al., 2005), and this should be considered when designing tasks for 
aMCI individuals.  Accuracy was also examined and was significantly higher for the aMCI and 
cognitive healthy groups compared to those with AD, but there was no significant difference 
between the aMCI and cognitively healthy groups; accuracy therefore did not contribute 
meaningfully to group identification (Gorus et al., 2008).   
 Ramratan and colleagues (2012) utilized a novel technique to examine IIV within-
session.  Using a computer-based repeated-blocks episodic memory task, the researchers 
examined episodic memory in addition to reaction time, which was an improvement on extant 
research that explored the two modals separately.  As expected, the cognitively healthy elderly 
group performed better than the aMCI group in terms of both greater accuracy and faster 
processing.  The researchers also used the unique approach of exploring trajectory of change 
across blocks to measure IIV.  By doing so, they found that although cognitively healthy elderly 
and aMCI had similar trajectories of performance in accuracy, greater IIV in processing speed 
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across blocks in aMCI indicated that IIV in processing speed classified aMCI better than 
traditional cognitive measures.  The authors did not extend their findings to examine 
performance across-session to see if the trajectory of performance was still present over longer 
periods of time.    
 
IIV Across-Domains 
 Allaire and Marsiske (2005) examined within-person IIV in cognitive tests across 
multiple testing sessions in cognitively healthy older adults.  The researchers investigated IIV 
utilizing tests of inductive reasoning, processing speed and memory and found higher IIV to be 
positively correlated only between memory and inductive reasoning.  IIV across all cognitive 
measures were not inter-related suggesting that IIV may not be a consistent phenomenon across 
all domains.  Allaire and Marsiske (2005) also found within-person performance across-sessions 
exhibited low variability for all tasks, while mean level of performance increased across-sessions 
for all measures.  This suggests adaptive IIV in which there is improvement over time as a result 
of repeated assessment and may reflect individuals’ active testing of new performance strategies 
(Allaire & Marsiske, 2005). While this study introduced the idea of examining IIV across 
different domains, only one test in each domain was examined, therefore not allowing for 
generalizability.  Additionally, the use of multiple testing occasions as a methodology provided 
insight to performance over time, but since the testing was self-administered and not strictly 
monitored by the researchers the quality of the data could be questioned. 
 Kalin and colleagues (2014) examined IIV in accuracy tests within-domain and across-
domains in healthy controls, MCI and AD.  To examine within-domain accuracy, the researchers 
used scores from the Letter Fluency task, Stroop test, and Five Point test (a figural fluency task).  
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To examine across-domain accuracy, the researchers used scores from the Digit Span, Word List 
Learning and Category Fluency task.  Results indicated that within-domain, ISD was greater in 
the AD group compared to healthy controls, but there was no difference between the AD and 
MCI groups.  There was also slightly higher ISD in the MCI group compared to healthy controls.  
Across-domain ISD was higher in the AD group compared to the MCI and healthy controls but 
there was no difference between the healthy controls and MCI groups.  These findings suggest 
that even at the level of accuracy, differences between groups can be observed, but accuracy 
alone is unable to distinguish changes between healthy controls and MCI.   
 Vaughan and colleagues (2013) investigated IIV across-domains and change in 
performance over time to predict risk of MCI and incident dementia in individuals classified as 
no impairment, MCI, and probable dementia.  In the overall sample, there was no significant 
difference in across-domain ISD between individuals with no impairment compared to MCI, but 
significant differences were present between individuals with no impairment compared to 
probable dementia.  Change in performance over time differed significantly between individuals 
with no impairment compared to MCI or probable dementia.  After controlling for baseline 
cognition, IIV across-domain was also predictive of incident dementia, but not MCI.  Also, 
change over time was predictive of MCI and probable dementia.  The authors concluded that the 
change in performance over time is particularly important in signaling the risk of incident 
cognitive impairment, especially in the early stages (Vaughan et al., 2013).   
 
IIV as a Predictor of Cognitive Outcome 
 Hultsch and colleagues (2000) used across-block IIV in reaction time tasks to predict 
group membership between healthy older adults and older adults with possible/probable AD.  
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The AD group had greater ISD and ICV in reaction time across blocks as compared to the 
healthy group, but there were no significant difference between groups across multiple testing 
sessions.  The researchers did not examine accuracy across blocks but did examine accuracy 
across-sessions for non-reaction time tasks and found no significant effects between groups.  
They also noted that ISD in reaction time across-blocks most consistently predicted group 
membership (Hultsch et al., 2000).  It would be interesting to observe whether accuracy across-
blocks also differed between groups, thus facilitating the determination of learning and retention 
patterns in various older adult subgroups and prediction of group membership.   
 Bielak and colleagues (2010a) examined IIV on reaction time tasks over multiple 
sessions for cognitively impaired and non-impaired individuals.  They found that ISD for all 
reaction time tasks was able to predict cognitive status change, but only ISD on complex tasks 
distinguished between groups.  These findings suggested that higher-order cognitive processes 
required to complete complex tasks are a reflection of the integrity of the neurological system 
and may serve as a sensitive predictor of meaningful cognitive change (Bielak et al., 2010a).  
Bielak, Hultsch, Strauss, MacDonald and Hunter (2010b) further investigated IIV across-
sessions to determine whether baseline IIV could be a predictor of subsequent cognitive decline.  
Tests were administered annually for four years and evaluated to determine if significant change 
in cognition or inconsistency in performance occurred.  In general, greater baseline ISD was 
associated with declining cognitive performance.  Also, baseline ISD, specifically complex task 
ISD, was related to later cognitive performance such that as ISD values increased, participants’ 
subsequent cognitive performance decreased.  These findings suggest that baseline ISD across-
session can be an independent predictor of the development of subsequent cognition decline in 
the elderly.   
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 In conclusion, there is a strong need to improve upon the quantitative assessment of 
prodromal AD stages such as MCI and possible pre-MCI conditions.  The extant literature 
suggests that IIV may be a valuable and sensitive measure to distinguish among cognitively 
unimpaired and impaired older adults.  Also, research with IIV has demonstrated some strength 
in predicting cognitive decline.  Within-session and across-domain testing measures have both 
provided useful information in characterizing cognition in the elderly.  Further research is 
required, however, to clarify the role of IIV in cognitive impairment and decline in the elderly.  
Ideally, IIV can be used to distinguish early changes that conventional neuropsychological tests 
have been unable to capture.  To measure the efficacy of IIV as a predictor of cognitive decline 
in the elderly, it is necessary to execute a study that utilizes the IIV measure to its full potential. 
 
Current Study 
 The current research investigated the role of IIV in the prediction of neurodegenerative 
cognitive impairment.  IIV is thought to be an indicator of neurological integrity where increased 
fluctuation in performance may be indicative of brain disturbance or compromised neurological 
mechanisms (Bielak et al., 2010a; Hultsch et al., 2000).  Short-term fluctuations in performance 
could be a marker for long-term cognitive change and potential decline (Bielak et al., 2010b).   
Thus, IIV may serve an important role in identifying older adults who are at the greatest risk for 
future cognitive decline (Sugarman et al., 2014).  Recently, a study by Roalf and colleagues 
(2016) examined global neurocognitive performance in addition to across-domain IIV and found 
the combination of variables to significantly improved diagnostic classification of MCI 
compared to utilizing global neurocognitive performance alone.  They suggested that IIV may 
reflect domain specific deterioration of cognitive performance and inconsistency across domains 
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may be an important signal of overall deterioration of the neural system.  Sugarman and 
colleagues (2014) examined within-domain IIV in relation to neuropsychological performance 
and also found that the combination of IIV and neuropsychological scores improved the 
prediction of cognitive decline.  In fact, IIV variables alone were able to predict cognitive 
decline better than traditional measures alone and could therefore serve as a prognostic indicator 
of future cognitive decline (Sugarman et al., 2014).  IIV could then be useful if incorporated 
within cognitive assessments aimed at detecting subtle changes in performance in older adults 
with overall “intact” cognitive functioning and preserved activities of daily living.  
 For the current study, we examined IIV using two different methods: across multiple 
blocks within one testing session (within-session) and within-session across-domains, to examine 
the effectiveness of these two methods for early detection in a sample of community-dwelling 
older adults who were non-demented at baseline.  The primary hypothesis was that IIV within-
session would be a stronger predictor of cognitive impairment than conventional 
neuropsychological tests.  It was further hypothesized that within-session across-domain 
variability would enhance understanding of how cognitive decline manifests in a healthy 
population.  Additionally, IIV within-session will aid in early detection of cognitive impairment 
compared to traditional neuropsychological tests. 
 
Study Rationale & Aims 
 Overall Objective: To determine whether experimental task intraindividual 
variability measures have greater efficacy at characterizing and predicting future MCI 
group status than conventional standard task measures.  Given the prevalence of AD, 
research has focused on developing methods to detect and treat the disease at its earliest point. 
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Research described above has shown that there is no “gold standard” for assessing MCI and 
determining who will decline from normal cognition to MCI and subsequent AD based on 
traditional cognitive tests.  A possible alternative to standard tests are tasks that examine 
variability in performance over time, which permit the evaluation of change over short periods of 
time between cognitively impaired and non-impaired groups.  Increases in intraindividual 
variability co-vary with cognitive changes occurring within a short period of time therefore 
intraindividual variability may be sensitive to even subtle changes of cognitive decline (Bielak et 
al. 2010a; Bielak et al., 2010b).  Therefore, this type of assessment could enhance detection of 
subtle cognitive impairment and prediction of future cognitive decline.   
 Preliminary analyses to determine whether within-domain baseline experimental 
task measures (each block) compared to the within-domain baseline standard task measure 
characterized future MCI group status.  Prior studies have shown that differences between 
MCI and HC groups exist at baseline.  We need to first establish that there are baseline 
differences between future MCI and HC groups on experimental and standard tasks.  We 
hypothesized that within each cognitive domain (episodic memory, processing speed, executive 
function), future MCI participants would exhibit poorer performance at baseline for the 
experimental and standard tasks.  We also hypothesized that the experimental task measures (at 
each block) would be better at discriminating between future MCI and HC groups compared to 
the standard task measure. 
 Preliminary analyses to determine whether within-domain baseline experimental 
task measures (across-block) characterized future MCI group status.  Research has shown 
that performance on multi-block tasks can be used to monitor change over time (Ramratan et al., 
2012; Tarnanas et al., 2014).  Change over time, or trajectory of performance, can be used to 
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discriminate between cognitively impaired and non-impaired groups as well.  We therefore need 
to establish that there is some change of performance over time for the experimental tasks.  We 
hypothesized within each cognitive domain (episodic memory, processing speed, executive 
function), future MCI participants would exhibit poorer across-block performance at baseline.  
We also hypothesized that the experimental task measures across-block would be able to 
discriminate between future MCI and HC groups. 
 Aim I: Determine whether within-domain baseline experimental task 
intraindividual variability measures compared to the within-domain baseline standard task 
measure characterized future MCI group status.  Multiple studies have shown that 
intraindividual variability can be used to distinguish between impaired and cognitively healthy 
groups (Christensen et al., 2005; Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000), but 
there has been limited success examining the ability of intraindividual variability to characterize 
future cognitive impairment, which may be due to insufficient task complexity that can capture 
subtle changes in cognition.  We hypothesized that within each cognitive domain (episodic 
memory, processing speed, executive function), future MCI participants would exhibit greater 
intraindividual variability at baseline for experimental task variability measures.  We also 
hypothesized that experimental task intraindividual variability measures would be better at 
discriminating between MCI and HC groups compared to the standard task measure. 
 Aim II: Determine whether within-domain baseline experimental task 
intraindividual variability measures compared to the within-domain baseline standard task 
measure predicted future MCI group status.  Prior studies (Bielak et al., 2010a; Hultsch et al., 
2000) have shown that intraindividual variability in reaction time tasks can be utilized to predict 
cognitive group membership.  We hypothesized that within each cognitive domain (episodic 
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memory, processing speed, executive function), baseline experimental task intraindividual 
variability measures would be able to predict future MCI group status.  We also hypothesized 
that baseline experimental task intraindividual variability measures would have greater efficacy 
at predicting future MCI group status compared to the standard task measure.    
 Aim III: Determine whether across-domain baseline experimental task 
intraindividual variability measures compared to across-domain baseline standard task 
measures characterized future MCI group status.  Research has revealed that across-domain 
intraindividual variability has the ability to be used to differentiate healthy cognition from 
dementia (Kalin et al., 2014; Vaughan et al., 2013).  We aimed to discover if across-domain 
intraindividual variability could be used to differentiate healthy cognition from MCI.  We 
hypothesized that across-domain (episodic memory, processing speed, executive function) 
intraindividual variability would be able to distinguish between the cognitive outcome groups of 
future MCI and HC.  We also hypothesized that across-domain baseline experimental task 
intraindividual variability measures would be able to classifying future MCI group status better 
than across-domain baseline standard task measures.   
 Aim IV: Determine whether across-domain baseline experimental task 
intraindividual variability measures compared to across-domain baseline standard task 
measures predicted future MCI group status at different time points.  There has been 
limited research investigating whether across-domain baseline intraindividual variability can be 
used to predict MCI group status at different time points.  We investigated cognitive decline at 
different time points to determine the earliest intervention stage for MCI.  We hypothesized that 
across-domain baseline experimental task intraindividual variability measures would be able to 
predict MCI at different time points.  We also hypothesized that across-domain baseline 
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experimental task intraindividual variability measures could be used to predict future MCI group 
status sooner than across-domain baseline standard task measures. 
 
Methods 
Participants 
 Participants were a subset of individuals drawn from the Einstein Aging Study (EAS), a 
longitudinal community-based study of aging of individuals 70 years and older residing in the 
Bronx, NY (Katz et al., 2012).  Since 2004, EAS participants have been recruited from the New 
York City Board of Elections-registered voter lists for Bronx County. Therefore, the sample was 
representative of the community.  Introductory letters were sent describing the study to those 70 
years and older and these individuals were then contacted by telephone to complete a brief 
screening interview (Katz et al., 2012).  Potential participants who met initial eligibility were 
invited for additional on-site screening to establish final eligibility. Participants who reported 
severe sensory loss or medical conditions that would interfere with completion of 
neuropsychological assessment were excluded.  The EAS was approved by the local institutional 
review board (IRB) and all participants provided written informed consent.   
 Data for the current study were collected as part of the aforementioned cohort study and 
represent a subset of the larger EAS study (i.e., those recruited/enrolled into the EAS between 
2005 and 2012 who completed their first and second visits).  The current study was approved by 
the local IRB and participants provided prior written informed consent.  There were 
approximately 250-400 participants (depending upon analyses).   
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Procedure 
 EAS participants completed a battery of standard neuropsychological tests along with 
clinical measures on their first visit.  Tasks were administered by highly trained examiners in a 
quiet room following standardized protocols.  Memory was measured using the Free and Cued 
Selective Reminding Test (Grober & Buschke, 1987) and the Logical Memory I subtest from the 
WMS-R (Wechsler, 1987).  Attention was measured using the Trail Making Test Part A (Army 
Individual Test Battery, 1944) and Digit Span subtest of the WAIS-III (Wechsler, 1997). 
Executive function was measured using the Trail Making Test Part B (Army Individual Test 
Battery, 1944) and the Letter Fluency “FAS” task (Benton & Hamsher, 1989).  Visuospatial 
construction was measured using the Block Design subtest and the Digit Symbol subtest from the 
WAIS-III (Wechsler, 1997).  Language was measured using the Category Fluency task (animals, 
vegetables, fruits) (Monsch et al., 1992) and the Boston Naming Test (Kaplan, Goodglass & 
Weintraub, 1983).   
 As noted above, standard neuropsychological tests are frequently used to evaluate 
cognitive performance and assess future likelihood of progressing to AD (though the field lacks a 
single “gold standard” test battery).  Therefore, non-demented participants were invited for a 
second visit where they completed a battery of experimental computer-based neuropsychological 
tasks (these tasks are described in detail below).  The computer-based experimental tasks were 
administered using a Dell Dimension 4500 computer.  The Dell computer ran on a Windows XP, 
2002 operating system.  The 19-inch monitor and keyboard were situated on a desk 30 inches 
high.  The monitor was directly in front of participants during the study.  The keyboard was in 
front of participants only during the exercises that required its use.  The Audio-Technica 
microphone was held by participants at a 45-degree angle, seven inches away from participants’ 
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mouths during the speaking exercise.  The computerized experimental tasks were displayed and 
data recorded using E-Prime software (http://www.pstnet.com/eprime.cfm).  The first and second 
visits where standard and experimental tasks were administered, respectively, were considered 
the baseline measurement stage.  On average, there was a four-week time span between the first 
and second EAS visits.   
 Participants also returned for annual follow-up visits that included both standard 
neuropsychological test assessment and medical examinations.  In addition, participant cognitive 
status (healthy, MCI, dementia) was evaluated annually at a diagnostic case conference attended 
by a study neurologist and neuropsychologist.  Participants who met criteria for dementia, based 
on the Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition-Revised (DSM-IV-
TR; American Psychiatric Association, 2000) were excluded.  Due to the longitudinal design of 
the EAS cohort and goal of maintaining consistent approaches to measurement, the DSM-IV-TR 
was used for clinical diagnosis of dementia where manifestations of cognitive deficits in memory 
and one (or more) other cognitive domains must be present.  These deficits must cause 
significant impairment and represent a significant decline from previous functioning.  The course 
of impairment is characterized by gradual onset and progressive decline not due to other medical 
or psychiatric conditions (American Psychiatric Association, 2000). 
 
Classification Criteria 
 Participants at baseline were healthy elderly with no cognitive or functional impairment.  
Cognitive profile was assessed using error scores on the BIMC.  As noted above, the BIMC is a 
33-item test that assesses orientation, long-term memory, recall and concentration (Blessed, 
Tomlinson & Roth, 1968).  Functional ability was assessed using the Lawton Instrumental 
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Activities of Daily Living Scale (IADL; Lawton & Brody, 1969).  We also assessed depressive 
symptoms using the Geriatric Depression Scale-short form (GDS; Sheikh & Yesavage, 1986), 
cognitive complaint using the Cognitive Impairment Questionnaire of the Consortium to 
Establish a Registry for Alzheimer’s Disease (CERAD; Heyman, Fillenbaum, & Mirra, 1991; 
Heyman, Fillenbaum, & Nash, 1997), and independent living skills using the IADL (Lawton & 
Brody, 1969).  These variables were examined to exclude participants who displayed significant 
symptomology (e.g., clinical depression, compromised IADL) that may interfere with task 
performance.   
 Healthy elderly (HC) were classified using a BIMC score of 3 or less (3 or fewer errors) 
to indicate no cognitive impairment; and no functional impairment was indicated by the IADL 
maximum score of 8 for females and 5 for males.  The representative activities for males were 
reduced in the IADL therefore leading to a lower maximum score for males compared to females 
(Lawton & Brody, 1969).  The outcome of interest was cognitive impairment: MCI.  Two 
classification methods for MCI were employed to prevent diagnostic circularity—i.e., when the 
same or similar tests are used both to classify groups and as the primary outcome variables.  All 
analyses were performed utilizing both MCI classification methods.    
 Classification of MCI (referred to as EAS MCI) followed the typical methodology 
reported in Katz et al. (2012), in which the domains of memory, attention, executive function, 
visuospatial construction, and language were assessed utilizing two tests for each domain. 
Diagnosis of EAS MCI consisted of objective cognitive impairment (impairment in one or more 
cognitive domains, as defined by 1.5 standard deviations below the age-adjusted mean on the 
two tests). In addition, participants must have a subjective cognitive complaint and little to no 
functional impairment (Albert et al., 2011; Petersen et al., 2014).  Subjective cognitive complaint 
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and little to no functional impairment was ascertained using items from the self- and informant-
report versions of the CERAD (e.g., does the participant have trouble remembering things that 
happened recently; does the participant have trouble finding words in carrying on a conversation; 
does the participant get lost in familiar surroundings). 
 For the current study, the alternative outcome of MCI - referred to as Alternate Criteria 
MCI (AC MCI) was classified using objective cognitive impairment, subjective cognitive 
complaint and little to no functional impairment (Petersen et al., 2014).  Objective cognitive 
impairment was measured using a BIMC score of 4 to 7 where a rate of change of 4 indicated a 
decline from prior non-impaired criteria (Katzman et al., 1988).  IADL scores of 7 or 8 for 
females and 4 or 5 for males were used to indicate little to no functional impairment per standard 
MCI criteria (Albert et al., 2011; Petersen et al., 2014).  Notably, some participants with MCI 
may have mild difficulty performing complex functional tasks, and a one-point decline in IADL 
could capture that change in performance while still preserving daily functionality.  Other 
participants with MCI may have no noticeable change in functionality; therefore, including no 
change in IADL is also acceptable.  Subjective cognitive complaint was ascertained using items 
on the Functional Assessment Staging (FAST; Reisberg, 1988) as indicated by a stage/score of 2 
or 3 (i.e. participant complaints of forgetting location of objects; decreased functioning evident 
to close friend/relative).   
 
Study Measures by Cognitive Domain   
 We now describe both the standard and experimental tasks by cognitive domain. The 
standard neuropsychological tests were administered and scored based on published procedures.  
The experimental (computer-based) tasks were developed by Sliwinski, Smyth, Hofer and 
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Stawski (2006) and Stawski, Sliwinski and Smyth (2006) to measure variability in performance 
over short intervals in older adults.  Short intervals of performance are measured as blocks (or 
trials) of performance and take into account performance for multiple items within that block of 
testing.  Stawski, Sliwinski and Hofer (2013) and Ramratan et al. (2012) demonstrated that these 
experimental tasks provided sensitive measures of intraindividual variability.  All experimental 
tasks independently measured participant performance per block by recording reaction time and 
accuracy.  
 
Episodic Memory Domain Tasks 
Standard task: Free and Cued Selective Reminding Task (FCSRT; Grober & Buschke, 1987) 
 The Free and Cued Selective Reminding Task is a test of verbal cued learning and 
memory that uses an encoding phase to maximize learning and ensure deep semantic processing 
(Grober & Buschke, 1987).  Participants were shown 16 images of objects on a computer screen 
and asked to verbally identify each.  Participants were then presented with the same 16 images 
(four at a time in a 2x2 grid) and asked to identify each item after a categorical prompt. The grid 
was removed and participants were asked to recall the item after being given the same 
categorical cue.  After all items were learned and recalled, participants were then asked to recall 
all 16 items in any order (free-recall).  For items not recalled, the researcher provided the 
category cue for each forgotten item (cued-recall).  This procedure was repeated for three blocks 
and each block was preceded by 20 seconds of counting backwards as a distractor task.  A total 
score of 48 was possible for free-recall.  If the number of items freely recalled totaled 24 or less, 
participants were classified as having memory impairment (Grober & Kawas, 1997; Grober, 
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Lipton, Hall, & Crystal, 2000).  The total number of items freely recalled (free-recall) was used 
for study analyses. 
 
Experimental task: Cued-Recall Retrieval Speed Task (CRRST; Ramratan et al., 2012) 
 The Cued-Recall Retrieval Speed Task is a computer-administered test of verbal learning 
and memory designed to simultaneously measure level and speed of performance over time.  The 
Cued-Recall Retrieval Speed Task had three phases: learning, cued-recall, and post-cued (Figure 
3).  In the learning phase, participants were presented with three words on a computer screen: a 
cue and two possible matching words (one correct and one incorrect).  Participants had 10 
seconds to speak the correct matching word for all 16 cues.  In the cued-recall phase, participants 
were presented with the cue alone and had to recall the correct matching word within a given 
time interval (5 seconds).  Participants spoke their responses into a microphone, which registered 
their reaction time while the examiner recorded whether responses were correct, incorrect, or no 
response was given.  Regardless of type of response given by participants, the correct matching 
word was presented to the participants in the post-cued phase (for 2 seconds), which immediately 
followed the cued-phase.  Each block of the cued-recall phase included the single presentation of 
each of the 16 cues.  There was one block of the learning phase and six blocks of the cued-recall 
and post-cued phases.  Participants provided a total of 96 item responses for the cued-recall 
phase, which was the primary outcome measure of interest.  The E-Prime program recorded 
participants’ reaction times in milliseconds.  Reaction time was measured as the time interval 
between the display of the cue to participants’ correct response for each item.  The examiner 
recorded participants’ accuracy by pressing either the 1, 2, 3 or 4 key on the keyboard.  A “1” 
indicated a correct answer, “2” indicated an incorrect answer, “3” indicated no response and “4” 
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indicated a correct answer but an incorrect response time.  Accuracy was measured as the percent 
correct for each block.  Mean reaction time and accuracy for each block was used for study 
analyses.  Variability was measured as the change in performance in reaction time and accuracy 
across the six blocks.   
 
Processing Speed Domain Tasks 
Standard task: Trail Making Test Part A (TMT-A; Army Individual Test Battery, 1944) 
 The Trail Making Test Part A is a task that requires visual scanning and sustained 
attention.  Participants received a sheet of paper with the numbers 1 through 25 written inside of 
circles that appeared to be randomly placed across the page.  Participants were asked to draw a 
line connecting the circles in numerical order, starting at 1 and ending at 25.  Participants were 
timed and told to complete the task as quickly as possible without making any errors.  Scores 
were generated as the time (recorded in seconds) that it took to complete the task. The number of 
errors was also recorded.  The time recorded was used for study analyses. 
 
Experimental task: Number Match (NM; Sliwinski et al., 2006; Stawski et al., 2006) 
 The Number Match task is a computer-administered test that examines processing speed 
efficiency.  Participants were presented with two rows of three-digit numbers and were asked to 
decide whether the rows of numbers were the same or different from each other, regardless of the 
orientation of the numbers.  If there was a difference, then the rows were considered different.  If 
only the orientation of numbers was different, but all numbers in the top row were present in the 
bottom row, then the rows were considered to be the same (Figure 4).  Participants pressed the 
red key to indicate the rows were different and the green key to indicate that the rows were the 
38 
 
same.  Note that the “backward slash key” had a green sticker over it and the “Z” key had a red 
sticker over it.  This enabled participants to easily recognize which key to tap to indicate a 
response.  For this task, there were two blocks and response time was measured by how quickly 
participants pressed the green or red key for each item within each block.  There were 30 item 
responses for each of the two blocks.  Participants provided a total of 60 item responses, which 
was the primary outcome measure of interest.  Accuracy was measured as the percent correct for 
each block. The mean reaction time and accuracy for each block was used for study analyses.  
Variability was measured as the change in performance in reaction time and accuracy across the 
two blocks.   
 
Executive Function Domain Tasks 
Standard task: Trail Making Test Part B (TMT-B; Army Individual Test Battery, 1944) 
 The Trail Making Test Part B is a test that requires mental planning and examines set 
shifting and flexibility.  Participants received a sheet of paper with circles that had the numbers 1 
through 13 and the letters A through M that appeared to be randomly placed across the page.  
Participants were asked to draw connecting lines between the circles, alternating between 
numbers and letters in order starting at 1 and ending at M (i.e., 1, A, 2, B, 3…L, 13, M).  
Participants were timed and told to complete the task as quickly as possible without making any 
errors.  Scores were generated as the time (recorded in seconds) that it took to complete the task. 
The number of errors was also recorded.  Time recorded was used for study analyses. 
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Experimental task: N-Back 2 (NB2; Sliwinski et al., 2006; Stawski et al., 2006) 
 The N-Back 2 task is a computer-administered test which requires controlled and 
effortful switching of attentional focus from one item to another.  Participants were presented 
with a single number at a time, continuously (Figure 5).  The number was presented for a 
maximum of 2 seconds before the next number was displayed.  Participants were asked to decide 
whether the number they saw was the same or different from two numbers prior.  If the number 
they saw was identical to the number seen two-before (i.e., 2-back), they pressed the green key; 
if the number they saw was different from the number seen two-before (i.e., 2-back), they 
pressed the red key.  As noted above, the “backward slash key” had a green sticker over it and 
the “Z” key had a red sticker over it for this task.  For this task, there were three blocks and 
response time was measured by how quickly participants pressed the green or red key for each 
item in each block.  There were 20 responses for each of the three blocks.  Participants provided 
a total of 60 responses, which was the primary outcome measure of interest.  Accuracy was 
measured as the percent correct for each block. The mean reaction time and accuracy for each 
block was used for study analyses.  Variability was measured as the change in performance in 
reaction time and accuracy across the three blocks.   
 
Testing Measures and Outcome 
 The domains of episodic memory, processing speed and executive function were initially 
examined separately to determine domain specificity for cognitive impairment.  Baseline 
performance on the experimental task measures was compared to baseline performance on the 
standard task measure.  To examine episodic memory, performance on the experimental CRRST 
was compared to performance on the standard FCSRT.  To examine processing speed, 
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performance on the experimental NM task was compared to performance on the standard TMT-
A.  To examine executive function, performance on the experimental NB2 task was compared to 
performance on the standard TMT-B.  Additional analyses to explore across-domain variability 
included tests from all three cognitive domains.  For the standard tasks we recorded the number 
of items correct and/or time to task completion – from here on will be referred to as standard task 
measures.  For the experimental tasks we recorded accuracy and reaction time (RT) for multiple 
blocks – from here on will be referred to as measures.  The repeated-block measurement allowed 
for a calculation of central tendency (mean) and variability (intraindividual standard deviation – 
ISD; intraindividual coefficient of variation – ICV (ISD divided by mean)) across all blocks 
(Table 1).  ISD and ICV measures of variability are widely used in studies examining changes in 
speed of performance between MCI and cognitively healthy participants (Christensen et al., 
2005; Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000).  In addition, basic 
demographics such as age, education, gender and race were recorded and included in all 
analyses.  Tables below describe the sample that comprised each cognitive testing domain. 
 Classification outcomes (Table 2) were examined using three methods: (1) EAS MCI – 
healthy controls (HC) and EAS definition of mild cognitive impairment (MCI); (2) AC MCI – 
HC and alternate criteria of MCI; and (3) EAS MCI3 – HC, EAS definition of amnestic MCI 
(aMCI) and EAS definition of non-amnestic MCI (naMCI).  EAS MCI3 was a partitioning of the 
EAS MCI outcome where within the EAS MCI outcome participants classified as MCI could be 
aMCI or naMCI.  The separation of MCI into aMCI and naMCI in the EAS MCI3 outcome 
allowed for greater specificity of impairment and prediction.  Incidence of MCI occurred at any 
point after the baseline assessment, which ranged from one to ten years after baseline testing. 
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Data Analysis 
 Overall Objective: To determine whether experimental task intraindividual variability 
(IIV) measures have greater efficacy at characterizing and predicting MCI compared to 
conventional standard task measures.  Aims were derived to address the overall objective.  
Specific statistics were used to address each aim.  Separate descriptive measures (Table 1) were 
calculated depending on aim and which domain(s) was/were examined.  IBM SPSS statistical 
software version 20 (IBM Corp., 2011) was used to calculate descriptive statistics and for within-
domain analyses; and R software version 3.2.3 (R Core Team, 2013) was used for across-domain 
analyses.  Analyses using the R software version 3.2.3 were implemented using the ExPosition 
Package (Beaton, Chin Fatt & Abdi, 2014).  Also, for each group of participants, corresponding 
classification rate of study-criteria healthy controls compared to EAS criteria of healthy/non-
impaired elderly at baseline were calculated.  The study-criteria group classification of healthy 
controls was implemented to avoid circularity.  In addition, each aim was also examined using an 
alternate outcome definition in order to avoid circularity.   
 Preliminary analyses: To determine whether within-domain baseline experimental task 
measures compared to the within-domain baseline standard task measure characterized future 
MCI group status.  Preliminary analyses were performed using a Multivariate Analysis of 
Variance (MANOVA) to determine whether within-domain baseline experimental task measures 
(at each block) characterized future MCI group status compared to the within-domain baseline 
standard task measure.  MANOVA examined whether differences between group means were 
present.  Levene’s test was conducted to test for homogeneity of variance.  If Levene’s test was 
significant, it was indicative of unequal variances between groups and a more robust test should 
be used that does not rely on equal variances.  If Levene’s test was significant, the Welch 
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ANOVA was implemented; if Levene’s test was not significant, then we can accept results from 
the MANOVA.  Post hoc analyses were conducted to determine differences between groups if 
there were more than three outcome groups (i.e., EAS MCI3).  If variances were homogenous, 
Tukey’s HSD, Fisher’s LSD and Bonferroni post hoc tests were used.  If variances were non-
homogenous, the Games-Howell post hoc test was used.  Preliminary analyses using a Repeated 
Measures MANOVA were also conducted to determine whether within-domain repeated blocks 
of baseline experimental (across-block) task measures characterized future MCI group status.  
Repeated measures MANOVA examined whether differences between group means were 
present for related test measures over time.  Mauchly’s test of sphericity was used to determine if 
variances of the differences between all possible pairs of groups were equal.  If the assumption 
of sphericity was not met, then the variances were not equal and measures were re-evaluated 
using a Greenhouse-Geisser correction, which allowed sphericity to be met.  Post hoc analyses 
using Tukey’s LSD were executed to examine specific differences between blocks and between 
groups over time.      
 Aim I: To determine whether within-domain baseline experimental task intraindividual 
variability (IIV) measures compared to the within-domain baseline standard task measure 
characterized future MCI group status.  MANOVA was conducted to test the hypothesis that 
experimental task IIV measures were able to differentiate between MCI and HC groups 
compared to the standard task measure.  Levene’s test was conducted to test for homogeneity of 
variance.  If significant (indicating that variances differed between groups), the Welch ANOVA 
was implemented.  Partial correlation analyses were used to test for relationships between testing 
measures, outcome and demographics.  Multivariate Analysis of Covariance (MANCOVA) were 
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conducted to test for covariates.  MANCOVA examined if covariates were present and if they 
influenced differences between group means. 
 Aim II: To determine whether within-domain baseline experimental task 
intraindividual variability (IIV) measures compared to the within-domain baseline standard 
task measure predicted future MCI group status.  Binomial Logistic Regression analyses were 
conducted to test the hypothesis that experimental task IIV measures were able to predict MCI 
compared to the standard task measure.  Binomial Logistic Regression analyses predicted the 
likelihood that the observed outcome occurred based on the testing measures.  Nagelkerke R 
Square values were calculated to determine the explained variance.  The percentage of accuracy 
was also calculated. Wald’s test was used to determine the predictive value of each measures.      
 Aim III: To determine whether across-domain baseline experimental task 
intraindividual variability (IIV) measures compared to across-domain baseline standard task 
measures characterized future MCI group status.  Principal Component Analysis (PCA) with 
Inference was conducted to test the hypothesis that across-domain experimental task IIV 
measures were able to reveal a pattern of incident MCI compared to standard task measures.  
PCA with inference used a data reduction procedure aimed at characterizing the data in terms of 
maximum variance explained (Abdi & Williams, 2010b).   
 Aim IV: To determine whether across-domain baseline experimental task 
intraindividual variability (IIV) measures compared to across-domain baseline standard task 
measures predicted future MCI group status at different time points.  Barycentric Discriminant 
Analyses (BADA) with Inference were conducted to test the hypothesis that experimental task 
IIV measures were able to significantly separate MCI groups from HC as compared to standard 
task measures.  BADA with inference maximized group differences, and simultaneously 
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determined which measures were responsible for significant differences between outcome groups 
(Abdi & Williams. 2010a). 
 
Results 
Episodic Memory Domain  
Descriptive Statistics 
 Participants who completed the CRRST and the FCSRT were included in these analyses. 
Descriptive statistics for demographics and outcomes are shown in Tables 3 and 4.  There were 
426 participants who had an approximate average age of 80 years.  The sample consisted of 
approximately 41% males and was primarily Caucasian (75%).  91.3% of the sample had a high 
school degree or higher and 95.1% had GDS classification of non-significant clinical symptoms 
of depression.  In addition, there was a 90.8% corresponding classification rate of healthy 
controls compared to the EAS definition of healthy/non-impaired elderly.  Table 5 includes 
means and standard deviations for CRRST RT and CRRST accuracy per block by group.     
 
Preliminary analyses to determine whether within-domain baseline experimental task 
measures (each block) compared to the within-domain baseline standard task measure 
characterized future MCI group status.   
 MANOVA was performed to examine the differences between HC and MCI (EAS MCI 
outcome) based on CRRST RT and CRRST accuracy compared to FCSRT (Figures 6, 7 and 12).  
Significant differences were found between groups for each block for CRRST RT (p<0.001), 
each block of CRRST accuracy (p<0.05) and FCSRT (F(1,424) = 11.175, p=0.001), indicating 
that group differences were present for both CRRST RT and CRRST accuracy and also FCSRT, 
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with the MCI group performing worse compared to HC on both tasks.  Levene’s test for 
homogeneity of variance was not significant for FCSRT, CRRST RT blocks and CRRST 
accuracy blocks 5 and 6 (p>0.05) indicating that variances did not differ between groups; it was 
significant for CRRST accuracy blocks 1 through 4 (p<0.05) indicating that variances did differ 
between groups and we may not be able to trust the above MANOVA results.  The Welch 
ANOVA, which does not depend on equal variances between groups, was performed and a 
significant difference was found in CRRST accuracy blocks 1 through 4 (p<0.01) between the 
MCI group and HC.  We can conclude that whether variances were equal or unequal, the results 
remained the same, which may be due to the large sample sizes utilized. 
 MANOVA was performed to examine the differences between HC and MCI (AC MCI 
outcome) based on CRRST RT and CRRST accuracy compared to FCSRT (Figures 8, 9 and 13).  
Significant differences were found between groups for each block of CRRST RT (p<0.01) and 
CRRST accuracy blocks 1 through 4 and block 6 (p<0.01), but not CRRST accuracy block 5 
(p>0.05) indicating that group differences were present for CRRST RT and most blocks of 
CRRST accuracy, with the MCI group performing worse compared to HC.  No significant 
differences were found between groups for FCSRT (F(1,424)=1.412, p>0.05).  Levene’s test for 
homogeneity of variance was not significant for FCSRT, CRRST RT blocks 1 through 5 and 
CRRST accuracy blocks 1 and 4 (p>0.05); it was significant for CRRST RT block 6 and CRRST 
accuracy blocks 2, 3, 5 and 6 (p<0.05).  The Welch ANOVA found a significant difference 
between groups for CRRST RT block 6 and CRRST accuracy blocks 2, 3 and 6 (p<0.05), but not 
block 5 (p>0.05) indicating that even when accounting for unequal variances, the MCI group and 
HC did not significantly differ for CRRST accuracy block 5. 
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 MANOVA was performed to examine the differences between HC, aMCI and naMCI 
(EAS MCI3 outcome) based on CRRST RT and CRRST accuracy compared to FCSRT (Figures 
10, 11 and 14).  Significant differences were found between groups for each block of CRRST RT 
(p<0.001), CRRST accuracy blocks 1 through 5 of accuracy (p<0.01), but not block 6 (p>0.05) 
and FCSRT (F(2,423) = 19.946, p<0.001), indicating that group differences were present for 
FCSRT, CRRST RT and most blocks of CRRST accuracy.  Levene’s test for homogeneity of 
variance was not significant for FCSRT (p>0.05), CRRST RT blocks 1, 2, 4 through 6 (p>0.05) 
and CRRST accuracy blocks 4 through 6 (p>0.05); but was significant for CRRST RT block 3 
(p<0.05) and CRRST accuracy blocks 1, 2 and 3 (p<0.05).  The Welch ANOVA revealed a 
significant difference between groups for CRRST RT block 3 and CRRST accuracy blocks 1, 2 
and 3 (p<0.05).  Post hoc analyses for measures with homogenous variances found that the aMCI 
group was significantly different from HC for FCSRT, CRRST RT blocks 1, 2, 4 through 6 and 
CRRST accuracy blocks 4 and 5 (p<0.05) and CRRST accuracy block 6 (when using Fisher’s 
LSD test, p<0.05) indicating that the aMCI group performed significantly poorer than HC on 
FCSRT and CRRST measures.  The naMCI group performed significantly worse than HC for 
CRRST RT blocks 2, 5 and 6 (p<0.05) but not blocks 1 or 4 (p>0.05).  Although the naMCI 
group performed worse for CRRST RT blocks 1, 2, 4, 5 and 6 compared to HC, a significantly 
poorer performance was only present for blocks 2, 5 and 6.  The naMCI group did not differ 
from HC in CRRST accuracy at blocks 4 through 6 (p>0.05) nor FCSRT (p>0.05).  The aMCI 
group significantly differed from the naMCI group on FCSRT (p<0.05) but not on any CRRST 
RT or CRRST accuracy blocks (p>0.05), therefore although the aMCI group performed worse on 
the FCSRT compared to the naMCI group, the aMCI group performed similarly to the naMCI 
group on the CRRST RT and CRRST accuracy.  Post hoc analyses for non-homogenous 
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measures found that the aMCI group performed significantly poorer than HC for CRRST RT 
block 3 and CRRST accuracy blocks 1, 2 and 3 (p<0.05); the naMCI group was significantly 
worse than HC at CRRST RT block 3 (p<0.05) but not at CRRST accuracy blocks 1, 2 and 3 
(p>0.05); the aMCI group did not significantly differ from the naMCI group on CRRST RT 
block 3 (p>0.05) or CRRST accuracy blocks 1, 2 and 3 (p>0.05).   
 
Preliminary analyses to determine whether within-domain repeated blocks of baseline 
experimental task (across-block) measures characterized future MCI group status. 
 Repeated Measures MANOVA was performed to examine differences between HC and 
MCI (EAS MCI outcome) based on repeated CRRST RT and CRRST accuracy over time 
(Figures 6 and 7).  There was a significant effect of blocks over time (F(10,415) = 89.966, 
p<0.001; Pillai’s Trace = 0.684) indicating repeated blocks had an effect on performance over 
time.  Mauchly’s test for sphericity found that the assumption of sphericity was not met 
(p<0.001) indicating that the variances of the differences between all possible pairs of groups 
were not equal.  When re-evaluated with a Greenhouse-Geisser correction, CRRST RT was 
statistically significant (F(3.614, 1532.259) = 245.794, p<0.001) and CRRST accuracy was 
statistically significant (F(4.194, 1778.277) = 157.246, p<0.001), thus indicating that regardless 
of equal or unequal variances, there was a significant effect of blocks over time for both CRRST 
RT and CRRST accuracy.   The MCI group performed significantly worse than HC on CRRST 
RT (F(1,424) = 22.977, p<0.001) and CRRST accuracy (F(1,424) = 11.545, p=0.001) over time.  
Post hoc analyses examining within-subjects repeated contrasts, when taking group membership 
into account, found that the MCI group performed significantly worse on CRRST RT at each 
block (p<0.001) and on CRRST accuracy at each block (p<0.05) compared to HC.  But, the MCI 
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group significantly improved in performance for CRRST RT from blocks 1 to 3 (p<0.01) and 
from block 5 to 6 (p<0.05) but not between blocks 3 to 5 (p>0.05).  And the MCI group 
significantly improved in CRRST accuracy from blocks 1 to 5 (p<0.01) but not from blocks 5 to 
6 (p>0.05).  HC significantly improved in CRRST RT over all blocks (p<0.01) and CRRST 
accuracy blocks (p<0.01) except from block 5 to 6 (p>0.05). 
 Repeated Measures MANOVA was performed to examine differences between HC and 
MCI (AC MCI outcome) based on repeated CRRST RT and CRRST accuracy over time (Figures 
8 and 9).  There was a significant effect of blocks over time (F(10,415) = 73.671, p<0.001; 
Pillai’s Trace = 0.640) indicating repeated blocks had an effect on performance over time.  
Mauchly’s test for sphericity found that the assumption of sphericity was not met (p<0.001).  
When re-evaluated with a Greenhouse-Geisser correction, CRRST RT was statistically 
significant (F(3.613, 1532.031) = 196.805, p<0.001) and CRRST accuracy was statistically 
significant (F(4.190, 1776.735) = 131.308, p<0.001).  The MCI group performed significantly 
poorer than HC on CRRST RT (F(1,424) = 13.375, p<0.001) and CRRST accuracy (F(1,424) = 
14.976, p<0.001) over time.  Post hoc analyses examining within-subjects repeated contrasts, 
when taking group membership into account, found that the MCI group performed significantly 
poorer on CRRST RT at each block (p<0.01) and CRRST accuracy at each block (p<0.01) 
except at block 5 (p>0.05) compared to HC.  In addition, the MCI group significantly improved 
in performance on CRRST RT from blocks 1 to 4 (p<0.05) but not between blocks 4 to 6 
(p>0.05).  The MCI group significantly improved in CRRST accuracy from blocks 1 to 3 
(p<0.01) and from blocks 4 to 6 (p<0.05) but not from block 3 to 4 (p>0.05).  HC significantly 
improved in CRRST RT over all blocks (p<0.01) and CRRST accuracy blocks (p<0.01) except 
from block 5 to 6 (p>0.05). 
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 Repeated Measures MANOVA was performed to examine differences between HC, 
aMCI and naMCI (EAS MCI3 outcome) based on repeated CRRST RT and CRRST accuracy 
over time (Figures 10 and 11).  There was a significant effect of blocks over time (F(10,414) = 
56.575, p<0.001; Pillai’s Trace = 0.577) indicating repeated blocks had an effect on performance 
over time.  Mauchly’s test for sphericity found that the assumption of sphericity was not met 
(p<0.001).  When re-evaluated with a Greenhouse-Geisser correction, CRRST RT was 
statistically significantly (F(3.609,1526.443) = 154.496, p<0.001) and CRRST accuracy was 
statistically significant (F(4.201,1776.831) = 97.835, p<0.001).  Outcome groups significantly 
differed in CRRST RT (F(2,423) = 11.591, p<0.001) and CRRST accuracy (F(2,423) = 7.475, 
p=0.001).  Post hoc analyses revealed the aMCI group performed significantly poorer than HC 
(p<0.001) but not the naMCI group (p>0.05) for CRRST RT; and the naMCI group performed 
significantly poorer than HC (p<0.05) for CRRST RT.  For CRRST accuracy, the aMCI group 
performed significantly poorer than HC (p<0.001) but was not significantly different from the 
naMCI group (p>0.05); the naMCI group did not significantly differ from HC (p>0.05).  Post 
hoc analyses examining within-subjects repeated contrasts, when taking group membership into 
account, revealed that the aMCI group performed significantly worse than HC on all CRRST RT 
blocks (p<0.01) and all CRRST accuracy blocks (p<0.05).  The aMCI group did not significantly 
differ from the naMCI group on any CRRST RT blocks (p>0.05); but did differ on CRRST 
accuracy blocks 1 and 3 (p<0.05) but not for blocks 2, 4, 5 and 6 (p>0.05). The naMCI group 
performed significantly poorer on CRRST RT for blocks 2, 3, 5 and 6 (p<0.05) but not for 
blocks 1 and 4 (p>0.05) or for any CRRST accuracy blocks (p>0.05) compared to HC.  In 
addition, the aMCI group significantly improved in CRRST RT from blocks 1 to 3 (p<0.01) and 
from blocks 4 to 5 (p<0.01) but not between blocks 3 to 4 (p>0.05) or blocks 5 to 6 (p>0.05).  
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The aMCI group significantly improved in CRRST accuracy from blocks 1 to 5 (p<0.05) but not 
from block 5 to 6 (p>0.05).  The naMCI group significantly improved in CRRST RT from 
blocks 1 to 4 (p<0.05) but not from blocks 4 to 6 (p>0.05).  The naMCI group significantly 
improved in CRRST accuracy from blocks 1 to 3 (p<0.05) and from block 4 to 5 (p<0.05) but 
not from blocks 3 to 4 (p>0.05) or 5 to 6 (p>0.05).  HC significantly improved in CRRST RT 
over all blocks (p<0.01) and CRRST accuracy blocks (p<0.01) except from block 5 to 6 
(p>0.05). 
 
Aim I: Determine whether within-domain baseline experimental task IIV measures 
compared to the within-domain baseline standard task measure characterized future MCI 
group status. 
 MANOVA was performed to examine differences between HC and MCI (EAS MCI 
outcome) based on CRRST RT and CRRST accuracy mean and variability (intraindividual 
standard deviation, intraindividual coefficient of variation) compared to FCSRT (Table 6).  The 
MCI group performed significantly worse compared to HC for FCSRT, CRRST RT mean, 
CRRST accuracy mean, CRRST RT ISD, CRRST accuracy ISD, and CRRST accuracy ICV 
(p<0.01) but not CRRST RT ICV (p>0.05).  Levene’s test for homogeneity of variance was not 
significant for FCSRT, CRRST RT mean, CRRST accuracy ISD and CRRST RT ICV (p>0.05) 
but was significant for CRRST accuracy mean, CRRST RT ISD and CRRST accuracy ICV 
(p<0.05).  The Welch ANOVA found a significant difference between groups for CRRST 
accuracy mean, CRRST RT ISD and CRRST accuracy ICV (p<0.05) thus indicating that when 
unequal variances were accounted for, the MCI group performed worse on all measures 
compared to HC.   
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 Partial correlations were computed to determine the association between the classification 
outcome groups of EAS MCI and all testing measures when controlling for demographic 
variables (age, gender, ethnicity, education, GDS).  Without controlling for demographics, there 
were significant correlations between outcome and all testing measures (p<0.05) except CRRST 
RT ICV (p>0.05).  Controlling for demographics did not affect the relationship between outcome 
and testing measures indicating that demographic variables had little influence on the 
relationship between outcome and testing measures.  MANCOVA testing for covariates showed 
there were no significant interactions between age, gender, ethnicity, education, GDS and 
outcome (p>0.05). 
 MANOVA was performed to examine differences between HC and MCI (AC MCI 
outcome) based on CRRST RT and CRRST accuracy mean and variability (intraindividual 
standard deviation, intraindividual coefficient of variation) compared to FCSRT (Table 6).  The 
MCI group performed significantly worse compared to HC for CRRST RT mean, CRRST 
accuracy mean, CRRST RT ISD, CRRST accuracy ISD, and CRRST accuracy ICV (p<0.01) but 
not FCSRT and CRRST RT ICV (p>0.05).  Levene’s test for homogeneity of variance was not 
significant for FCSRT, CRRST RT mean, CRRST accuracy ISD, CRRST RT ICV and CRRST 
accuracy ICV (p>0.05) but was significant for CRRST accuracy mean and CRRST RT ISD 
(p<0.05).  The Welch ANOVA found a significant difference between groups for CRRST 
accuracy mean and CRRST RT ISD (p<0.05), thus indicating that when unequal variances were 
accounted for, the MCI group performed worse on most of the mean and variability CRRST 
measures compared to HC.   
 Partial correlations were computed to determine the association between the classification 
outcome groups of AC MCI and all testing measures when controlling for demographic variables 
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(age, gender, ethnicity, education, GDS).  Without controlling for demographics, there were 
significant correlations between outcome and all testing measures (p<0.05) except FCSRT and 
CRRST RT ICV (p>0.05).  Controlling for demographics did not affect the relationship between 
outcome and testing measures indicating that demographic variables had little influence on the 
relationship between outcome and testing measures.  MANCOVA testing for covariates showed 
there were no significant interactions between age, ethnicity, education, GDS and outcome 
(p>0.05). There was a significant interaction between ethnicity-dichotomized groups (Caucasian 
vs. non-Caucasian) and outcome (p<0.05) – when ethnicity was accounted for, outcome groups 
were still significantly different (p<0.05).  There was a significant interaction between gender 
and outcome – when gender was accounted for, outcome groups were still significantly different 
(p<0.05). 
 MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS 
MCI3 outcome) based on CRRST RT and CRRST accuracy mean and variability (intraindividual 
standard deviation, intraindividual coefficient of variation) compared to FCSRT (Table 6).  The 
outcome groups were significantly different in FCSRT, CRRST RT mean, CRRST accuracy 
mean, CRRST RT ISD, CRRST accuracy ISD, and CRRST accuracy ICV (p<0.05) but not 
CRRST RT ICV (p>0.05).  Levene’s test for homogeneity of variance was not significant for 
FCSRT, CRRST RT mean and CRRST RT ICV (p>0.05) but was significant for CRRST 
accuracy mean, CRRST RT ISD, CRRST accuracy ISD and CRRST accuracy ICV (p<0.05).  
The Welch ANOVA found a significant difference between groups for CRRST accuracy mean, 
CRRST RT ISD, CRRST accuracy ISD and CRRST accuracy ICV (p<0.05).  Post hoc analyses 
for measures with homogenous variances found that the aMCI group performed significantly 
poorer compared to HC for FCSRT and CRRST RT mean (p<0.05) but not CRRST RT ICV 
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(p>0.05).  The naMCI group performed significantly poorer compared to HC for CRRST RT 
mean (p<0.05) but not for FCSRT or CRRST RT ICV (p>0.05).  The aMCI group performed 
significantly worse than the naMCI group for FCSRT (p<0.05) but not for CRRST RT mean or 
CRRST RT ICV (p>0.05). Post hoc analyses for non-homogenous measures found that the aMCI 
group performed significantly poorer than HC for CRRST accuracy mean, CRRST RT ISD, 
CRRST accuracy ISD and CRRST accuracy ICV (p<0.05).  The naMCI group did not 
significantly differ from HC on any measure (p>0.05).  The aMCI group performed significantly 
worse compared to the naMCI group in CRRST accuracy ICV (p<0.05) but not on other 
measures (p>0.05).   
 Partial correlations were computed to determine the association between the classification 
outcome group of EAS MCI3 and all testing measures when controlling for demographic 
variables (age, gender, ethnicity, education, GDS).  Without controlling for demographics, there 
were significant correlations between outcome and CRRST RT mean and CRRST accuracy 
mean (p<0.05) but no other measures (p>0.05).  When controlling for demographics, only the 
relationship between outcome and CRRST RT mean remained significant (p<0.05) indicating 
that demographic variables had some influence on the relationship between outcome and CRRST 
accuracy mean but not CRRST RT mean.  MANCOVA testing for covariates showed that there 
were no significant interactions between age, gender, ethnicity, education, GDS and outcome 
(p>0.05). 
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Aim II: Determine whether within-domain baseline experimental task IIV measures 
compared to the within-domain baseline standard task measure predicted future MCI 
group status. 
 Binomial Logistic Regression was performed to examine the prediction of HC and aMCI 
(EAS aMCI outcome) based on variability (intraindividual standard deviation, intraindividual 
coefficient of variation) in CRRST RT and CRRST accuracy compared to FCSRT.  A model for 
goodness of fit with only FCSRT as a predictor of aMCI was statistically significant, (χ2(1) = 
32.262, p<0.001). The model explained 11.7% (Nagelkerke R2) of the variance and correctly 
classified 81.2% of cases.  When CRRST RT ISD, CRRST accuracy ISD, CRRST RT ICV and 
CRRST accuracy ICV were added to the model, it did not significantly differ from the prior 
model (χ2(4) = 6.587, p>0.05).  Examining all predictors in the model, only FCSRT was 
significant (Wald χ2(1) = 19.424, p<0.001), while other variability measures were not (p>0.05).  
A model for goodness of fit with CRRST RT ISD, CRRST accuracy ISD, CRRST RT ICV and 
CRRST accuracy ICV as predictors of aMCI was statistically significant, (χ2(4) = 18.147, 
p=0.001). The model explained 6.7% (Nagelkerke R2) of the variance and correctly classified 
80.8% of cases.  When FCSRT was added to the model, it was significantly different from the 
prior model (χ2(1) = 20.703, p<0.001).  Examining all predictors in model, only FCSRT was 
significant (Wald χ2(1) = 19.424, p<0.001), while other variability measures were not (p>0.05). 
 Binomial Logistic Regression was performed to examine the prediction of HC and MCI 
(AC MCI outcome) based on variability (intraindividual standard deviation, intraindividual 
coefficient of variation) in CRRST RT and CRRST accuracy compared to FCSRT.  A model for 
goodness of fit with only FCSRT as a predictor of MCI was not statistically significant, (χ2(1) = 
1.392, p>0.05).  When CRRST RT ISD, CRRST accuracy ISD, CRRST RT ICV and CRRST 
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accuracy ICV were added to the model, it was significantly different from the prior model (χ2(4) 
= 13.571, p<0.01).  The model explained 5.5% (Nagelkerke R2) of the variance and correctly 
classified 80.3% of cases.  When all predictors in the model were included, none were significant 
(p>0.05).  The model for goodness of fit with CRRST RT ISD, CRRST accuracy ISD, CRRST 
RT ICV and CRRST accuracy ICV as predictors of MCI was statistically significant, (χ2(4) = 
14.942, p<0.01). The model explained 5.5% (Nagelkerke R2) of the variance and correctly 
classified 80.3% of cases.  When FCSRT was added to the model, it was not significantly 
different from the prior model (p>0.05).  When all predictors in the model were included, none 
were significant (p>0.05). 
 
Processing Speed Domain 
Descriptive Statistics 
 Participants who completed NM and TMT-A were included in these analyses. 
Descriptive statistics for demographics and outcome are shown in Tables 3 and 7.  There were 
423 participants who had an approximate average age of 80 years.  The sample consisted of 
approximately 41% males and was primarily Caucasian (75%).  91.5% of the sample had a high 
school degree or higher and 95% had GDS classification of non-significant clinical symptoms of 
depression.   In addition, there was a 90.8% corresponding classification rate of healthy controls 
compared to the EAS definition of healthy/non-impaired elderly.  Table 8 includes means and 
standard deviations for NM RT and NM accuracy per block per group.     
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Preliminary analyses to determine whether within-domain baseline experimental task 
measures (each block) compared to the within-domain baseline standard task measure 
characterized future MCI group status.   
 MANOVA was performed to examine differences between HC and MCI (EAS MCI 
outcome) based on NM RT and NM accuracy compared to TMT-A (Figures 15, 16 and 21).  
There was a significant difference between groups for each block of NM RT (p<0.05) but not for 
NM accuracy blocks (p>0.05) or TMT-A (F(1,421) = 0.982, p>0.05) indicating that significant 
group differences were present for only NM RT with the MCI group performing significantly 
worse for NM RT but not for other measures compared to HC.  Levene’s test for homogeneity of 
variance was not significant for TMT-A, NM RT blocks or NM accuracy blocks (p>0.05). 
 MANOVA was performed to examine differences between HC and MCI (AC MCI 
outcome) based on NM RT and NM accuracy compared to TMT-A (Figures 17, 18 and 22).  
There was a significant difference between groups for NM RT (p=0.001) and NM accuracy 
block 1 (p<0.05) but not for NM accuracy block 2 (p>0.05) or TMT-A (F(1,421) = 2.392, 
p>0.05) indicating that the MCI group performed significantly worse for NM RT and for NM 
accuracy block 1 but not for NM accuracy block 2 nor TMT-A.  Levene’s test for homogeneity 
of variance was not significant for TMT-A and NM accuracy block 2 (p>0.05); it was significant 
for NM RT blocks and NM accuracy block 1 (p<0.05).  The Welch ANOVA found a significant 
difference between groups for NM RT blocks (p<0.01) but not NM accuracy block 1 (p>0.05) 
indicating that when we account for unequal variances the MCI group performed significantly 
worse than HC on NM RT blocks, but no other measures. 
 MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS 
MCI3 outcome) based on NM RT and NM accuracy compared to TMT-A (Figures 19, 20 and 
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23).  There were significant differences between groups for NM RT block 2 (p<0.05) but not for 
NM RT block 1 (p>0.05), NM accuracy blocks (p>0.05) or TMT-A (F(2, 420) = 0.841, p>0.05) 
indicating that group differences were present for NM RT only at block 2 but not for any blocks 
of NM accuracy or TMT-A.  Levene’s test for homogeneity of variance was not significant for 
TMT-A, NM RT or NM accuracy blocks (p>0.05).  Post hoc analyses for homogeneous 
measures found that the naMCI group performed significantly worse than HC for NM RT blocks 
1 and 2 (p<0.05) and NM accuracy block 2 when using Fisher’s LSD test (p<0.05) but did not 
differ in NM accuracy block 1 or TMT-A (p>0.05).  The aMCI group was not significantly 
different from HC or the naMCI group for TMT-A, NM RT and NM accuracy blocks (p>0.05).   
 
Preliminary analyses to determine whether within-domain repeated blocks of baseline 
experimental task (across-block) measures characterized future MCI group status. 
 Repeated Measures MANOVA was performed to examine differences between HC and 
MCI (EAS MCI outcome) based on repeated NM RT and NM accuracy over time (Figures 15 
and 16).  There was a significant effect of blocks over time (F(2,420) = 8.227, p<0.001; Pillai’s 
Trace = 0.038) indicating repeated blocks had an effect on performance over time.  Mauchly’s 
test for the assumption of sphericity was not necessary because we were examining only two 
levels.  When sphericity was assumed, NM RT was statistically significant (F(1, 421) = 9.729, 
p<0.01) but NM accuracy was not statistically significant (F(1, 421) = 0, p>0.05).  The MCI 
group performed significantly poorer compared to HC for NM RT (F(1,421) = 5.970, p<0.05) 
but not NM accuracy (F(1,421) = 2.539, p>0.05) over time.  Post hoc analyses examining within-
subjects repeated contrasts, while taking group membership into account, found that the MCI 
group performed significantly worse compared to HC for each block of NM RT (p<0.05) but not 
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on any NM accuracy blocks (p>0.05).  In addition, the MCI group showed no significant 
improvement in NM RT (p>0.05) or NM accuracy over time (p>0.05), while HC improved in 
NM RT (p<0.001) but not NM accuracy over time (p>0.05). 
 Repeated Measures MANOVA was performed to examine differences between HC and 
MCI (AC MCI outcome) based on repeated NM RT and NM accuracy over time (Figures 17 and 
18).  There was a significant effect of blocks over time (F(2,420) = 4.031, p<0.05; Pillai’s Trace 
= 0.019) indicating that repeated blocks had an effect on performance over time.  When 
sphericity was assumed NM RT was statistically significant (F(1, 421) = 6.192, p<0.05) but NM 
accuracy was not statistically significant (F(1, 421) = 0.294, p>0.05).  The MCI group performed 
significantly worse compared to HC in NM RT (F(1,421) = 12.597, p<0.001) but not NM 
accuracy (F(1,421) = 1.581, p>0.05) over time.  Post hoc analyses examining within-subjects 
repeated contrasts, while taking group membership into account, found that the MCI group 
performed significantly poorer compared to HC for each block of NM RT (p=0.001) and NM 
accuracy block 1 (p<0.05) but did not significantly differ for NM accuracy block 2 (p>0.05).  In 
addition, the MCI group showed no significant improvement in NM RT (p>0.05) or NM 
accuracy over time (p>0.05), while HC improved in NM RT (p<0.001) but not NM accuracy 
over time (p>0.05). 
 Repeated Measures MANOVA was performed to examine differences between HC, 
aMCI and naMCI (EAS MCI3 outcome) based on repeated NM RT and NM accuracy over time 
(Figures 19 and 20).  There was a significant effect of blocks over time (F(2,419) = 7.133, 
p=0.001; Pillai’s Trace = 0.033) indicating repeated blocks had an effect on performance over 
time.  When sphericity was assumed, NM RT was statistically significant (F(1,420) = 5.337, 
p<0.05) while NM accuracy was not statistically significant (F(1,420) = 0.658, p>0.05).  
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Outcome groups significantly differed in NM RT (F(2,420) = 3.254, p<0.05) but not NM 
accuracy (F(2,420) = 1.973, p>0.05).  Post hoc analyses examining within-subjects repeated 
contrasts, while taking group membership into account, found that the naMCI group performed 
significantly worse compared to HC on all NM RT blocks and NM accuracy block 2 (p<0.05) 
but not NM accuracy block 1 (p>0.05).  The aMCI group was not significantly different from HC 
or the naMCI group on any NM RT or NM accuracy blocks (p>0.05).  In addition, the naMCI 
group showed no improvement over time in NM RT (p>0.05) or NM accuracy (p>0.05), the 
aMCI group showed no significant improvement in NM RT (p>0.05) or NM accuracy over time 
(p>0.05), while HC improved in NM RT (p<0.001) but not NM accuracy over time (p>0.05). 
 
Aim I: Determine whether within-domain baseline experimental task IIV measures 
compared to the within-domain baseline standard task measure characterized future MCI 
group status. 
 MANOVA was performed to examine differences between HC and MCI (EAS MCI 
outcome) based on NM RT and NM accuracy mean and variability (intraindividual standard 
deviation, intraindividual coefficient of variation) compared to TMT-A (Table 9).  The MCI 
group performed significantly worse compared to HC for NM RT mean and NM RT ISD 
(p<0.05) but not TMT-A, NM accuracy mean, NM accuracy ISD, NM RT ICV and NM 
accuracy ICV (p>0.05).  Levene’s test for homogeneity of variance was not significant for TMT-
A, NM RT mean, NM accuracy mean, and NM RT ICV (p>0.05) but was significant for NM RT 
ISD, NM accuracy ISD and NM accuracy ICV (p<0.05).  The Welch ANOVA found no 
significant difference between groups for NM RT ISD, NM accuracy ISD and NM accuracy ICV 
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(p>0.05).  Thus, when unequal variances were accounted for, the MCI group performed worse 
only on NM RT mean compared to HC. 
 Partial correlations were computed to determine the association between the classification 
outcome group of EAS MCI and all testing measures when controlling for demographic 
variables (age, gender, ethnicity, education, GDS).  Without controlling for demographics, there 
were significant correlations between outcome and NM RT mean and NM RT ISD (p<0.05) but 
no other variables (p>0.05).  When controlling for demographics, the relationship between 
outcome and NM RT mean and NM RT ISD were no longer significant (p>0.05) indicating that 
demographic variables had a strong influence on the relationship between outcome and testing 
measures.  MANCOVA testing for covariates found no significant interactions between age, 
gender, education, GDS and outcome (p>0.05).  There was a significant interaction between 
ethnicity and outcome – when ethnicity was accounted for outcome groups were no longer 
significantly different (p>0.05), thus after adjusting for ethnicity as a covariate, there was no 
longer a difference between outcome groups. 
 MANOVA was performed to examine differences between HC and MCI (AC MCI 
outcome) based on NM RT and NM accuracy mean and variability (intraindividual standard 
deviation, intraindividual coefficient of variation) compared to TMT-A (Table 9).  The MCI 
group performed significantly worse than HC in NM RT mean (p<0.05) but not TMT-A, NM 
accuracy mean, NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05).  
Levene’s test for homogeneity of variance was not significant for TMT-A, NM accuracy mean, 
NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05) but was significant for NM RT 
mean and NM RT ISD (p<0.05).  The Welch ANOVA found a significant difference between 
groups for NM RT mean (p<0.05) but not NM RT ISD (p>0.05).   
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 Partial correlations were computed to determine the association between the classification 
outcome group of AC MCI and all testing measures when controlling for demographic variables 
(age, gender, ethnicity, education, GDS).  Without controlling for demographics, there was a 
significant correlation only between outcome and NM RT mean (p<0.05) but no other measures 
(p>0.05).  When controlling for demographics, the relationship between outcome and NM RT 
mean remained significant (p<0.05) indicating that demographic variables had little influence on 
the relationship between outcome and testing measures.  MANCOVA testing for covariates 
found no significant interactions between age, gender, ethnicity, education, GDS and outcome 
(p>0.05).   
 MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS 
MCI3 outcome) based on NM RT and NM accuracy mean and variability (intraindividual 
standard deviation, intraindividual coefficient of variation) compared to TMT-A (Table 9).  
Outcome groups significantly differed for NM RT mean (p<0.05) but not TMT-A, NM accuracy 
mean, NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05).  Levene’s 
test for homogeneity of variance was not significant for TMT-A, NM RT mean and NM 
accuracy mean (p>0.05) but was significant for NM RT ISD, NM accuracy ISD, NM RT ICV 
and NM accuracy ICV (p<0.05).  The Welch ANOVA found no significant differences between 
groups for NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05).  Post 
hoc analyses for homogenous measures found that the naMCI group performed significantly 
worse compared to HC for NM RT mean when using Fisher’s LSD test (p<0.05) but did not 
significantly differ on TMT-A or NM accuracy mean (p>0.05).   The naMCI group did not 
significantly differ from the aMCI group for TMT-A, NM RT mean or NM accuracy mean 
(p>0.05).  The aMCI group did not significantly differ from HC for TMT-A, NM RT mean or 
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NM accuracy mean (p>0.05).  Post hoc analyses for non-homogenous measures found that the 
naMCI group did not significantly differ from aMCI or HC for NM RT ISD, NM accuracy ISD, 
NM RT ICV and NM accuracy ICV (p>0.05); aMCI did not significantly differ from HC on any 
measure (p>0.05).  
 Partial correlations were computed to determine the association between the classification 
outcome groups of EAS MCI3 and all testing measures when controlling for demographic 
variables (age, gender, ethnicity, education, GDS).  Without controlling for demographics, there 
were significant correlations between outcome and NM RT mean and NM RT ISD (p<0.05) but 
no other measures (p>0.05).  When controlling for demographics, only the relationship between 
outcome and NM RT ISD remained significant (p<0.05) indicating that demographic variables 
had an influence on the relationship between outcome and NM RT mean but not NM RT ISD.  
MANCOVA testing for covariates found no significant interactions between age, gender, 
ethnicity, education, GDS and outcome (p>0.05). 
 
Aim II: Determine whether within-domain baseline experimental task IIV measures 
compared to the within-domain baseline standard task measure predicted future MCI 
group status. 
 Binomial Logistic Regression was performed to examine the prediction of HC and 
naMCI (EAS naMCI outcome) based on variability (intraindividual standard deviation, 
intraindividual coefficient of variation) in NM RT and NM accuracy compared to TMT-A.  A 
model for goodness of fit with only TMT-A as a predictor of naMCI was not statistically 
significant, (χ2(1) = 1.310, p>0.05).  When NM RT ISD, NM accuracy ISD, NM RT ICV and 
NM accuracy ICV were added to the model, it did not significantly differ from the prior model 
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(χ2(4) = 1.966, p>0.05).  A model for goodness of fit with NM RT ISD, NM accuracy ISD, NM 
RT ICV and NM accuracy ICV as predictors of naMCI was not statistically significant, (χ2(4) = 
2.231, p>0.05).  When TMT-A was added to the model, it was not significantly different from 
the prior model (χ2(1) = 1.045, p>0.05).  A model for goodness of fit with NM RT mean, NM 
accuracy mean, NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV as 
predictors of naMCI was not statistically significant, (χ2(6) = 7.808, p>0.05).  Examining all 
predictors in the model, only NM accuracy mean was significant (Wald χ2(1) = 4.469, p<0.05), 
while other measures were not (p>0.05).  When TMT-A was added to the model, it was not 
significantly different from the prior model (χ2(1) = 0.164, p>0.05).  Examining all predictors in 
the model, only NM accuracy mean was significant (Wald χ2(1) = 4.221, p<0.05), while other 
measures were not (p>0.05). 
 Binomial Logistic Regression was performed to examine the prediction of HC and MCI 
(AC MCI outcome) based on variability (intraindividual standard deviation, intraindividual 
coefficient of variation) in NM RT and NM accuracy compared to TMT-A.  A model for 
goodness of fit with only TMT-A as a predictor of MCI was not statistically significant (χ2(1) = 
2.191, p>0.05).  When NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV 
were added to the model, it was not significantly different from the prior model (χ2(4) = 8.569, 
p>0.05).  A model for goodness of fit with NM RT ISD, NM accuracy ISD, NM RT ICV and 
NM accuracy ICV as predictors of MCI was statistically significant, (χ2(4) = 10.265, p<0.05). 
The model explained 3.8% (Nagelkerke R2) of the variance and correctly classified 80.1% of 
cases.  Examining all predictors in model, NM RT ISD (Wald χ2(1) = 6.977, p<0.01) and NM 
RT ICV (Wald χ2(1) = 4.929, p<0.05) were significant while other measures were not significant 
(p>0.05).  When TMT-A was added to the model, it was not significantly different from the prior 
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model (χ2(1) = 0.495, p>0.05); and only NM RT ISD remained a significant predictor (Wald 
χ2(1) = 5.423, p<0.05).  A model for goodness of fit with NM RT mean, NM accuracy mean, 
NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV as predictors of MCI was 
statistically significant, (χ2(6) = 17.299, p<0.01).  The model explained 6.4% (Nagelkerke R2) of 
the variance and correctly classified 80.9% of cases.  Examining all predictors in the model, NM 
RT mean (Wald χ2(1) = 3.910, p<0.05) and NM accuracy mean were significant (Wald χ2(1) = 
4.042, p<0.05), while other measures were not (p>0.05).  When TMT-A was added to the model, 
it was not significantly different from the prior model (χ2(1) = 0.001, p>0.05).  Examining all 
predictors in the model, only NM accuracy mean remained significant (Wald χ2(1) = 4.014, 
p<0.05), while other measures were not (p>0.05).   
 
Executive Function Domain 
Descriptive Statistics  
 Participants who completed NB2 and TMT-B were included in these analyses. 
Descriptive statistics for demographics and outcome are shown in Tables 3 and 10.  There were 
248 participants who had an approximate average age of 80 years.  The smaller sample size is 
due to the implementation of the NB2 task into the normal EAS testing protocol one year after 
other measures.  The current sample consisted of approximately 42% males and was primarily 
Caucasian (76%).  91.1% of the sample had a high school degree or higher and 96.8% had GDS 
classification of non-significant clinical symptoms of depression.  In addition, there was a 94% 
corresponding classification rate of healthy controls compared to the EAS definition of 
healthy/non-impaired elderly.  Table 11 includes means and standard deviations for NB2 RT and 
NB2 accuracy per block per group.     
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 Participants who did not have executive function domain testing did not significantly 
differ in age, gender and education (p>0.05) from those who had such testing.  Participants with 
executive function testing had a slightly greater distribution of Caucasian individuals and 
displayed fewer depressive symptoms but were not significantly different (p>0.05) from those 
without executive function testing.  In addition, at follow-up, participants with executive 
function testing had fewer incidences of MCI compared to participants without executive 
function testing but were not significantly different (p>0.05).  Descriptive statistics for 
demographics and outcome are shown in Table 3. 
 
Preliminary analyses to determine whether within-domain baseline experimental task 
measures (each block) compared to the within-domain baseline standard task measure 
characterized future MCI group status.   
 MANOVA was performed to examine differences between HC and MCI (EAS MCI 
outcome) based on NB2 RT and NB2 accuracy compared to TMT-B (Figures 24, 25 and 30).  
The MCI group performed significantly worse compared to HC on NB2 RT block 1 (p<0.05) 
and NB2 accuracy block 1 (p<0.05) but there were no significant differences between groups for 
NB2 RT blocks 2 and 3 (p>0.05), NB2 accuracy blocks 2 and 3 (p>0.05) and TMT-B (F(1,246) 
= 0.117, p>0.05); indicating that group differences were only present at the beginning of NB2 
RT and NB2 accuracy.  Levene’s test for homogeneity of variance was significant for NB2 
accuracy block 1 (p>0.05) but no other blocks of NB2 accuracy or NB2 RT or TMT-B (p>0.05).  
The Welch ANOVA found a significant difference between groups for NB2 accuracy block 1 
(p<0.05), indicating that whether variances were equal or unequal, the MCI group performed 
significantly worse than HC on NB2 RT block 1 and NB2 accuracy block 1. 
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 MANOVA was performed to examine differences between HC and MCI (AC MCI 
outcome) based on NB2 RT and NB2 accuracy compared to TMT-B (Figures 26, 27 and 31).  
The MCI group performed significantly worse than HC on NB2 RT blocks 1 and 3 (p<0.05) and 
NB2 accuracy blocks 1 and 3 (p<0.05) but not for NB2 RT block 2 or NB2 accuracy block 2 
(p>0.05) indicating that group differences were present for both NB2 RT and NB2 accuracy at 
the beginning and end of the session, but not in the middle. No significant differences were 
found between groups for TMT-B (F(1,246) = 0.076, p>0.05).  Levene’s test for homogeneity of 
variance was not significant for NB2 RT block 1, NB2 accuracy blocks 1 and 2 and TMT-B 
(p>0.05); it was significant for NB2 RT blocks 2 and 3 and NB2 accuracy block 3 (p<0.05).  The 
Welch ANOVA found a significant difference between groups for NB2 accuracy block 3 
(p<0.05) but not for NB2 RT blocks 2 and 3 (p>0.05).  Therefore, when we account for unequal 
variances, the MCI group performed significantly worse compared to HC only for NB2 RT block 
1 and NB2 accuracy blocks 1 and 3. 
 MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS 
MCI3 outcome) based on NB2 RT and NB2 accuracy compared to TMT-B (Figures 28, 29 and 
32).  There were no significant differences between groups for TMT-B (F(2,245) = 0.063, 
p>0.05), or any NB2 RT blocks (p>0.05) or any NB2 accuracy blocks (p>0.05) indicating that 
group differences were not present for TMT-B, NB2 RT and NB2 accuracy.  Levene’s test for 
homogeneity of variance was not significant for TMT-B, any NB2 RT blocks and NB2 accuracy 
blocks 1 and 2 (p>0.05); it was significant for NB2 accuracy block 3 (p<0.05).  The Welch 
ANOVA found no significant difference between groups for NB2 accuracy block 3 (p>0.05).  
Post hoc analyses for measures with homogenous variances found that the naMCI group did not 
significantly differ from the aMCI group or HC for TMT-B, any NB2 RT blocks and NB2 
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accuracy blocks 1 and 2 (p>0.05).  The aMCI group was not significantly different from HC for 
any measure (p>0.05).  Post hoc analyses for non-homogenous measures found the naMCI group 
was not significantly different from the aMCI or HC on accuracy block 3 (p>0.05); aMCI group 
was not significantly different from HC for NB2 accuracy block 3 (p>0.05).  Therefore, when we 
account for unequal variances, there were no significant differences between the groups. 
 
Preliminary analyses to determine whether within-domain repeated blocks of baseline 
experimental task (across-block) measures characterized future MCI group status. 
 Repeated Measures MANOVA was performed to examine differences between HC and 
MCI (EAS MCI outcome) based on repeated NB2 RT and NB2 accuracy over time (Figures 24 
and 25).  There was a significant effect of blocks over time (F(4,243) = 16.233, p<0.001; Pillai’s 
Trace = 0.211) indicating that repeated blocks had an effect on performance over time.  
Mauchly’s test for sphericity found that the assumption of sphericity was not met (p<0.001).  
When re-evaluated with a Greenhouse-Geisser correction, NB2 RT was not statistically 
significantly (F(1.405, 345.595) = 0.497, p>0.05) but NB2 accuracy was statistically significant 
(F(1.509, 371.231) = 12.401, p<0.001).  The MCI group was not significantly different from HC 
in NB2 RT (F(1,246) = 2.464, p>0.05) and NB2 accuracy (F(1,246) = 3.248, p>0.05) over time.  
Post hoc analyses examining within-subjects repeated contrasts, while taking group membership 
into account, showed that the MCI group performed significantly worse compared to HC for 
NB2 RT block 1 (p<.05) but not blocks 2 or 3 (p>0.05).  The MCI group performed significantly 
worse compared to HC for NB2 accuracy block 1 (p<0.05) but not blocks 2 or 3 (p>0.05).  In 
addition, the MCI group did not significantly improve over time for NB2 RT (p>0.05).  The MCI 
group performed significantly poorer in NB2 accuracy from block 1 to 2 (p<0.05) but did not 
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significantly improve or worsen from block 2 to 3 (p>0.05).  When we compared NB2 accuracy 
performance at the beginning compared to the end of the task, the MCI group performed 
significantly worse at block 3 compared to block 1 (p<0.05) indicating the MCI group had poorer 
performance over time for NB2 accuracy.  HC did not significantly improve in NB2 RT over 
time (p>0.05).  HC performed significantly worse in NB2 accuracy from block 1 to 2 (p<0.01) 
but did not significantly improve or worsen in performance from block 2 to 3 (p>0.05).  When 
we compared NB2 accuracy performance at the beginning compared to the end of the task, HC 
performed significantly worse at block 3 compared to block 1 (p<0.05) indicating HC had poorer 
performance over time for NB2 accuracy.   
 Repeated Measures MANOVA was performed to examine differences between HC and 
MCI (AC MCI outcome) based on repeated NB2 RT and NB2 accuracy over time (Figures 26 
and 27).  There was a significant effect of blocks over time (F(4,243 = 14.673, p<0.001; Pillai’s 
Trace = 0.195), indicating that repeated blocks had an effect on performance over time.  
Mauchly’s test for sphericity found that the assumption of sphericity was not met (p<0.001).  
When re-evaluated with a Greenhouse-Geisser correction, NB2 RT was not statistically 
significantly (F(1.405, 345.556) = 0.122, p>0.05) but NB2 accuracy was statistically significant 
(F(1.508, 370.845) = 15.027, p<0.001) indicating that the effect of blocks was only present for 
NB2 accuracy.  The MCI group performed significantly poorer compared to HC for NB2 RT 
(F(1,246) = 5.541, p<0.05) and NB2 accuracy (F(1,246) = 8.481, p<0.01) over time.  Post hoc 
analyses examining within-subjects repeated contrasts, while taking group membership into 
account, showed that the MCI group performed significantly worse than HC for NB2 RT and 
NB2 accuracy blocks 1 and 3 (p<0.05) but not block 2 (p>0.05).  In addition, the MCI group did 
not significantly improve over time in NB2 RT (p>0.05).  The MCI group performed 
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significantly worse in NB2 accuracy (p<0.05) over time.  HC did not significantly improve from 
NB2 RT block 1 to 2 (p>0.05) but did improve from block 2 to 3 (p<0.05).  HC performed 
significantly worse in NB2 accuracy from block 1 to 2 (p<0.05) but did not improve or worsen 
from block 2 to 3 (p>0.05).  When we compared NB2 accuracy performance at the end of task 
compared to the beginning, HC performed significantly worse at block 3 compared to block 1 
(p<0.05) indicating HC had poorer performance over time. 
 Repeated Measures MANOVA was performed to examine differences between HC, 
aMCI and naMCI (EAS MCI3 outcome) based on repeated NB2 RT and NB2 accuracy over 
time (Figures 28 and 29).  There was a significant effect of blocks over time (F(4,242) = 11.414, 
p<0.001; Pillai’s Trace = 0.159) indicating that repeated blocks had an effect on performance 
over time.  Mauchly’s test for sphericity found that the assumption of sphericity was not met 
(p<0.001).  When re-evaluated with a Greenhouse-Geisser correction, NB2 RT was not 
statistically significantly (F(1.405, 344.134) = 0.571, p>0.05) while NB2 accuracy was 
statistically significant (F(1.506,369.074) = 7.922, p=0.001).  Outcome groups did not 
significantly differ in NB2 RT (F(2,245) = 1.386, p>0.05) nor NB2 accuracy (F(2,245) = 1.668, 
p>0.05).  Post hoc analyses examining within-subjects repeated contrasts, while taking group 
membership into account, found that the naMCI group was not significantly different from the 
aMCI or HC groups for any NB2 RT or NB2 accuracy blocks (p>0.05).  The aMCI group did not 
significantly differ from HC for any NB2 RT or NB2 accuracy blocks (p>0.05).  In addition, the 
naMCI group did not significantly improve in NB2 RT or NB2 accuracy over time (p>0.05).  
The aMCI group did not significantly improve in NB2 RT (p>0.05), but did perform poorer at 
the end of NB2 accuracy compared to the beginning (p<0.05) indicating that the aMCI group had 
poorer performance over time for NB2 accuracy.  HC did not significantly improve in NB2 RT 
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(p>0.05) over time.  HC performed significantly poorer from NB2 accuracy block 1 to 2 
(p<0.05) and did not improve or worsen from block 2 to 3 (p>0.05).  When we compare NB2 
accuracy performance at the end compared to the beginning of the task, HC performed 
significantly worse at block 3 compared to block 1 (p<0.05) indicating HC had poorer 
performance over time. 
 
Aim I: Determine whether within-domain baseline experimental task IIV measures 
compared to the within-domain baseline standard task measure characterized future MCI 
group status. 
 MANOVA was performed to examine differences between HC and MCI (EAS MCI 
outcome) based on NB2 RT and NB2 accuracy mean and variability (intraindividual standard 
deviation, intraindividual coefficient of variation) compared to TMT-B (Table 12).  The MCI 
group performed significantly worse than HC for NB2 RT ICV (p<0.05) but not TMT-B, NB2 
RT mean, NB2 accuracy mean, NB2 RT ISD, NB2 accuracy ISD and NB2 accuracy ICV 
(p>0.05).  Levene’s test for homogeneity of variance was not significant for TMT-B, NB2 RT 
mean, NB2 accuracy mean, NB2 RT ISD, NB2 accuracy ISD and NB2 accuracy ICV (p>0.05) 
but was significant for NB2 RT ICV (p<0.05).  The Welch ANOVA found no significant 
difference between groups for NB2 RT ICV (p>0.05), indicating that when unequal variances 
were accounted for, there were no significant differences between groups. 
 Partial correlations were computed to determine the association between the classification 
outcome groups of EAS MCI and all testing measures when controlling for demographic 
variables (age, gender, ethnicity, education, GDS).  Without controlling for demographics, there 
were significant correlations between outcome and NB2 RT ICV (p<0.05) but no other measures 
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(p>0.05).  When controlling for demographics, the relationship between outcome and NB2 RT 
ICV was no longer significant (p>0.05) indicating that demographic variables had a strong 
influence on the relationship between outcome and testing measures.  MANCOVA testing for 
covariates found no significant interactions between age, gender, ethnicity, education, GDS and 
outcome (p>0.05). 
 MANOVA was performed to examine differences between HC and MCI (AC MCI 
outcome) based on NB2 RT and NB2 accuracy mean and variability (intraindividual standard 
deviation, intraindividual coefficient of variation) compared to TMT-B (Table 12).  The MCI 
group performed significantly worse compared to HC for NB2 RT mean, NB2 accuracy mean, 
NB2 RT ISD and NB2 RT ICV (p<0.05) but not TMT-B, NB2 accuracy ISD and NB2 accuracy 
ICV (p>0.05).  Levene’s test for homogeneity of variance was not significant for TMT-B and 
NB2 accuracy mean (p>0.05) but was significant for NB2 RT mean, NB2 RT ISD, NB2 
accuracy ISD, NB2 RT ICV and NB2 accuracy ICV (p<0.05).  The Welch ANOVA found a 
significant difference between groups for NB2 RT mean (p<0.05) but not RT ISD, accuracy ISD, 
RT ICV and accuracy ICV (p>0.05).  Therefore, after accounting for unequal variances, the MCI 
group was significantly different from HC for only NB2 RT mean and NB2 accuracy mean.  
 Partial correlations were computed to determine the association between the classification 
outcome groups of AC MCI and all testing measures when controlling for demographic variables 
(age, gender, ethnicity, education, GDS).  Without controlling for demographics, there were 
significant correlations between outcome and NB2 RT mean, NB2 accuracy mean, NB2 RT ISD 
and NB2 RT ICV (p<0.05) but no other measures (p>0.05).  When controlling for demographics, 
the relationship between outcome and NB2 RT mean and NB2 accuracy mean were still 
significant (p<0.05) but the relationship between outcome and NB2 RT ISD and NB2 RT ICV 
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was no longer significant (p>0.05) indicating that demographic variables had some influence on 
the relationship between outcome and testing measures – specifically variability measures.  
MANCOVA testing for covariates found no significant interactions between age, gender, 
ethnicity, education, GDS and outcome (p>0.05).   
 MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS 
MCI3 outcome) based on NB2 RT and NB2 accuracy mean and variability (intraindividual 
standard deviation, intraindividual coefficient of variation) compared to TMT-B (Table 12).  
There were no significant differences between groups for TMT-B, NB2 RT mean, NB2 accuracy 
mean, NB2 RT ISD, NB2 accuracy ISD and NB2 accuracy ICV (p>0.05) but there was a 
significant difference between groups for NB2 RT ICV (p<0.05).  Levene’s test for homogeneity 
of variance was not significant for TMT-B, NB2 RT mean, NB2 accuracy mean, NB2 accuracy 
ISD and NB2 accuracy ICV (p>0.05) but was significant for NB2 RT ISD and NB2 RT ICV 
(p<0.05).  The Welch ANOVA found no significant difference between groups for NB2 RT ISD 
and NB2 RT ICV (p>0.05), thus indicating that when unequal variances were accounted for, 
groups were no longer significantly different.  Post hoc analyses for measures with homogenous 
variances found that the naMCI was not significantly different from the aMCI or HC groups for 
TMT-B, NB2 RT mean, NB2 accuracy mean, NB2 accuracy ISD and NB2 accuracy ICV 
(p>0.05); the aMCI group did not significantly differ from HC for any measure (p>0.05).  Post 
hoc analyses for measures with non-homogenous variances found the naMCI group was not 
significantly different from the aMCI or HC groups for NB2 RT ISD and NB2 RT ICV (p>0.05); 
the aMCI group was not significantly different from HC for any measure (p>0.05).   
 Partial correlations were computed to determine the association between the classification 
outcome groups of EAS MCI3 and all testing measures when controlling for demographic 
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variables (age, gender, ethnicity, education, GDS).  Without controlling for demographics, there 
were no significant correlations between outcome and testing measures (p>0.05).  MANCOVA 
testing for covariates found no significant interactions between age, gender, ethnicity, education, 
GDS and outcome. There was a significant interaction between ethnicity dichotomized groups 
(Caucasian vs. non-Caucasian) and outcome – when ethnicity was accounted for, outcome 
groups were not significantly different (p>0.05). 
 
Aim II: Determine whether within-domain baseline experimental task IIV measures 
compared to the within-domain baseline standard task measure predicted future MCI 
group status. 
 Binomial Logistic Regression was performed to examine the prediction of HC and 
naMCI (EAS naMCI outcome) based on variability (intraindividual standard deviation, 
intraindividual coefficient of variation) in NB2 RT and NB2 accuracy compared to TMT-B.  A 
model for goodness of fit with only TMT-B as a predictor of naMCI was not statistically 
significant, (χ2(1) = 0.011, p>0.05).  When NB2 RT ISD, NB2 accuracy ISD, NB2 RT ICV and 
NB2 accuracy ICV were added to the model, it did not significantly differ from the prior model 
(χ2(4) = 2.714, p>0.05).  A model for goodness of fit with NB2 RT ISD, NB2 accuracy ISD, 
NB2 RT ICV and NB2 accuracy ICV as predictors of naMCI was not statistically significant, 
(χ2(4) = 2.715, p>0.05).  When TMT-B was added to the model, it was not significantly different 
from the prior model (χ2(1) = 0.010, p>0.05). 
 Binomial Logistic Regression was performed to examine the prediction of HC and MCI 
(AC MCI outcome) based on variability (intraindividual standard deviation, intraindividual 
coefficient of variation) in NB2 RT and NB2 accuracy compared to TMT-B.  A model for 
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goodness of fit with only TMT-B as a predictor of MCI was not statistically significant, (χ2(1) = 
0.094, p>0.05).  When NB2 RT ISD, NB2 accuracy ISD, NB2 RT ICV and NB2 accuracy ICV 
were added to the model, it was not significantly different from the prior model (χ2(4) = 5.499, 
p>0.05).  A model for goodness of fit with NB2 RT ISD, NB2 accuracy ISD, NB2 RT ICV and 
NB2 accuracy ICV as predictors of MCI was not statistically significant, (χ2(4) = 5.562, p>0.05).  
When TMT-B was added to the model, it was not significantly different from the prior model 
(χ2(2) = 12.747, p<0.05).  When NB2 RT mean and NB2 accuracy mean were added to the 
model, it was significantly different from the prior model (χ2(4) = 5.499, p>0.05).  The model 
explained 11.7% (Nagelkerke R2) of the variance and correctly classified 81.5% of cases.  
Examining all predictors in the model, NB2 RT mean (Wald χ2(1) = 5.101, p<0.05) and NB2 
accuracy mean were significant (Wald χ2(1) = 6.317, p<0.05), while other measures were not 
(p>0.05). 
 
Across-Domain 
Descriptive Statistics  
 Participants who completed the CRRST, NM, NB2, FCSRT, TMT-A and TMT-B were 
included in these analyses. Descriptive statistics for demographics and outcome are shown in 
Table 3 under the heading for the executive function domain.  Principle component analyses 
(PCA) and Barycentric discriminant analyses (BADA) were executed and initial results indicated 
a possible outlier – which was then removed for the following analyses and results.  
Additionally, the intraindividual coefficient of variation was strongly correlated with the 
intraindividual standard deviation and indicated they were redundant variables; therefore, the 
intraindividual coefficient of variation was removed from the following analyses.  Also, scores 
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on the FCSRT were reverse-scored in order to have the same directionality for all variables (i.e. 
higher scores indicate poorer task performance). 
 
Aim III: Determine whether across-domain baseline experimental task IIV measures 
compared to across-domain baseline standard task measures characterized future MCI 
group status.   
 PCA was performed to examine variability (intraindividual standard deviation) in 
CRRST, NM and NB2 RT and CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A 
and TMT-B.  Statistical significance of the components was determined via a permutation test, 
and the first three components (which accounted for approximately 56% of the total variance) 
were found to be significant (p<0.001; Tables 13 and 14, Figure 33).  Component one had the 
highest positive loadings for: TMT-B, TMT-A, CRRST RT ISD, NB2 RT ISD, NB2 accuracy 
ISD, FCSRT, CRRST accuracy ISD and NM accuracy ISD (Figures 33 and 34).   This 
component represented participants who had better performance on all of these tasks at baseline 
and as such, showed lower variability on experimental tasks and lower scores on standard tasks 
for all domains.  Component two had the highest positive loadings for: NB2 Accuracy ISD and 
NB2 RT ISD; and the highest negative loadings for: TMT-A, FCSRT, TMT-B, CRRST RT ISD 
and CRRST accuracy ISD (Figures 33 and 35).  This component represented participants that 
who had greater variability on the executive function experimental task IIV measures, but lesser 
variability on the episodic memory experimental task variability measures and better 
performance on all standard task measures.  Component three had the highest positive loadings 
for: CRRST accuracy ISD, CRRST RT ISD, NM accuracy ISD, FCSRT and NM RT ISD; and 
the highest negative loadings for: TMT-A and TMT-B (Figure 36).  This component represented 
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participants who had lower variability for the episodic memory and processing speed 
experimental task variability measures and better performance on the episodic memory standard 
task measure but poorer performance on other standard task measures.  The FCSRT, TMT-A, 
TMT-B, CRRST RT ISD and CRRST accuracy ISD contributed to all three components 
indicating that these measures were the most meaningful when examining cognitive impairment.  
 
Aim IV: Determine whether across-domain baseline experimental task IIV measures 
compared to across-domain baseline standard task measures predicted future MCI group 
status at different time points.   
 Outcome (Table 2) was measured using two methods: (1) EAS MCI3 – EAS definition of 
HC, aMCI and naMCI; and (2) AC pre-MCI – HC, pre-MCI and MCI.  AC pre-MCI was a 
partitioning of the AC MCI outcome where within the AC MCI outcome participants who were 
classified as HC could be HC or fall somewhere between HC and MCI.  Participants who did not 
fit the criteria of HC or the criteria of MCI, but were somewhere in-between, were considered to 
be representative of a possible pre-MCI stage. This group of participants included individuals 
who (1) have a cognitive impairment as described by the BIMC, little or no functional 
impairment as described by the IADL and no cognitive complaint as described by the FAST or 
(2) no cognitive impairment as described by the BIMC, slight functional impairment as described 
by the IADL and cognitive complaint or no complaint as described by the FAST.  Additionally, 
when we examined incidence of MCI or pre-MCI, we noted that these outcomes could occur at 
any point following baseline testing. 
 BADA was performed to examine differences between HC, aMCI and naMCI (EAS 
MCI3 outcome) based on variability (intraindividual standard deviation) in CRRST, NM and 
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NB2 RT and CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.  
Because there were three groups, BADA extracted two components that explained 100% of the 
variance (Abdi & Williams, 2010a).  The percentage of variance explained by the first 
component was 73.497% (p=0.283).  Component one had significant loadings for FCSRT 
(p<0.05).  In addition, the HC and aMCI groups were significantly different for component one 
(p<0.05), based on bootstrap confidence intervals (Beaton et al., 2014).  The percentage of 
variance explained by the second component was 26.503% (p=0.717).  Component two had 
significant loadings for TMT-B (p<0.05).  The HC and naMCI groups were significantly 
different for component two (p<0.05), based on bootstrap confidence intervals (Beaton et al., 
2014).  Thus, when examining the EAS MCI3 outcome, standard task measures contributed 
reliably to the first two components while experimental task IIV measures did not.   
 BADA was then performed to examine differences between HC, pre-MCI and MCI (AC 
pre-MCI outcome) based on variability (intraindividual standard deviation) in CRRST, NM and 
NB2 RT and CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.  
Because there were three groups, BADA extracted two components that explained 100% of the 
variance.  The percentage of variance explained by the first component was 77.91% (p=0.125).  
The percentage of variance explained by the second component was 22.09% (p=0.875).  No 
measures significantly contributed to component one or two (p>0.05) when examining the AC 
pre-MCI outcome.  But, based on bootstrap confidence intervals, the HC and the MCI groups 
were significantly different for component one (p<0.05). 
 Participants were classified as MCI at any point during their successive waves.  
Participants were not classified as MCI during the same follow-up period (i.e. some participants 
had incident MCI three years after baseline while others had incident MCI seven years after 
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baseline).  Also, participants did not continue in the study for the same follow-up period (i.e. 
some participants only completed one year of follow-up while others completed five years of 
follow-up).  Table 15 summarizes the follow-up period for participants that completed the entire 
baseline testing and also includes incident MCI occasions.  This information allowed for 
analyses that examined when MCI occurred following baseline measurement, and when 
experimental task IIV measures compared to standard task measures were able to predict the 
incidence of MCI.  Outcome (Table 2) was measured using four methods: (1) EAS MCI 3 vs 4 - 
HC, EAS definition of first incidence of MCI within three years after baseline and EAS 
definition of first incidence of MCI four or more years after baseline; (2) AC MCI 3 vs 4 – HC, 
Alternate Criteria definition of first incidence of MCI within three years after baseline and 
Alternate Criteria definition of first incidence of MCI four or more years after baseline; (3) AC 
pre-MCI 3- HC, Alternate Criteria definition of first incidence of pre-MCI within three years 
after baseline and Alternate Criteria definition of first incidence of MCI within three years after 
baseline; and (4) AC pre-MCI 4 - HC, Alternate Criteria definition of first incidence of pre-MCI 
four or more years after baseline and Alternate Criteria definition of first incidence of MCI four 
or more years after baseline.    
 BADA was performed to examine differences between HC, MCI within three years after 
baseline and MCI four or more years after baseline (EAS MCI 3 vs 4 outcome) based on 
variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and CRRST, NM 
and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.  Because there were three groups, 
BADA extracted two components that explained 100% of the variance.  The percentage of 
variance explained by the first component was 80.531% (p=0.092).  Component one had 
significant loadings for FCSRT, CRRST RT ISD and TMT-B (p<0.05) when examining the EAS 
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MCI 3 vs 4 outcome.  In addition, the HC and the MCI within three years after baseline groups 
were significantly different for component one (p<0.05).  The percentage of variance explained 
by the second component was 19.469% (p=0.908).  No measures significantly contributed to 
component two (p>0.05).  Also, groups did not significantly differ for component two (p>0.05). 
 BADA was performed to examine differences between HC, MCI within three years after 
baseline and MCI four or more years after baseline (AC MCI 3 vs 4 outcome) based on 
variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and CRRST, NM 
and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.  Because there were three groups, 
BADA extracted two components that explained 100% of the variance.  The percentage of 
variance explained by the first component was 74.705% (p=0.268).  The HC and the MCI within 
three years after baseline groups were significantly different for component one (p<0.05).  The 
percentage of variance explained by the second component was 25.295% (p=0.732).  No 
measures significantly contributed to component one or two (p>0.05) when examining the AC 
MCI 3 vs 4 outcome.   
 BADA was performed to examine differences between HC, pre-MCI within three years 
after baseline and MCI within three years after baseline (AC pre-MCI 3 outcome) based on 
variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and CRRST, NM 
and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.  Because there were three groups, 
BADA extracted two components that explained 100% of the variance.  The percentage of 
variance explained by the first component was 80.102% (p=0.171).  The HC and the MCI within 
three years after baseline groups were significantly different for component one (p<0.05).  The 
percentage of variance explained by the second component was 19.898% (p=0.829). The HC and 
the pre-MCI within three years after baseline groups were significantly different for component 
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two (p<0.05).  No measures significantly contributed to component one or component two 
(p>0.05) when examining the AC pre-MCI 3 outcome.    
 Participants who did not have four or more years of follow-up data were removed from 
the final analysis below (descriptive statistics included in Table 16).  Participants with three or 
fewer waves of follow-up data did not significantly differ in age, gender, ethnicity, education or 
depressive symptoms (p>0.05) from those who had four or more waves of follow-up data.  In 
addition, participants with 3 or fewer waves of follow-up data had significantly fewer incidences 
of MCI and pre-MCI compared to participants with four or more waves of follow-up data 
(p<0.01).  Descriptive statistics for demographics and outcome are shown in Table 16. 
 BADA with inference was performed to examine differences between HC, pre-MCI four 
or more years after baseline and MCI four or more years after baseline (AC pre-MCI 4 outcome) 
based on variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and 
CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.  Because there were 
three groups, BADA extracted two components that explained 100% of the variance.  The 
percentage of variance explained by the first component was 71.618% (p=0.298).  Component 
one had no significant loadings (p>0.05).  The percentage of variance explained by the second 
component was 28.382% (p=0.702).  Component two had significant loadings for TMT-A 
(p<0.05).  In addition, the HC and the pre-MCI four or more years after baseline groups were 
significantly different for component two (p<0.05). 
 
Discussion 
 The overall objective of the current study was to determine whether novel, experimental 
task measures of intraindividual variability are better able to characterize and predict MCI as 
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compared to standard neuropsychological task measures within the same cognitive domains.  We 
examined across-block performance within and across domains to determine if measures of 
variability and performance over time were able classify and predict future MCI group status 
better than conventional standard measures.  We also examined incident MCI group status at 
varying time intervals, to determine if measures of variability were able to predict MCI group 
status at earlier time points compared to conventional measures.  Experimental task variability 
measures were able to distinguish between MCI and HC groups for the episodic memory domain 
but not processing speed or executive function domains.  Experimental task variability measures 
were able to predict future MCI for the episodic memory domain when utilizing the alternate 
criteria but not when examining the traditional MCI classification.  Non-variability experimental 
task measures were able to distinguish between MCI and HC and predict future MCI but 
standard task measures were unable to do so.  Experimental task variability measures and 
standard task measures examined together were meaningful in distinguishing between MCI and 
HC.  Experimental task variability measures and standard task measures together were able to 
predict MCI up to 3 years prior to diagnosis.  Results are summarized (Table 17) and discussed 
below with implications for current practice and future research efforts.   
 
Episodic Memory Domain 
Preliminary analyses to determine whether within-domain baseline experimental task 
measures compared to the within-domain baseline standard task measure characterized future 
MCI group status.  
 Within the episodic memory domain, we examined differences between future MCI and 
HC at baseline using EAS MCI as the outcome.  The MCI group performed worse on all blocks 
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of reaction time and accuracy for the experimental task and performed worse on the standard 
task compared to HC, supporting our hypothesis that baseline differences between groups were 
present before MCI classification was determined.  We were surprised, however, that group 
differences in episodic memory performance between HC and MCI could be present up to 10 
years before an actual MCI diagnosis.  To further explore this idea, we also examined the 
measures using a different outcome – AC MCI.  As noted above, we employed an alternate 
classification criterion to avoid diagnostic circularity.  In a cross-sectional analysis, circularity 
becomes an issue when the same measures are used both to classify groups and as the primary 
outcome measures.  For the current study, we used the standard task measures at baseline and the 
same standard task measures at a later time point for diagnoses – a type of longitudinal 
assessment where we should not have had an issue with circularity.  Nevertheless, we also 
examined differences in baseline performance on all testing measures between MCI and HC 
using AC MCI as the outcome. 
 We examined differences between future MCI and HC at baseline using AC MCI as the 
outcome and found that the MCI group performed significantly worse than HC on all blocks of 
reaction time and most blocks of accuracy for the experimental task.  Experimental task 
performance differences found between future MCI and HC groups for the AC MCI outcome 
were similar to the results found for the EAS MCI outcome indicating that even when using an 
alternate group classification method, baseline differences between groups were still present.  
The experimental task was very robust such that even when groups were diagnosed using an 
alternate criteria, differences between MCI and HC were still present at baseline.  The most 
interesting difference was that when utilizing the AC MCI outcome, the HC and MCI groups had 
no significant baseline differences for the standard task, whereas with the EAS MCI outcome 
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there were significant baseline differences.  It is possible that there is some issue of circularity 
with the EAS MCI classification criteria even years after baseline testing.  The experimental task 
is able to distinguish future MCI from HC regardless of the classification method used.  As there 
is no “gold standard” for assessing MCI, a task utilizing repeated measurement in a short amount 
of time could provide a good option for assessing subtle deficits in episodic memory years before 
clinical changes manifest.    
 We further investigated the specificity of using episodic memory tasks to assess 
individuals with future impairment in memory compared to individuals with future impairment 
in non-memory domains.  The EAS MCI3 outcome divides participants previously classified as 
future MCI into future aMCI and naMCI – participants with and without memory impairment.  
We found that HC and MCI groups significantly differed on the standard and experimental tasks.  
Specifically, the aMCI group performed significantly poorer than HC on all blocks of reaction 
time and accuracy for the experimental task and also for the standard task.  The aMCI group 
performed significantly worse than the naMCI group only for the standard task and not the 
experimental task.  In this instance, the experimental task was able to distinguish between future 
memory-impaired individuals from cognitively healthy, but was unable to distinguish at a more 
sensitive level – between memory-impaired and non-memory impaired.  When testing at a cross-
sectional level, individuals classified as memory-impaired present with poorer recall of learned 
items resulting as reduced total item scores or poorer accuracy.  In this instance, we again note 
that individuals present with poorer episodic memory performance years before diagnosis as 
memory-impaired.  Also, these individuals present with slower processing speed indicating that 
not only do they have difficulty retrieving items, they also require more time to do so.  This 
could mean that these individuals also have deficits in non-memory domains or their deficiency 
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in speed may be directly related to episodic memory tasks alone.  Further investigation 
examining processing speed performance in aMCI is required in order to discern whether the 
observed deficit is related to episodic memory or a combination of impairments.   
 In addition, the naMCI group performed significantly worse than HC on measures of 
speed but not on measures of accuracy for the experimental task, nor did the groups differ for the 
standard task.  The future naMCI group had deficits in speed of performance but not recall of 
items.  Also, the naMCI group did not perform poorer compared to HC at all blocks of reaction 
time, but on most.  Thus, it appears that the naMCI group only had deficits in non-memory 
domains and also those deficits may be slight and not noticeable on an every-day basis.  Also, 
when we re-examine the prior EAS MCI outcome, we observed differences between groups for 
all measures, but at the EAS MCI3 outcome, differences between groups are not present for all 
measures.  We conclude that the differences in episodic memory recall in the MCI participants 
are related to memory impairment in the aMCI group – these participants had a large influence 
on the overall MCI group performance when we analyzed data using EAS MCI as the outcome. 
 
Preliminary analyses to determine whether within-domain repeated blocks of baseline 
experimental task (across-block) measures characterized future MCI group status. 
 We examined differences between future MCI and HC at baseline using EAS MCI as the 
outcome and found that the MCI group performed worse on the experimental task over time 
compared to HC.  This finding supported our hypothesis that baseline differences between 
groups were present before MCI classification was determined.  The CRRST was a repeated-
block task (as are the other experimental tasks) in which repeated test blocks were implemented 
primarily to measure learning potential over time.  Taking the repeated-block aspect of the 
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experimental task into account, the MCI group performed significantly different at each block of 
reaction time and accuracy compared to HC.  Interestingly, the MCI and HC groups had a similar 
trend of performance over time such that both groups generally improved in performance for 
reaction time and accuracy.  The MCI group significantly improved in reaction time at the 
beginning and end of the session but not in the middle – there was no consistent improvement.  
However, HC improved in all reaction time blocks over time illustrating constant improvement 
over the course of the task.  Those with MCI could have become fatigued and therefore were 
unable to improve on their speed over time, whereas HC did not suffer the same effects.  The 
MCI and HC groups improved in accuracy over time, but reached their plateau and displayed no 
significant increase in words retrieved after the fifth block.  Although the amount of words 
recalled differed between groups, the ability to retrieve words over time were similar.  We 
conclude that both groups shared a similar trend of reaching their maximum threshold for 
accessing stored information but there are differences between groups in the threshold limits, 
years before an actual MCI or HC diagnosis. 
 We examined differences between future MCI and HC at baseline using AC MCI as the 
outcome and found that the MCI group performed poorer on the experimental task over time 
compared to HC.  As observed with the EAS MCI outcome, HC significantly improved in 
reaction time across all blocks and most blocks of accuracy – plateauing at block 5, with no 
significant difference between block 5 and 6.  The MCI group significantly improved in reaction 
time at the beginning of the testing session but not on later blocks (the MCI group plateaued at 
block 4).  In addition, the MCI group improved in accuracy at the beginning and at the end of the 
session but not in the middle.  Again, we observed that those with MCI are unable to consistently 
improve throughout the testing session.  This could indicate that those with MCI are more prone 
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to fatigue and tests of repeated measurement are more difficult due to the constant effort that 
must be sustained.  With a multi-block design we are able to measure performance at different 
time points, but traditional tasks sum up performance and do not allow for subtle changes in 
performance to be detected across blocks.   
 We further investigated if the fluctuation in performance in the MCI group could be a 
result of differing performance profiles between aMCI and naMCI participants.  Utilizing the 
EAS MCI3 outcome, we found that HC and MCI groups were significantly different on reaction 
time and accuracy over time.  Specifically, the aMCI group performed significantly poorer than 
HC on all blocks of reaction time and accuracy, but performed poorer than the naMCI group 
only for a few blocks of accuracy and no blocks of reaction time.  We note that the future aMCI 
group took longer to retrieve words and had less accuracy compared to HC and was therefore 
unable to utilize the repeated-block design to their advantage.  We also observed that the 
repeated speed and accuracy measures of the episodic memory task were able to discriminate 
between future aMCI and HC but were unable to discriminate at a more finite level – between 
aMCI and naMCI.  When we examined the naMCI in comparison to HC, we found the naMCI 
group performed poorer than HC on most blocks of reaction time but did not differ for accuracy 
blocks.  When we examined the EAS MCI outcome, we noted that the MCI group had poorer 
reaction time and accuracy performance over time in comparison to HC.  When we separated the 
MCI group into aMCI and naMCI, we found that the poorer accuracy was due to the aMCI 
group, while poorer reaction time was exhibited by both aMCI and naMCI years before actual 
diagnosis.   
 In the Ramratan and colleagues (2012) cross-sectional study, the authors examined 
experimental task performance in aMCI compared to HC and found that the aMCI group 
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exhibited poorer reaction and accuracy over time compared to HC.  In the current study, we have 
similar findings – but to a lesser degree, suggesting that we may be tapping into the early stages 
of decline and deficits in episodic memory that present years before previously thought.  In 
addition, we further examined within-group performance and found that the HC were able to 
consistently improve on their reaction and accuracy performance over time, whereas the aMCI 
and naMCI groups had less consistency in performance over time.  This change, or variation in 
performance over short periods of time could indicate cognitive instability, which is detrimental 
on tasks requiring speeded and efficient processing of information (Walhovd & Fjell, 2007).  
Further analyses are required to explore these changes in performance over time. 
 
Aim I: Determine whether within-domain baseline experimental task IIV measures compared 
to the within-domain baseline standard task measure characterized future MCI group status. 
 We examined differences between future MCI and HC at baseline using EAS MCI as the 
outcome and found that the MCI group performed worse on mean and variability measures for 
the experimental task and also for the standard task measure compared to HC.  This finding 
supported our hypothesis that differences between groups in baseline mean and variability 
measures were present before MCI classification was established.  In the preliminary analyses 
we found differences between groups examining baseline performance on experimental and 
standard tasks.  We did not change how we interpreted performance on the standard task 
therefore the results should remain unchanged, which they did.  The experimental task mean and 
variability measures used for the current analyses were derived from the original block data, 
therefore if differences between groups were present at each block and across-block it is fair to 
assume that these differences between groups should also exist when examining change or 
88 
 
variability over multiple blocks, which they were.  Within-person variability was calculated 
using a standard deviation score across-block per participant.  Standard deviation is a measure of 
spread of scores within a set of data – in this case, participant performance across multiple 
blocks.  A large spread indicates that there are probably large differences or greater variation 
between individual scores.  And within the MCI group there was a larger spread of scores 
compared to HC thus indicating that there was greater inconsistency in performance for the MCI 
group compared to HC.  Also, after controlling for demographics, no significant associations 
remained between outcome and testing measures.  Also, there were no significant interactions 
between demographics and outcome.   
 We then examined differences between future MCI and HC at baseline using AC MCI as 
the outcome and found that the MCI group performed worse on most mean and variability 
measures for the experimental task compared to HC, but there was no difference between groups 
for the standard task.  Similar to the prior preliminary analyses, we did not find a significant 
difference between the HC and MCI groups for the standard task, so we did not expect to find a 
difference in this analysis.  When utilizing the alternate classification for MCI, differences 
between MCI and HC groups for the experimental task reaction time and accuracy mean and 
variability measures were still present.  Surprisingly, the HC and MCI groups also did not differ 
when we measured the coefficient of variation for reaction time.  The coefficient of variation is 
calculated based on the standard deviation divided by the mean across-blocks per person.  The 
coefficient of variation measures spread and captures the amount of variability relative to the 
mean.  The amount of reaction time variability relative to the mean did not differ between MCI 
and HC groups.  Gorus and colleagues (2008) previously found that those with aMCI had greater 
intraindividual coefficient of variation values compared to HC only when performing complex 
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tasks; simple tasks did not provide any difference in the intraindividual coefficient of variation 
between groups.  It is possible that a reaction time measure for an episodic memory task may not 
provide enough complexity to reveal differences between HC and MCI when utilizing the 
coefficient of variation.  We therefore later examined these experimental task variability 
measures specifically in the aMCI group.  Also, after controlling for demographic variables, no 
significant associations remained between outcome and testing measures.  There was a 
significant interaction between ethnicity and outcome and gender and outcome.  When 
demographics were accounted for, outcome groups were still significantly different.  It therefore 
appears that the differences between groups were a result of baseline task performance and not 
due to the influence of other contributing factor.   
 Utilizing the EAS MCI3 outcome, we investigated if baseline experimental task mean 
and variability measures and performance on the standard task differed between HC, aMCI and 
naMCI groups.  The aMCI group performed significantly poorer than HC on the standard task 
(which we saw earlier) and most mean and variability measures of the experimental task but 
groups did not differ for the reaction time coefficient of variation measure.  These findings 
correspond to the results by Gorus and colleagues (2008) and lend support to the idea that the 
reaction time component of an episodic memory task may not be sufficiently complex to allow 
for differentiation between groups when examined using the coefficient of variation.  Other 
variability measures, such as the intraindividual standard deviation, may be better equipped to 
reveal group differences.   
 We also found the aMCI group performed significantly poorer than naMCI for the 
experimental task accuracy coefficient of variation measure.  Thus, the aMCI group had a 
significantly greater amount of dispersion of accuracy scores across-block compared to the 
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naMCI group.   Also, the episodic memory level of performance may be a better measure of task 
complexity compared to speed of performance when comparing aMCI and naMCI groups.  The 
naMCI group performed poorer than HC only for the experimental task reaction time mean 
measure.  In the prior analysis, the naMCI group performed worse than HC on most 
experimental task reaction time blocks but still maintained a similar trajectory of improvement.  
Due to the similar performance over time, differences between the HC and naMCI groups were 
only present for the experimental task reaction time mean but not variability measures.  After 
controlling for demographics, the relationship between outcome and the experimental task 
reaction time mean remained significant.  There were no significant interactions between 
demographic variables and outcome.   
 
Aim II: Determine whether within-domain baseline experimental task IIV measures compared 
to the within-domain baseline standard task measure predicted future MCI group status. 
 Previous analyses revealed that the HC and MCI groups differed at baseline on 
experimental task variability measures and standard task performance.  In addition, group 
differences between HC and aMCI groups were present for experimental task variability 
measures and the standard task measure.  Because the experimental task variability measures and 
standard task measure were both able to characterize future MCI group status, and also specify to 
future aMCI group status, we hypothesized that experimental task variability measures at 
baseline would also be able to predict which individuals in the future would be classified as 
aMCI.  A model for goodness of fit with the standard task measure as a predictor of aMCI was 
significant thus indicating that the baseline standard task performance was able to predict which 
participants would transition to aMCI.  When the experimental task variability measures were 
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added as predictors to the model, the model for goodness of fit did not significantly improve and 
only the standard task measure remained a significant predictor.  Thus, while baseline 
experimental task variability measures were able to characterize future aMCI group status, these 
measures were unable to predict which participants would transition to aMCI.  The standard task 
measure was very robust and was shown to have great utility in characterizing future memory 
impairment and also in predicting future memory impairment.  However, this could be due to the 
issue of diagnostic circularity, and thus findings should be interpreted with caution.  We further 
examined the prediction of the alternate classification of MCI and whether the standard task 
continued to reveal group differences. 
 We examined if differences between groups in baseline experimental task variability 
measures were able to predict which individuals would in the future be classified as MCI for the 
AC MCI outcome.  A model for goodness of fit with a combination of experimental task 
variability measures as predictors of MCI was significant thus indicating that baseline 
experimental task variability measures were able to predict which participants would transition to 
MCI – although, no specific measure was individually significant.  Although the model was 
significant, it explained only a small amount of the variance.  When the standard task measure 
was added to the model, the model for goodness of fit did not significantly improve and there 
were no significant predictors.  The addition of the standard task to the model eliminated the 
ability of the experimental task measures to predict future MCI.  We should also note that the 
standard task measure was unable to aid in the prediction of MCI when using an alternate 
classification approach and could only aid in prediction when utilizing the EAS MCI outcome.  
Thus, for the EAS MCI outcome, future cognitive functionality appears to depend upon baseline 
cognitive function and traditional tests may provide a better indicator of future impairment.   
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Processing Speed Domain 
Preliminary analyses to determine whether within-domain baseline experimental task 
measures compared to the within-domain baseline standard task measure characterized future 
MCI group status.  
 We examined differences between future MCI and HC at baseline using EAS MCI as the 
outcome and found that the MCI group performed poorer on all blocks of reaction time for the 
experimental task but not for accuracy blocks or for the standard task measure.  This finding 
supported our hypothesis that baseline experimental task differences between groups were 
present before MCI classification was established.  The experimental task was a simple 
processing speed task that enabled participants to have high accuracy scores regardless of their 
future cognitive status.  Although we hypothesized that differences would be present at baseline 
for the experimental task reaction time and accuracy measures, due to the relative simplicity of 
the task, only differences in reaction time were present – many years before an actual MCI 
diagnosis.  Processing speed tasks measure the ability to focus and sustain attention and capture 
the time it takes to perceive information.  Basic processing speed tasks, like the ones used here, 
focus more on an individual’s speed of performance than their cognitive ability.  Therefore the 
accuracy component of the task should be appropriate no matter the cognitive ability or reserve 
of an individual or group being measured.  Differences in speed of performance between the 
future MCI and HC groups indicate that deficits in perceiving and processing information for 
MCI occur earlier than previously believed.  Interestingly, there were no differences between 
groups for baseline performance on the standard task.  We were then interested in examining 
whether these same results would be applicable when employing a different outcome – AC MCI.      
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 When we examined differences between future MCI and HC at baseline using AC MCI 
as the outcome, the MCI group performed poorer on all blocks of the experimental task reaction 
time but not accuracy blocks or the standard task measure.  These results are analogous to our 
findings for the EAS MCI outcome.  Thus, regardless of how MCI is classified, MCI individuals 
have slower performance on the processing speed experimental task.  We also observed that for 
the standard task, there was no issue of circularity – group performance on the standard task did 
not change when an alternate classification was used.  Also, with both classification outcomes, 
only baseline experimental task reaction time blocks reliably differentiated groups.  The standard 
task measure showed no efficacy in discriminating groups, but that could be because traditionally 
the standard task measure has been used as a basic processing speed task to differentiate MCI– 
specifically naMCI from HC.   
 The EAS MCI3 outcome permitted examination of differences at baseline in the 
experimental task reaction time and accuracy performance and the standard task performance for 
future classification of HC, aMCI and naMCI.  The naMCI group performed significantly poorer 
than HC on the experimental task but not the standard task.  By contrast, the aMCI group did not 
significantly differ from the naMCI or HC groups for the experimental or standard task.  Thus, 
even at baseline, the naMCI group performed significantly different from HC – these differences 
are measurable years before an actual diagnosis.  When we previously examined the EAS MCI 
outcome, we noticed that the MCI and HC groups differed only on experimental task reaction 
time blocks.  When we separated MCI participants into aMCI and naMCI groups we observed 
that the aMCI and HC groups were not significantly different but the naMCI group was 
significantly different from HC.  Thus, the aMCI group, which is classified as memory impaired, 
did not differ from HC in its processing speed task performance, which we expected to find 
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based on their previous performance for the episodic memory experimental task (greater reaction 
time and poorer accuracy).  We can conclude that the slower speed of the aMCI group was 
directly related to the retrieval aspect of the episodic memory task rather than reduced speed of 
processing information.  We can also speculate that the prior significant difference between MCI 
and HC groups when examining the EAS MCI outcome was really a result of differences 
between the naMCI group and HC.  We can note that domain specific decline is present for the 
naMCI group years before diagnosis when utilizing the experimental task but not the standard 
task.  As the standard task is traditionally used to differentiate groups when impairment is 
already present, the experimental task may detect subtle changes in processing speed that are not 
tapped by traditional techniques and require further investigation.        
 
Preliminary analyses to determine whether within-domain repeated blocks of baseline 
experimental task (across-block) measures characterized future MCI group status. 
 As the experimental task utilizes repeated blocks of testing, we examined whether 
differences between groups in baseline performance over time for the experimental task were 
present for future MCI and HC using EAS MCI as the outcome.  We found that the MCI group 
performed significantly worse compared to HC on reaction time blocks over time but not 
accuracy.  Also, the MCI group showed no significant improvement in reaction time or accuracy 
blocks over time, while HC did improve in performance over time in reaction time but not 
accuracy.  These findings support our hypothesis that baseline differences between groups were 
present before MCI classification.  The experimental task is simple and employs a two-block 
design.  We could presume that because there were so few blocks, participants were not given 
ample opportunity to show significant improvement over time.  While both groups displayed 
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some improvement, the MCI group did not show any significant improvement while HC 
demonstrated a significant change over time for reaction time.  In this instance, HC were able to 
utilize the limited two-block design of the task to their advantage for the reaction time 
component while future MCI participants were unable to do so.  Another aspect of early 
cognitive decline could be the inability to utilize multi-block testing to improve performance 
over time. 
 We also examined whether differences in baseline performance over time for the 
experimental task were present for future MCI and HC using AC MCI as the outcome.  The MCI 
group performed significantly worse than HC on reaction time blocks over time but not 
accuracy.  The MCI group also showed no significant improvement in reaction time or accuracy 
while HC improved in reaction time but not accuracy.  These results match the prior EAS MCI 
outcome results.  As with the prior results, we could assume that the MCI group was unable to 
utilize the limited two-block design of the task to its advantage for the reaction time and 
accuracy.  This does not explain why HC did not improve on accuracy performance over time; 
rather, there was no significant change in their performance.  Due to the simplicity of the 
processing speed task, it was easy to attain high accuracy for both blocks.  HC achieved almost 
perfect accuracy for both blocks and the same trend in performance can be seen for the MCI 
group, though to a lesser degree.  Therefore the accuracy component of the processing speed task 
was unable to differentiate groups but performance on the reaction time component over time 
provided discriminant group information.        
 We also examined whether differences in baseline performance over time for the 
experimental task were present for future naMCI, aMCI and HC using EAS MCI3 as the 
outcome.  Outcome groups differed on reaction time over time but not accuracy.  The naMCI and 
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aMCI groups showed no significant improvement in reaction time or accuracy over time, while 
HC improved in reaction time but not accuracy.  Neither of the impaired groups was able to 
improve speed of performance or accuracy over time.  Additionally, the naMCI group had poorer 
performance on the reaction time compared to HC but the aMCI group did not differ from HC.  
Therefore, the poorer performance for reaction time in the MCI group from the EAS MCI 
outcome appears to be due to the naMCI participants (as seen here in the EAS MCI3 outcome).  
We predicted that the naMCI group would perform poorer than the aMCI group, and the aMCI 
group performance may even be comparable to HC performance.  While we did observe that the 
aMCI group performance was similar to HC performance, it was also similar to the naMCI 
group.  The simplicity of the task may not allow for true differences between groups to be 
revealed.  We hope to re-examine these groups using a more complex task that and determine 
whether differences between aMCI and naMCI groups are present.    
 
Aim I: Determine whether within-domain baseline experimental task IIV measures compared 
to the within-domain baseline standard task measure characterized future MCI group status. 
 We examined baseline differences in the experimental task mean and variability 
measures and the standard task measure between future MCI and HC using EAS MCI as the 
outcome.  Results indicated that the MCI group performed worse on the experimental task 
reaction time mean measure compared to HC.  There were no significant differences between 
MCI and HC groups for variability measures.  Although these findings supported our hypothesis 
that the experimental task measure was able to differentiate groups at baseline better than the 
standard task measure, they did not support our hypothesis that differences between groups in 
baseline experimental task variability measures would be present prior to MCI classification was 
97 
 
determined.  For both the MCI and HC groups there was little change in performance over time 
for the experimental task accuracy measure and baseline performance did not differ at the block 
level.  Therefore, it is reasonable that there were no differences between groups when we 
examined experimental task variability measures.   
 Because there were differences between the MCI and HC groups for the experimental 
task reaction time measure at the block level as well as between groups, we expected differences 
in experimental task variability measures also to be present.  Instead, MCI and HC group 
differences were only present for the experimental task reaction time mean measure.  It is 
possible that utilizing too few blocks of performance may not be effective when trying to 
determine variability over a short time.  This aspect of variability should be examined further to 
fully understand how many blocks are required for adequate measurement of variability over 
short periods of time.  Also, after controlling for demographics, no significant associations 
remained between outcome and testing measures.  There was a significant interaction for 
ethnicity and outcome- when accounted for, outcome groups were no longer significantly 
different.  Thus, differences between groups may be a result of unequal distributions of ethnic 
groups.   
 We next examined differences in the experimental task mean and variability measures 
and standard task measure between future MCI and HC using AC MCI as the outcome.  Results 
indicated that the MCI group performed poorer on only the experimental task reaction time mean 
measure compared to HC, matching our results when we examined the EAS MCI outcome.  In 
addition, we found a significant association between the experimental task reaction time mean 
measure and outcome; when demographics were controlled for, the relationship remained 
significant.  There were no significant interactions between demographics and outcome.  Thus, 
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differences between groups were a result of baseline task performance and not due to the 
influence of any additional contributing factor. 
 We further examined EAS MCI3 outcome, which allowed for examination of differences 
at baseline in the experimental task mean and variability measures and the standard task measure 
for future classification of HC, aMCI and naMCI.  Results indicated that the outcome groups 
significantly differed on the experimental task reaction time mean but no other measures.  The 
naMCI performed significantly worse than HC on the experimental task reaction time mean 
measure but the aMCI group did not differ from HC or naMCI groups on any task measure.  
Again, we can conclude that the poorer performance on the experimental task reaction time mean 
measure in the MCI group from the EAS MCI outcome is due to the performance of the naMCI 
participants.  There was a significant association between outcome and the experimental task 
reaction time mean measure that remained significant after controlling for demographics.  There 
were no significant interactions between outcome and demographics, therefore it appears that 
differences between groups were a result of baseline task performance and not due to covariates. 
 
Aim II: Determine whether within-domain baseline experimental task IIV measures compared 
to the within-domain baseline standard task measure predicted future MCI group status. 
 Previous analyses showed that HC and MCI groups differ at baseline for the experimental 
task reaction time mean measure but not any other experimental task measures or the standard 
task measure.  In addition, group differences at baseline were present between the HC and 
naMCI groups only for the experimental task reaction time mean measure.  Because only one 
experimental task measure was able to classify future MCI group status, and also specify to 
future naMCI group status, we hypothesized that the experimental task reaction time mean at 
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baseline would be able to predict which individuals would be classified as naMCI in the future.  
A model for goodness of fit with experimental task mean and variability measures was not 
significant, but the experimental task accuracy mean measure was a significant predictor.  When 
the standard task measure was added as a predictor to the model, the model for goodness of fit 
did not significantly improve, but the experimental task accuracy mean remained a significant 
predictor.  These results indicate that although the experimental task accuracy mean measure was 
unable to classify groups it may have some utility predicting which individuals will transition to 
naMCI. 
 We also examined whether these results would be replicated when using groups defined 
with the AC MCI outcome.  When we previously compared groups using the AC MCI outcome, 
differences between groups were consistently found for the experimental task reaction time mean 
measure.  As there was only one experimental task measure that was able to consistently 
characterize future MCI group status, we hypothesized that the experimental task reaction time 
mean measure at baseline would be able to predict which individuals in the future would be 
classified as MCI for the AC MCI outcome.  The model for goodness of fit with experimental 
task mean and variability measures was significant, with the reaction time mean and accuracy 
mean measures as significant predictors of MCI.  When the standard task measure was added to 
the model, the model for goodness of fit did not significantly improve and only the experimental 
task accuracy mean measure remained a significant predictor.  These results indicate that 
although the experimental task accuracy mean measure was unable to reliably classify groups, it 
may have some utility predicting which individuals will transition to MCI.  In addition, the 
experimental task reaction time mean measure also had value in predicting who would transition 
to MCI, but that effect was not maintained when the standard task measure was added to the 
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model.  It is notable that the experimental task accuracy mean measure rather than reaction time 
mean measure was able to consistently predict future group status when it had no influence in 
characterizing groups, and reaction time mean measure was able to characterize groups but 
unable to predict group membership.  This was an unexpected finding and requires further 
investigation in other non-memory domains. 
 
Executive Function Domain 
Preliminary analyses to determine whether within-domain baseline experimental task 
measures compared to the within-domain baseline standard measure characterized future 
MCI group status.  
 We examined baseline differences for the experimental task reaction time and accuracy 
measures and the standard task measure between future MCI and HC groups for the EAS MCI 
outcome.  Results indicated that the MCI group performed poorer on the experimental task at the 
beginning, but at no other time and did not differ on the standard task measure compared to HC.  
This finding supported our hypothesis that baseline differences between groups for the 
experimental task measures were present before MCI classification was determined.  The 
executive function experimental task requires controlled and effortful switching of attentional 
focus from one item to another (Sliwinski et al., 2006).  Compared to the standard task, the 
experimental task may be a more complex task and thus tap into higher-order processing which 
may begin to deteriorate at the earliest stages of cognitive decline.  We were then interested in 
examining whether these same results would be applicable when employing the alternate 
outcome – AC MCI.   
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 We examined differences at baseline for the experimental task reaction time and accuracy 
measures and the standard task measure between future MCI and HC groups for the AC MCI 
outcome.  Results indicated that the MCI group performed poorer on the experimental task at the 
beginning (block 1) and at the end (block 3) of the session but did not differ on the standard task 
measure compared to HC.  These results are similar to our prior findings where we examined 
groups using the EAS MCI outcome group classification.  Again, the standard task measure 
showed no efficacy in discriminating groups years prior to diagnosis, but that could be because 
the standard task has customarily aimed to detect participants with impairment in non-memory 
cognitive domains who transition from MCI to AD (Gomar et al., 2011). 
 We next examined differences at baseline for the experimental task reaction time and 
accuracy measures and the standard task measure for future naMCI, aMCI and HC.  
Surprisingly, we found no significant differences between groups for any task measure. These 
findings did not support our hypothesis that differences between groups would be present at 
baseline for an executive function task.  When we tested group differences using the EAS MCI 
and AC MCI outcome we found that the MCI group performed significantly worse on the 
experimental task compared to HC.  We then expected to find that the naMCI group would have 
greatly influenced those findings (as we observed for processing speed).  It is possible that 
differences for the executive function task between naMCI, aMCI and HC groups were not 
discernible due to the small sample sizes utilized for the impaired groups – specifically the 
naMCI group, which was reduced by almost half compared to sample in the processing speed 
task analyses.  The smaller sample size was a result of the later implementation of the executive 
function task into the EAS protocol.  In the future, research could explore performance on the 
executive function experimental task with a larger sample to discover whether differences 
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between amnestic and non-amnestic groups were present (as were observed for the processing 
speed and episodic memory tasks). 
 
Preliminary analyses to determine whether within-domain repeated blocks of baseline 
experimental task (across-block) measures characterized future MCI group status. 
 As the executive function experimental task is a repeated block task, we examined 
whether differences in baseline performance over time for the experimental task reaction time 
and accuracy measures were present for future MCI and HC groups using EAS MCI as the 
outcome.  We found that the MCI group was not significantly different from HC for reaction 
time or accuracy over time.  The MCI group did not show any significant change in performance 
over time for reaction time but did have poorer performance in accuracy.  HC showed no 
significant change over time for reaction time performance, but did perform significantly worse 
for accuracy.  These findings did not support our hypothesis that group differences were present 
at baseline.  These results indicate that the executive function task was difficult to complete for 
individuals who did not display current or future cognitive impairment (HC). We would expect 
those with cognitive impairment to have even more difficulty with this task – which they did, but 
not enough to discriminate between cognitive groups.  The future MCI and HC groups 
performed similarly over time such that their performance worsened over time for accuracy but 
not for reaction time.  Neither of the groups were able to utilize the multi-block design of the 
task to improve their speed of performance or accuracy.   
 Because both groups also had poorer accuracy over time, this could indicate that 
participants actually found the task to be more difficult over time and the repeated block-design 
was a detriment to performance.  This could mean that the cognitive demands of the task 
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(requiring participants to constantly attend to new information and reject old information) are 
greater and as a result participants were unable to maintain a constant alertness to enhance their 
performance.  Chan and colleagues (2008) proposed that the inability to activate inhibitory and 
excitatory commands within the neural network stems from reduced neurotransmitters and when 
the levels of these chemicals (i.e. dopamine) are restored cognitive performance may improve.  
Nagaraja and Jayashree (2001) stated that there was an association between age-related decrease 
in dopamine D2 receptors and impaired performance on neurocognitive tasks such as executive 
function and response inhibition.  They proposed that age-related decline in dopamine activity 
may contribute to cognitive impairment and introduced a dopamine receptor agonist to patients.  
They found that patients with cognitive impairment had improved global cognitive function 
when treated with the dopamine receptor agonist.  Future studies could extend this research by 
examining preclinical and MCI participants with reduced dopamine neurotransmitters and 
determine if restoring neurotransmitters improves performance on complex executive function 
tasks. 
  Next, we examined differences in baseline performance over time for the experimental 
task reaction time and accuracy measures between future MCI and HC groups for the AC MCI 
outcome.  The MCI group showed no change in performance over time for reaction time but 
performed significantly worse in accuracy over time.  And HC showed no change in 
performance over time for reaction time but did perform significantly worse in accuracy over 
time.  The similar findings when utilizing the alternate criteria for MCI indicate that regardless of 
how MCI is classified, the experimental task may place strong cognitive demands on the 
individual and therefore provide no utility in distinguishing cognitive groups.  Sliwinski and 
colleagues (2006) stated that the executive function experimental task required controlled and 
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effortful switching of attentional focus from one item to another but older adults may have a 
diminished capacity to inhibit off-task information and therefore are unable to cope with the high 
functional demands of the task.  Further investigation examining performance in a younger age 
group could clarify whether poorer performance is a result of older age and poorer cognitive 
ability to cope with task demands.   
 We next examined differences at baseline for the experimental task reaction time and 
accuracy measures over time between future naMCI, aMCI and HC groups using the EAS MCI3 
outcome.  The naMCI group showed no change in performance for reaction time or accuracy 
measures.  The aMCI group showed no change in performance for reaction time but did perform 
poorer on accuracy over time.  HC showed no change in performance over time for reaction time 
but did perform poorer in accuracy.  Interestingly, we found that the aMCI group (of EAS MCI3) 
influenced the results of the MCI group (from EAS MCI) such that poorer accuracy over time 
could be attributed to the aMCI group rather than to the naMCI group.  We expected that 
individuals with future impairment in non-memory cognitive domains would perform poorer on 
an executive function task, but instead, we found that there was no change in their performance 
over time and the future memory-impaired group displayed poorer accuracy.  This could indicate 
that individuals with future memory impairment may also present with other non-memory 
impairments and these individuals may decline as a faster rate compared to others who have 
impairment in only a single cognitive domain (Garcia-Herranz, Diaz-Mardomingo & Peraita, 
2015; Loewenstein et al., 2009; Peraita, Garcia-Herranz & Diaz-Mardomingo, 2010; Summers & 
Saunders, 2012).   
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Aim I: Determine whether within-domain baseline experimental task IIV measures compared 
to the within-domain baseline standard task measure characterized future MCI group status. 
  We examined differences in baseline experimental mean and variability measures and the 
standard task measure between future MCI and HC using EAS MCI as the outcome and found 
that after accounting for unequal variances, there were no differences between the MCI and HC 
groups.  After controlling for demographics, no significant associations remained between 
outcome and testing measures.  There were no significant interactions between demographics 
and outcome.  These findings did not support our hypothesis that baseline differences in 
experimental task variability measures are able to discriminate future MCI and HC groups.  
However, based on our prior analyses in which the MCI and HC groups had a similar trajectory 
of performance decline over time, we therefore did not expect to find group differences for the 
experimental task variability measures or the standard task measure. 
 We next examined differences in baseline experimental mean and variability measures 
and the standard task measure between future MCI and HC using AC MCI as the outcome.  
Results indicated that after accounting for unequal variances, the MCI group was significantly 
different from HC for the experimental task reaction time mean and accuracy mean measures.  
After controlling for demographics, significant associations between task measures and outcome 
remained.  There were no significant interactions between demographics and outcome.  When 
we utilized the alternate criteria for MCI we found that there were differences between cognitive 
groups in mean performance.  Future MCI cognitive status is based on decline in global 
cognition (as noted by BIMC scores) - but at baseline there were no differences in global 
cognition.  However, differences for the experimental task reaction time and accuracy mean 
measures between groups were still present.  At baseline slight changes in performance may 
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present in those who will later decline beyond normative aging and the experimental task may 
capture those subtle changes. 
   We next examined differences in baseline experimental mean and variability measures 
and the standard task measure between future naMCI, aMCI and HC using EAS MCI3 as the 
outcome.  After accounting for unequal variances, there were no significant differences between 
groups.  Further, the naMCI did not differ from the HC for any task measure and the aMCI group 
did not differ from the naMCI or HC groups for any task measure.  After controlling for 
demographics, no significant associations remained between outcome and testing measures.  
While these results do not support our hypothesis, they are not surprising based on the null 
findings from our previous analyses when we examined group performance using the EAS MCI 
outcome. 
 
Aim II: Determine whether within-domain baseline experimental task IIV measures compared 
to the within-domain baseline standard task measure predicted future MCI group status. 
 Previous analyses did not reveal that experimental task variability measures or the 
standard task measure in the executive function domain characterized future MCI group status.  
We then examined whether experimental task variability measures or the standard task had any 
ability to predict future MCI group status, specifically naMCI.  A model for goodness of fit with 
the experimental task variability measures as predictors of naMCI was not significant.  When the 
standard task was added as a predictor to the model, the model for goodness of fit did not 
significantly improve.  We concluded that neither experimental task variability measures nor the 
standard task measure were able to predict which participants would transition to naMCI.  The 
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limited sample size of naMCI participants may account for why there were no differences 
between groups and also why no prediction of naMCI was possible.  
 We then examined whether the experimental task variability measures would be able to 
predict future MCI group status compared to the standard task measure when using the AC MCI 
outcome.  We previously found that the experimental task reaction time mean and accuracy 
mean measures were able to characterize future MCI group status; therefore, we tested an 
additional model that included these measures.  A model for goodness of fit with the 
experimental task variability measures was not significant and when the standard task measure 
was added to the model, the model for goodness of fit did not significantly improve.  When the 
experimental task reaction time and accuracy mean measures were added to the model, the 
model for goodness of fit significantly improved, and reaction time mean and accuracy mean 
measures were significant predictors of group status.  These results indicated that the 
experimental task reaction time and accuracy mean measures may have some ability to not only 
characterize future MCI group status but also predict who will transition to MCI when utilizing 
the AC MCI outcome. 
 
Across-Domain 
 Up to this point, we examined performance in each cognitive domain separately.  We 
were also interested in examining performance across-domain.  Dementia is diagnosed when 
impairments are present across domains, not just within one domain, so this may provide 
additional information on how we conceptualize the role of variability as an early indicator of 
disease.  For the next set of aims, we utilized participants that completed testing in all three 
cognitive domains previously explored.  These analyses aimed at examining performance on the 
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experimental task variability measures and the standard task measures across all domains in 
order to determine if variability in multiple domains would enhance classification and prediction 
of future MCI group status.  We initially examined MCI classification at any point (anytime 
between one to ten years after baseline) and later examined MCI after differing time periods 
(within three years after baseline compared to four or more years after baseline) to determine 
whether prediction was improved based on when MCI group status was diagnosed.  
 
Aim III: Determine whether across-domain baseline experimental task IIV measures 
compared to across-domain baseline standard task measures characterized future MCI group 
status.   
 We examined the experimental task variability measures and the standard task measures 
to determine if there was a particular grouping among task measures.  The PCA found three 
significant components that accounted for approximately 56% of the total variance.  Component 
one had the highest positive loadings for all standard task measures and most of the experimental 
task measures.  For this component, higher scores on all tasks indicated better performance; 
therefore, this component most likely represented participants who performed well on all of these 
tasks at baseline and have a lower likelihood of being classified as MCI.  Component two had the 
highest positive loadings for the executive function experimental task measures and the highest 
negative loadings for all standard task measures and the episodic memory experimental task 
measures.  For this component, higher scores on the executive function experimental task 
measures were associated with lower scores on all standard task measures and the episodic 
memory experimental task measures, therefore participants performed poorly on the 
experimental executive function task but better on all standard tasks and the experimental 
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episodic memory task.  These participants could be impaired only in the executive function 
domain as measured by the experimental task.  Component three had the highest positive 
loadings for the episodic memory and processing speed experimental task measures and the 
episodic memory standard task measure and the highest negative loadings for: processing speed 
and executive function standard task measures.  For this component, lower scores on episodic 
memory and processing speed experimental tasks measures and episodic memory standard task 
measure were associated with higher scores on processing speed and executive function standard 
task measures, therefore these participants performed better on both episodic memory tasks and 
the experimental processing speed task but poorer on the processing speed and executive 
function standard tasks.  These participants may have impairment in non-memory domains as 
noted by performance on the standard tasks.  From these components, we see groups of 
participants that performed poorly: (1) across no domains, (2) only on executive functioning 
experimental task, or (3) only processing speed and executive function standard tasks. 
 
Aim IV: Determine when across-domain baseline experimental task IIV measures compared to 
across-domain baseline standard task measures predicted future MCI group status.   
 We examined which baseline experimental task variability measures and/or standard task 
measures predicted MCI group status at any time using the EAS MCI3 outcome.  Components 
one and two had significant loadings for the episodic memory standard task and the executive 
function standard task, respectively.  When utilizing the EAS MCI3 outcome, standard task 
measures were better predictors of MCI group status than experimental task variability measures.  
Also, performance on the episodic memory standard task was significantly different for the 
aMCI and HC groups.  These results concur with our prior findings, which showed that the 
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performance on the episodic memory standard task was related to MCI group status.  In addition, 
performance on the executive function standard task was significantly different for the naMCI 
and HC groups.  These findings did not agree with our previous results where we were unable to 
utilize the executive function standard task to characterize or predict naMCI and HC groups.  We 
suggested that using such a small sample size for prior analyses could explain why there were no 
differences between groups.  By using the BADA technique, we maximized the group 
differences, and used bootstrap resampling to determine significance between the groups; we 
were then able to determine that the executive function standard task significantly contributes to 
the difference between the naMCI and HC groups.    
 Next, we examined which baseline experimental task variability measures and/or 
standard task measures predicted MCI group status at any time using the AC pre-MCI outcome.  
Components one and two had no significant loadings—and the HC and MCI groups were 
significantly different for component one.  While there was no specific measure that was 
significant along component one, the episodic memory experimental task accuracy measures 
approached significance.   Notably, along both components, the pre-MCI group was not 
significantly different from the MCI or HC groups.  By definition pre-MCI participants did not 
correspond to either the MCI or HC groups.  We also observed that their performance for the 
experimental and standard task measures were unable to provide any aid in diagnostic 
characterization or prediction.   
 Roberts and colleagues (2014) examined the rate of progression from MCI to dementia in 
individuals who reverted to cognitively healthy after a previous MCI diagnosis.  They found that 
participants who reverted from MCI to cognitively healthy eventually regressed to MCI or 
progressed further to dementia.  Although individuals who fluctuated between MCI and 
111 
 
cognitively healthy had a lower incidence of dementia compared to those with a consistent MCI 
diagnosis, they had a greater incidence compared to those that never transitioned to MCI.  Thus, 
an MCI diagnosis at any time may have prognostic value (Roberts et al., 2014).  Also, 
participants who vacillate may represent the low-risk individuals that Jack and colleagues (2013) 
hypothesized.  These results suggest that individuals who revert may have a pathological process 
that presents as cognitive impairment but due to greater cognitive reserve, these individuals are 
better able to compensate for their physiological burden.  Further research is needed to 
understand the mechanisms underlying MCI stability and progression. 
 Up to this point, all of our analyses included using classification of MCI group status at 
any time point.  We then decided to examine classification of MCI group status at differing time 
points with the assumption that participants who were diagnosed as MCI closer to their baseline 
testing period (within three years) may differ from participants who were diagnosed much later 
following their baseline testing (four or more years later).  We were able to address this 
hypothesis using a variety of outcome definitions.  Howieson and colleagues (2008) found that 
individuals with MCI had a preclinical stage of accelerated cognitive loss on tests of verbal 
memory, animal fluency, and visuospatial constructions, which was observed three to four years 
before the diagnosis of MCI.   They reported that evidence from memory performance before the 
change point suggests that a slow decline in memory precedes the period of accelerated decline 
in the development of MCI.  We were also able to see this preclinical stage of decline in our 
results.  
 We examined which baseline experimental task variability measures and/or standard task 
measures predicted MCI group status using the EAS MCI 3 vs 4 outcome.  Component one had 
significant loadings for the episodic memory and executive function standard task measures and 
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episodic memory experimental task variability measures, while no task measures loaded 
significantly for component two.  The HC and “MCI within three years” groups were 
significantly different along component one.  Therefore, participants who may never transition to 
MCI were different from those who transition to MCI within three years – specifically when we 
examined baseline performance for the episodic memory and executive function standard task 
measures and episodic memory experimental task variability measures.  There was no significant 
difference between the HC and “MCI four or more years later” groups.  Our results indicated that 
baseline performance for the episodic memory and executive function standard task measures 
and episodic memory experimental task variability measures have greater efficacy distinguishing 
participants who will transition to MCI sooner after baseline testing rather than later.   
   We then examined which baseline experimental variability measures and/or standard task 
measures predicted MCI group status using the AC MCI 3 vs 4 outcome.  Components one and 
two had no significant loadings.  Yet, the HC and “MCI within three years” groups were 
significantly different along component one.   Again, while no specific task measure was 
significant along component one, the episodic memory experimental task variability measure 
was approaching significance.  We also observed that when we used the alternate classification 
criteria for MCI, the results were the same, such that participants who may never transition to 
MCI were different from those who transition to MCI within three years but not different from 
those who transition to MCI four or more years after baseline testing.  Therefore, again we 
observe that baseline task performance has greater utility at distinguishing participants who 
transition to MCI sooner rather than later. 
 We were then interested in examining if future pre-MCI participants displayed any 
differences in baseline performance compared to future MCI participants.  We examined which 
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baseline experimental task variability measures and/or standard task measures predicted MCI 
group status using the AC pre-MCI 3 outcome.  Components one and two had no significant 
loadings.  Interestingly, the HC and “MCI within three years” groups were significantly different 
along component one, which agreed with our previous results.  While no specific task measure 
was significant along component one, the episodic memory experimental task variability 
measure was approaching significance level.   We also found the HC and “pre-MCI within three 
years” groups were significantly different along component two.  While there was no specific 
measure that was significant along component one, the episodic memory standard task measure 
and processing speed experimental variability measures approached significance.  Thus, for this 
outcome, participants classified as pre-MCI and MCI appear to be different from HC.  This 
means that baseline performance of participants that transition to pre-MCI or MCI within three 
years differed from baseline performance of participants that may never transition to MCI.  We 
were unable to observe baseline performance differences between the pre-MCI and MCI groups, 
indicating that pre-MCI participants may be more like MCI participants and that any change 
from HC may be noted as the beginning of MCI. 
 Finally, we examined which baseline experimental task variability measures and/or 
standard task measures predicted MCI group status using the AC pre-MCI 4 outcome.  
Component one had no significant loadings.  Component two had significant loadings for the 
processing speed standard task measure.  The HC and “pre-MCI four or more years later” groups 
were significantly different along component two.  We can conclude that for this outcome, 
participants classified as pre-MCI were different from HC, but they did not differ from MCI 
participants.  Based on our prior findings and these results, we observed that baseline 
performance of participants classified as “pre-MCI within three years” and “pre-MCI four or 
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more years later” differed from HC.  We were also able to discern that pre-MCI participants did 
not differ from MCI at any time point – these groups had similar baseline performance, while 
still differed from HC baseline performance.  The pre-MCI group baseline performance 
corresponded more to the MCI group baseline performance, which leads us to believe that the 
pre-MCI are closer to MCI along the cognitive spectrum compared to HC.   
 
General Conclusions  
Our overall objective was to determine whether experimental intraindividual variability 
measures have greater efficacy at characterizing and predicting MCI compared to conventional 
standard task measures.  When we examined specific cognitive domains we found that baseline 
experimental task measures of variability and performance over time were able to characterize 
and predict future MCI group status better than conventional standard task measures.  When we 
examined performance across all domains, we found that both experimental task variability 
measures and standard task measures had efficacy in predicting future MCI group status.  When 
we examined incident MCI group status at different time intervals, we found both experimental 
task variability measures and standard task measures were reliable at predicting MCI, 
specifically incident MCI diagnosed closer to the baseline testing period.  We were able to utilize 
large samples of participants and also longitudinal outcomes to investigate the relationship 
between baseline performance and future cognitive decline.   
 It is important to determine which tests have the greatest accuracy in predicting cognitive 
decline and also utilize tests in memory and non-memory domains to allow for enhanced 
sensitivity and specificity in detecting future impairment.  An inherent problem within the 
construct of MCI diagnosis is the rate of false diagnoses, in which participants revert to non-
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impaired status at later testing periods.  Klekociuk and colleagues (2014) reported, using a 
combination of complex sustained attention, semantic memory, working memory, episodic 
memory and selective attention neuropsychological measures, increased correct classification 
and decreased rate of false positive diagnoses of MCI.  For the current study, we utilized testing 
measures from multiple cognitive domains.  As a result, we revealed that at baseline, participants 
who transitioned to MCI demonstrate poorer performance for experimental tasks in more than 
one cognitive domain.  We also examined specific cognitive impairment sub-groups (amnestic 
versus non-amnestic) and found that within each sub-group there was a primary impairment 
followed by a lesser secondary impairment, such that aMCI individuals presented with poorer 
episodic memory performance but also poorer performance on processing speed and executive 
function tasks.  The aMCI group did not perform as poorly as the naMCI group for non-episodic 
memory tasks, but still performed poorer than the HC.  In addition, when we examined the full 
MCI group across-domains we also observed poorer performance in more than one cognitive 
domain.  The DSM-V (2013) classifies major neurocognitive disorder due to probable/possible 
AD when impairments are in more than one cognitive domain; therefore, these early 
presentations of poorer performance in multiple domains may signal a more rapid transition to 
MCI. 
 We also employed an alternate method of MCI classification to independently test for 
relationships between standard task measures and incident MCI.  As a result we were able to 
determine whether the relationship between task measures was in fact real or misleading due to 
circularity.  We found that once we used the alternate MCI classification criterion, future MCI 
and HC groups no longer differed in their performance on the episodic memory standard task 
measure.  In this instance, we observed that performance on the episodic memory standard task 
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at baseline, years before actual transition, may have an effect on later diagnosis.  We did not see 
this effect for the processing speed and executive functioning standard task measures – there 
were no baseline differences between MCI and HC groups therefore an alternate MCI was 
unnecessary, but still examined.  Baerrensen and colleagues (2015) found tests of episodic 
memory predicted conversion to MCI two years prior to conversion.  The entorhinal-
hippocampus system plays an important role in episodic and spatial memories.  Research has 
suggested that tau protein tangles and amyloid plaques spread in a predictable, nonrandom 
manner beginning in the entorhinal region, spreading to the hippocampus and neocortex.  
Baerrensen and colleagues (2014) suggested that because the entorhinal region is one of the first 
areas impacted by tau tangles – accumulating and eventually causing neuronal death – it is 
expected that the relying on adequate structure and function in this region would predict 
conversion before tests reliant on domains impacted later in the disease process (such as 
processing speed and executive function).  It is possible that the brain regions accessed for tests 
of processing speed and executive function have not sustained sufficient damage to induce 
impaired performance and therefore differences between groups were unnoticeable for standard 
task measures.   
 Grand and colleagues (2016) found that greater intraindividual variability at baseline was 
associated with poorer cognitive performance at the initial year of assessment, declining 
cognitive function, and also predicted poorer cognitive performance six years later.  
Additionally, because intraindividual variability measures fluctuation or change in performance 
over time, persistent fluctuations, despite experience with a task, may reflect a lack of processing 
robustness and maladaptive functioning (Grand, Stawski & MacDonald, 2016).  Increased 
performance fluctuations may reflect diminished processing capacity and poorer underlying 
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neural integrity, which could indicate limited extent to which neural resources are available to 
support higher level cognitive processing.  As a result, when these neural mechanisms are 
compromised, there is greater observable cognitive impairment, such as we find in individuals 
with MCI.  Intraindividual variability may pose as a neurocognitive marker and serve to denote 
preclinical changes associated with subtle cognitive decline/impairment. 
 Our overall objective was to examine the utility of intraindividual variability measures to 
discriminate groups prior to diagnosis.  We observed that intraindividual variability measures for 
the experimental episodic memory task distinguished and predicted future MCI group status.  
Intraindividual variability measures for processing speed and executive function experimental 
tasks were unable to reveal differences between groups at baseline.  The episodic memory 
experimental task was a six-block task, while the processing speed and executive function 
experimental tasks utilized two- and three-blocks, respectively.  MacDonald and colleagues 
(2009) stated that in order to reliably index intraindividual variability, the task must have more 
than seven blocks.  The episodic memory experimental task was closer to meeting this criterion 
than the other tasks and could explain why intraindividual variability measures for processing 
speed and executive function were inconclusive, even though the groups fluctuated in 
performance across blocks. In addition, MacDonald and colleagues (2009) stated that the mean 
has a greater proportion of systematic variance available for association with cognitive 
outcomes.  In our results, for the processing speed and executive function experimental tasks, we 
observed that the MCI group had a poorer mean performance compared to HC.  This supports 
the idea that there were noticeable differences across-blocks that were undetected by measures of 
variability due to the limited resources available for computation. 
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Limitations 
 In order to utilize the large sample sizes available, we did not re-examine classification 
outcomes per domain (memory and processing speed) for participants who completed all tasks.  
Null findings from the executive function analyses led us to believe that by reducing the sample 
size, we would have limited significance between outcome groups due to small sample size 
rather than no actual differences between groups.  It would be beneficial to examine the 
executive function domain with a larger sample to discover if our previous null findings are 
replicated or learn that the small sample size led to false results. 
 Within the current study, our sample was comprised of participants that we defined as 
healthy elderly.  Our sample did not fully correspond to the EAS classification of healthy elderly.  
Due to the small difference between classification criteria (5-10%), we felt it was unnecessary to 
remove non-corresponding participants and reduce our sample.  Also, when further evaluated, 
participants classified as EAS MCI within this sample reverted to healthy elderly at later time 
points.  Nevertheless, it would be interesting to analyze a group of participants that had a 100% 
corresponding classification rate and determine if our results were replicated. 
 In addition, for the current study we established a “pre-MCI” group based on specific 
criteria.  This group was not validated nor fully examined to establish whether these criteria are 
maintained over time for different populations.  In addition, we failed to monitor these “pre-
MCI” participants to determine if they transition to MCI or if they revert to back to healthy 
elderly.  Further investigation is required to fully understand this group. 
 
 
 
119 
 
Conclusions and Future Directions 
 Sperling and colleagues (2011) proposed that subtle cognitive decline and subjective 
complaints can be observed throughout the preclinical trajectory several years before MCI or AD 
onset.  They hypothesized that cognitively normal individuals with abnormal AD biomarkers are 
in the long preclinical phase of AD that precedes MCI, where there is evolving AD 
pathophysiology, particularly Aβ peptide accumulation and initial neuronal injury.  Rajan and 
colleagues (2015) found differences in baseline cognitive functioning on tests of episodic 
memory, executive function, and global cognition, up to 18 years before the clinical diagnosis of 
AD.  In addition poorer baseline performance also predicted the development of AD (Rajan, 
Wilson, Weuve, Barnes & Evans, 2015).  If we follow the theory that abnormal AD biomarkers 
are present before subtle cognitive decline presents, then as Rajan and colleagues (2015) suggest, 
we must extend our study of aging to include middle-aged individuals to understand the earliest 
manifestations of the disease process.  Thus, it would be of value to repeat our study in a younger 
cohort of individuals with subtle objective cognitive difficulties.  
 In addition, cognitively healthy participants who exhibit subtle cognitive deficits could be 
representative of a pre-clinical AD asymptomatic stage where there is evidence of biomarkers 
associated with AD present, such as amyloid of tau protein alterations (Edmonds et al., 2015).  
The next stage would be to examine these cognitively healthy participants who later transition to 
MCI and discover if they also possess abnormal AD biomarkers at this asymptomatic stage.  If 
abnormal biomarkers are present then we can assume that these participants may be in the 
preclinical stage of AD.  If abnormal biomarkers are not present, we can assume that the 
differences in baseline cognitive performance may present before AD pathogenesis begins.  
Impaired baseline performance on tests that measure subtle cognitive deficits (such as tests that 
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measure one’s performance in respect to self) may allow for detection of cognitive decline at the 
point of onset.   
 Edmonds and colleagues (2015) proposed that cognitive decline reflected by sensitive 
episodic memory measures is as valuable or even superior to biomarkers in predicting 
development of AD.  Bondi and colleagues (2014) suggested that examination of within-person 
cognitive change may better identify trajectories of decline than comparisons to group norms. 
Intraindividual variability measures allow for the detection of within-person change and can help 
quantify the trajectory of cognitive decline over time.  Future research should attempt to clarify 
the cognitive and neural mechanisms underlying intraindividual variability, as well as the utility 
of intraindividual variability for identifying those who will go on to develop MCI and AD.  
Increased intraindividual variability may represent subtle cognitive decline that goes undetected 
by traditional methods.  Cognitively normal individuals who present with increased 
intraindividual variability may characterize the preclinical AD stage.  Increased intraindividual 
variability on multi-block cognitive tests (especially for the domain of episodic memory) could 
serve as a cognitive biomarker for the onset of MCI and AD pathology.  In particular, a multi-
block episodic memory task (like the one used in the current study) could provide valuable 
information relating to subtle cognitive decline.  Finally, it would be instructive to determine 
whether greater intraindividual variability is associated with neuropathology of AD or if neural 
changes have yet to manifest.  Intraindividual variability may also serve as a novel predictor of 
future neural changes associated with AD.   
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Tables 
Table 1 
List of abbreviations and full name/title 
______________________________________________________________________________ 
Abbreviation  Full Name/Title 
AC MCI  Alternate Criteria Mild Cognitive Impairment 
AD   Alzheimer’s Disease 
aMCI   amnestic Mild Cognitive Impairment 
BIMC   Blessed Information-Memory-Concentration Test 
CRRST  Cued-Recall Retrieval Speed Task 
EAS MCI  Einstein Aging Study Mild Cognitive Impairment 
FAST   Functional Assessment Staging 
FCSRT  Free and Cued Selective Reminding Test 
FCSRT Rev  Free and Cued Selective Reminding Test reverse scored 
HC   Healthy Controls 
IADL   Instrumental Activities of Daily Living Scale 
ICV   Intraindividual Coefficient of Variation 
IIV   Intraindividual Variability 
ISD   Intraindividual Standard Deviation 
MCI   Mild Cognitive Impairment 
naMCI   non-amnestic Mild Cognitive Impairment 
NM   Number Match Task 
NB2   N-Back 2 Task 
RT   Reaction Time 
TMT-A  Trail Making Test Part A 
TMT-B  Trail Making Test Part B 
______________________________________________________________________________ 
 
122 
 
Table 2 
Outcome group definition 
______________________________________________________________________________ 
Outcome  Group 1   Group 2   Group 3 
EAS MCI  HC   EAS MCI   N/A 
AC MCI  HC   AC MCI   N/A 
EAS MCI3  HC   EAS aMCI   EAS naMCI 
EAS aMCI  HC + naMCI  aMCI    N/A 
EAS naMCI  HC + aMCI  naMCI    N/A 
AC pre-MCI  HC   pre-MCI   AC MCI 
EAS MCI 3 vs 4 HC  EAS MCI within 3 yrs EAS MCI 4 or more yrs later 
AC MCI 3 vs 4 HC  AC MCI within 3 yrs  AC MCI 4 or more yrs later 
AC pre-MCI 3  HC  pre-MCI within 3 yrs  AC MCI within 3 years 
AC pre-MCI 4  HC  pre-MCI 4 or more yrs later AC MCI 4 or more yrs later 
______________________________________________________________________________ 
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Table 3 
Descriptive statistics by cognitive domain 
______________________________________________________________________________ 
    Episodic Processing Executive No Executive  
    Memory Speed  Function Function 
N    426  423  248  178 
Age in years M(SD)  79.89(5.05) 79.86(5.05) 79.67(4.94) 80.18(5.20) 
Males (%)   40.8  40.7  41.9  39.3 
Caucasian (%)   74.9  74.9  76.2  73.0 
Education HS or higher (%) 91.3  91.5  91.1  91.6 
GDS 5 or less (%)  95.1  95.0  96.8  92.7 
EAS Baseline HC (%) 90.8  90.8  94.0  86.5 
EAS Follow-up MCI (%) 28.2  28.4  26.2  30.9 
EAS Follow-up aMCI (%) 19.0  19.1  16.9  N/A 
EAS Follow-up naMCI (%) 9.2  9.2  9.3  N/A 
AC Follow-up MCI (%) 19.7  19.9  17.7  22.5 
______________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
124 
 
  T
ab
le
 4
 
D
es
cr
ip
ti
v
e 
st
at
is
ti
cs
 f
o
r 
th
e 
ep
is
o
d
ic
 m
em
o
ry
 d
o
m
ai
n
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
 
 
E
A
S
 H
C
 
 
E
A
S
 M
C
I 
 
E
A
S
 a
M
C
I 
 
A
C
 H
C
 
 
A
C
 M
C
I 
N
 
 
 
 
3
0
6
 
 
 
1
2
0
 
 
 
8
1
 
 
 
3
4
2
 
 
 
8
4
 
A
g
e 
in
 y
ea
rs
 M
(S
D
) 
 
7
9
.5
2
(5
.0
3
) 
 
8
0
.8
1
(4
.9
9
) 
 
8
1
.1
4
(5
.0
3
) 
 
7
9
.6
2
(5
.0
2
) 
 
8
0
.9
6
(5
.0
7
) 
M
al
es
 (
%
) 
 
 
4
3
.1
 
 
 
3
5
.0
 
 
 
3
5
.8
 
 
 
4
0
.6
 
 
 
4
1
.7
 
C
au
ca
si
an
 (
%
) 
 
 
7
7
.8
 
 
 
6
7
.5
 
 
 
7
0
.4
 
 
 
7
7
.5
 
 
 
6
4
.3
 
E
d
u
ca
ti
o
n
 H
S
 o
r 
h
ig
h
er
 (
%
) 
9
1
.2
 
 
 
9
1
.7
 
 
 
9
0
.1
 
 
 
9
1
.8
 
 
 
8
9
.3
 
G
D
S
 5
 o
r 
le
ss
 (
%
) 
 
9
5
.8
 
 
 
9
3
.3
 
 
 
9
2
.6
 
 
 
9
5
.6
 
 
 
9
2
.9
 
B
IM
C
 M
(S
D
) 
 
 
0
.9
7
(0
.9
8
) 
 
1
.3
3
(1
.0
2
) 
 
1
.3
0
(0
.9
8
) 
 
0
.9
3
(0
.9
5
) 
 
1
.6
5
(1
.0
2
) 
F
C
S
R
T
 M
(S
D
) 
 
3
2
.5
9
(5
.5
8
) 
 
3
0
.5
4
(5
.9
7
) 
 
2
8
.6
8
(5
.7
2
) 
 
3
2
.1
8
(5
.7
3
) 
 
3
1
.3
5
(5
.8
9
) 
C
R
R
S
T
 R
T
 M
(S
D
) 
  
  
  
  
  
1
2
4
7
.7
8
(2
5
6
.2
4
) 
  
  
  
  
 1
3
8
3
.2
2
(2
7
7
.3
0
) 
  
  
  
  
 1
3
9
1
.4
8
(2
9
1
.2
) 
  
  
  
  
 1
2
6
2
.6
5
(2
5
8
.6
7
) 
  
  
  
 1
3
8
0
.7
5
(2
9
0
.4
6
) 
C
R
R
S
T
 A
cc
u
ra
c
y
 M
(S
D
) 
0
.8
3
8
(0
.1
2
) 
 
0
.7
9
1
(0
.1
5
) 
 
0
.7
7
6
(0
.1
6
) 
 
0
.8
3
6
(0
.1
2
) 
 
0
.7
7
6
(0
.1
6
) 
C
R
R
S
T
 R
T
 I
S
D
 M
(S
D
) 
1
7
9
.7
0
(8
7
.3
2
) 
 
2
0
7
.5
8
(1
0
6
.2
3
) 
2
1
6
.9
5
(1
1
5
.3
1
) 
1
8
0
.9
2
(8
7
.6
1
) 
  
  
  
  
  
 2
1
4
.5
4
(1
1
2
.0
4
) 
C
R
R
S
T
 R
T
 I
C
V
 M
(S
D
) 
0
.1
4
3
(0
.0
6
) 
 
0
.1
4
8
(0
.0
6
) 
 
0
.1
5
3
(0
.0
7
) 
 
0
.1
4
3
(0
.0
6
) 
 
0
.1
5
3
(0
.0
6
) 
C
R
R
S
T
 A
cc
u
ra
c
y
 I
S
D
 M
(S
D
) 
  
0
.1
0
3
(0
.0
5
) 
 
0
.1
1
6
(0
.0
6
) 
 
 
0
.1
2
3
(0
.0
6
) 
 
0
.1
0
3
(0
.0
5
) 
 
0
.1
2
1
(0
.0
5
) 
C
R
R
S
T
 A
cc
u
ra
c
y
 I
C
V
 M
(S
D
) 
  
0
.1
3
3
(0
.0
9
) 
 
0
.1
6
5
(0
.1
2
) 
 
0
.1
8
0
(0
.1
3
) 
 
0
.1
3
3
(0
.0
9
) 
 
0
.1
7
6
(0
.1
1
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
125 
 
  T
ab
le
 5
 
R
ea
ct
io
n
 t
im
e 
(i
n
 m
il
li
se
co
n
d
s)
 a
n
d
 a
cc
u
ra
c
y
 (
p
ro
p
o
rt
io
n
 c
o
rr
ec
t)
 b
lo
ck
 p
er
fo
rm
an
ce
 b
y
 g
ro
u
p
 f
o
r 
th
e 
ep
is
o
d
ic
 m
em
o
ry
 e
x
p
er
im
en
ta
l 
ta
sk
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
  
  
  
  
 E
A
S
 H
C
  
  
  
 E
A
S
 M
C
I 
 
  
E
A
S
 a
M
C
I 
 
 E
A
S
 n
aM
C
I 
  
  
  
  
  
  
  
A
C
 H
C
 
  
  
  
  
  
 A
C
 M
C
I 
 
  
  
  
  
 R
T
 M
(S
D
) 
  
  
 R
T
 M
(S
D
) 
 
  
R
T
 M
(S
D
) 
 
 R
T
 M
(S
D
) 
  
  
  
  
  
  
  
R
T
 M
(S
D
) 
  
  
  
  
  
 R
T
 M
(S
D
) 
B
lo
ck
 1
  
  
  
 1
4
8
9
.7
5
(3
4
7
.8
3
) 
  
  
1
6
4
3
.2
9
(3
7
6
.2
2
) 
  
  
  
1
6
6
7
.8
2
(4
0
6
.1
9
) 
  
  
  
  
1
5
9
2
.3
4
(3
0
3
.2
2
) 
  
  
  
 1
5
0
4
.9
3
(3
5
0
.1
9
) 
  
  
  
1
6
4
7
.3
0
(3
8
9
.4
6
) 
B
lo
ck
 2
  
  
  
 1
2
9
6
.0
8
(3
0
7
.9
4
) 
  
  
1
4
4
1
.0
2
(3
7
2
.3
1
) 
 1
4
3
9
.4
3
(3
8
4
.4
6
) 
1
4
4
4
.3
3
(3
5
0
.5
7
) 
  
  
  
  
1
3
1
2
.3
9
(3
0
9
.4
4
) 
  
  
  
1
4
3
6
.7
5
(4
0
3
.8
2
) 
B
lo
ck
 3
  
  
  
 1
2
1
7
.4
1
(2
8
2
.5
0
) 
  
  
1
3
4
7
.8
8
(3
2
9
.3
0
) 
 1
3
5
0
.9
3
(3
5
9
.4
4
) 
1
3
4
1
.5
4
(2
5
9
.8
7
) 
  
  
  
  
1
2
3
0
.7
0
(2
9
1
.1
3
) 
  
  
  
1
3
4
9
.6
7
(3
2
6
.6
5
) 
B
lo
ck
 4
  
  
  
 1
1
8
8
.4
6
(2
7
5
.5
3
) 
  
  
1
3
1
6
.8
9
(2
9
5
.8
9
) 
 1
3
4
1
.2
7
(3
2
1
.8
5
) 
1
2
6
6
.2
6
(2
2
8
.4
6
) 
  
  
  
  
1
2
0
4
.6
2
(2
8
0
.5
7
) 
  
  
  
1
3
0
6
.1
2
(2
9
9
.7
6
) 
B
lo
ck
 5
  
  
  
 1
1
6
0
.9
4
(2
6
2
.8
3
) 
  
  
1
2
9
0
.1
7
(2
8
9
.9
2
) 
 1
2
9
0
.2
4
(2
8
3
.6
8
) 
1
2
9
0
.0
4
(3
0
6
.2
7
) 
  
  
  
  
1
1
7
7
.1
5
(2
7
1
.1
1
) 
  
  
  
1
2
7
9
.5
6
(2
8
4
.9
5
) 
B
lo
ck
 6
  
  
  
 1
1
3
4
.0
7
(2
5
9
.5
9
) 
  
  
1
2
6
0
.0
7
(2
7
1
.2
5
) 
 1
2
5
9
.1
9
(2
7
4
.8
0
) 
1
2
6
1
.5
6
(2
6
7
.2
6
) 
  
  
  
  
1
1
4
6
.0
9
(2
4
8
.8
0
) 
  
  
  
1
2
6
5
.1
1
(3
2
2
.1
4
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
  
  
  
  
 E
A
S
 H
C
  
  
  
  
  
  
  
  
  
E
A
S
 M
C
I 
  
  
  
  
  
  
  
E
A
S
 a
M
C
I 
  
  
  
  
  
  
  
E
A
S
 n
aM
C
I 
  
  
  
  
  
  
 A
C
 H
C
 
  
  
  
  
  
A
C
 M
C
I 
 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
  
 A
cc
u
ra
cy
 M
(S
D
) 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
B
lo
ck
 1
  
  
  
  
0
.7
2
6
(0
.1
8
) 
  
  
0
.6
6
6
(0
.2
1
) 
 
0
.6
4
0
(0
.2
2
) 
 
0
.7
2
1
(0
.1
6
) 
 
0
.7
2
5
(0
.1
9
) 
 
0
.6
4
5
(0
.1
9
) 
B
lo
ck
 2
  
  
  
  
0
.8
1
0
(0
.1
6
) 
  
  
0
.7
5
1
(0
.2
1
) 
 
0
.7
3
6
(0
.2
3
) 
 
0
.7
8
2
(0
.1
5
) 
 
0
.8
0
8
(0
.1
7
) 
 
0
.7
3
6
(0
.2
1
) 
B
lo
ck
 3
  
  
  
  
0
.8
4
5
(0
.1
5
) 
  
  
0
.7
9
3
(0
.1
7
) 
 
0
.7
7
2
(0
.1
9
) 
 
0
.8
3
8
(0
.1
4
) 
 
0
.8
4
4
(0
.1
5
) 
 
0
.7
7
8
(0
.1
8
) 
B
lo
ck
 4
  
  
  
  
0
.8
7
0
(0
.1
3
) 
  
  
0
.8
2
3
(0
.1
6
) 
 
0
.8
1
4
(0
.1
7
) 
 
0
.8
4
3
(0
.1
4
) 
 
0
.8
7
0
(0
.1
3
) 
 
0
.8
0
4
(0
.1
6
) 
B
lo
ck
 5
  
  
  
  
0
.8
8
7
(0
.1
3
) 
  
  
0
.8
5
7
(0
.1
5
) 
 
0
.8
4
3
(0
.1
7
) 
 
0
.8
8
6
(0
.1
3
) 
 
0
.8
8
3
(0
.1
3
) 
 
0
.8
6
0
(0
.1
7
) 
B
lo
ck
 6
  
  
  
  
0
.8
8
9
(0
.1
3
) 
  
  
0
.8
5
3
(0
.1
5
) 
 
0
.8
5
0
(0
.1
6
) 
 
0
.8
5
9
(0
.1
3
) 
 
0
.8
9
0
(0
.1
3
) 
 
0
.8
3
3
(0
.1
7
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
126 
 
 
T
ab
le
 6
  
A
im
 I
 r
es
u
lt
s 
fo
r 
th
e 
ep
is
o
d
ic
 m
em
o
ry
 d
o
m
ai
n
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
 
 
 
C
R
R
S
T
 
C
R
R
S
T
 
C
R
R
S
T
 
C
R
R
S
T
 
  
  
  
C
R
R
S
T
 
 
  
C
R
R
S
T
 
O
u
tc
o
m
e 
 
F
C
S
R
T
 
R
T
 m
ea
n
 
R
T
 I
S
D
 
R
T
 I
C
V
  
  
  
 A
cc
u
ra
c
y
 m
ea
n
 
  
 A
cc
u
ra
c
y
 I
S
D
  
  
  
  
A
cc
u
ra
c
y
 I
C
V
 
E
A
S
 M
C
I 
M
C
I 
v
s 
H
C
 
 
p
<
0
.0
1
  
p
<
0
.0
1
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
<
0
.0
5
  
  
  
p
<
0
.0
1
 
 
p
<
0
.0
5
 
A
C
 M
C
I 
M
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
<
0
.0
1
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
<
0
.0
5
  
  
  
p
<
0
.0
1
 
 
p
<
0
.0
1
 
E
A
S
 M
C
I3
 
aM
C
I 
v
s 
H
C
 
 
p
<
0
.0
5
  
p
<
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
<
0
.0
5
  
  
  
p
<
0
.0
5
 
 
p
<
0
.0
5
 
E
A
S
 M
C
I3
 
aM
C
I 
v
s 
n
aM
C
I 
p
<
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
<
0
.0
5
 
E
A
S
 M
C
I3
 
n
aM
C
I 
v
s 
H
C
  
p
>
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 N
o
te
: 
S
ig
n
if
ic
an
t 
re
su
lt
s 
in
 b
o
ld
. 
F
C
S
R
T
 =
 F
re
e 
an
d
 C
u
ed
 S
el
ec
ti
v
e 
R
em
in
d
in
g
 T
es
t;
 C
R
R
S
T
 =
 C
u
ed
-R
ec
al
l 
R
et
ri
ev
al
 S
p
ee
d
 T
as
k
; 
R
T
 
=
 r
ea
ct
io
n
 t
im
e;
 I
S
D
 =
 I
n
tr
ai
n
d
iv
id
u
al
 s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
; 
IC
V
 =
 I
n
tr
ai
n
d
iv
id
u
al
 c
o
ef
fi
ci
en
t 
o
f 
v
ar
ia
ti
o
n
. 
 
127 
 
  T
ab
le
 7
 
D
es
cr
ip
ti
v
e 
st
at
is
ti
cs
 f
o
r 
th
e 
p
ro
ce
ss
in
g
 s
p
ee
d
 d
o
m
ai
n
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
 
 
E
A
S
 H
C
 
 
E
A
S
 M
C
I 
 
E
A
S
 n
aM
C
I 
 
A
C
 H
C
 
 
A
C
 M
C
I 
N
 
 
 
 
3
0
3
 
 
 
1
2
0
 
 
 
3
9
 
 
 
3
3
9
 
 
 
8
4
 
A
g
e 
in
 y
ea
rs
 M
(S
D
) 
 
7
9
.4
9
(5
.0
3
) 
 
8
0
.8
1
(4
.9
9
) 
 
8
0
.1
3
(4
.9
2
) 
 
7
9
.5
9
(5
.0
2
) 
 
8
0
.9
6
(5
.0
7
) 
M
al
es
 (
%
) 
 
 
4
2
.9
 
 
 
3
5
.0
 
 
 
3
3
.3
 
 
 
4
0
.4
 
 
 
4
1
.7
 
C
au
ca
si
an
 (
%
) 
 
 
7
7
.9
 
 
 
6
7
.5
 
 
 
6
1
.5
 
 
 
7
7
.6
 
 
 
6
4
.3
 
E
d
u
ca
ti
o
n
 H
S
 o
r 
h
ig
h
er
 (
%
) 
9
1
.4
 
 
 
9
1
.7
 
 
 
9
4
.9
 
 
 
9
2
.0
 
 
 
8
9
.3
 
G
D
S
 5
 o
r 
le
ss
 (
%
) 
 
9
5
.7
 
 
 
9
3
.3
 
 
 
9
4
.9
 
 
 
9
5
.6
 
 
 
9
2
.9
 
B
IM
C
 M
(S
D
) 
 
 
0
.9
7
(0
.9
8
) 
 
1
.3
3
(1
.0
2
) 
 
1
.4
1
(1
.1
2
) 
 
0
.9
3
(0
.9
5
) 
 
1
.6
5
(1
.0
2
) 
T
M
T
-A
 M
(S
D
) 
 
5
2
.7
9
(2
6
.1
1
) 
 
5
5
.3
9
(1
9
.3
2
) 
 
5
8
.0
8
(1
8
.7
3
) 
 
5
2
.6
1
(2
4
.4
1
) 
 
5
7
.2
0
(2
4
.0
5
) 
N
M
 R
T
 M
(S
D
) 
  
  
  
  
  
2
1
8
9
.0
3
(6
6
8
.3
0
) 
  
  
  
  
2
3
6
7
.1
6
(6
9
4
.8
9
) 
  
  
  
  
 2
4
3
2
.8
5
(6
4
9
.6
7
) 
  
  
  
  
2
1
8
1
.9
5
(6
1
0
.6
4
) 
  
  
  
 2
4
7
2
.0
9
(8
7
3
.7
7
) 
N
M
 A
cc
u
ra
c
y
 M
(S
D
) 
 
0
.9
6
9
(0
.0
5
) 
 
0
.9
6
0
(0
.0
7
) 
 
0
.9
5
1
(0
.0
8
) 
 
0
.9
6
8
(0
.0
6
) 
 
0
.9
6
0
(0
.0
6
) 
N
M
 R
T
 I
S
D
 M
(S
D
) 
 
1
7
5
.2
0
(2
1
4
.9
4
) 
2
4
5
.4
1
(4
5
1
.4
1
) 
2
7
0
.0
2
(5
1
7
.6
6
) 
1
8
2
.2
3
(2
6
5
.3
3
) 
  
  
  
  
 2
4
7
.1
5
(4
1
8
.6
4
) 
N
M
 R
T
 I
C
V
 M
(S
D
) 
 
0
.0
7
8
(0
.0
6
9
) 
 
0
.0
9
2
(0
.1
1
) 
 
0
.0
9
8
(0
.1
3
) 
 
0
.0
8
0
(0
.0
8
) 
 
0
.0
9
0
(0
.1
0
) 
N
M
 A
cc
u
ra
c
y
 I
S
D
 M
(S
D
) 
0
.0
2
2
(0
.0
5
) 
 
0
.0
3
4
(0
.0
9
) 
 
0
.0
3
6
(0
.1
1
) 
 
0
.0
2
5
(0
.0
6
) 
 
0
.0
2
9
(0
.0
7
9
) 
N
M
 A
cc
u
ra
c
y
 I
C
V
 M
(S
D
) 
0
.0
2
7
(0
.0
9
) 
 
0
.0
4
7
(0
.1
8
) 
 
0
.0
5
5
(0
.2
2
) 
 
0
.0
3
1
(0
.1
1
) 
 
0
.0
3
9
(0
.1
5
) 
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
128 
 
  
T
ab
le
 8
 
R
ea
ct
io
n
 t
im
e 
(i
n
 m
il
li
se
co
n
d
s)
 a
n
d
 a
cc
u
ra
c
y
 (
p
ro
p
o
rt
io
n
 c
o
rr
ec
t)
 b
lo
ck
 p
er
fo
rm
an
ce
 b
y
 g
ro
u
p
 f
o
r 
th
e 
p
ro
ce
ss
in
g
 s
p
ee
d
 e
x
p
er
im
en
ta
l 
ta
sk
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
E
A
S
 H
C
 
  
  
  
  
E
A
S
 M
C
I 
  
  
 E
A
S
 a
M
C
I 
 
  
  
E
A
S
 n
aM
C
I  
 A
C
 H
C
 
  
  
  
  
  
  
  
A
C
 M
C
I 
 
 
R
T
 M
(S
D
) 
  
  
  
  
R
T
 M
(S
D
) 
  
  
 R
T
 M
(S
D
) 
 
  
  
R
T
 M
(S
D
) 
 
 R
T
 M
(S
D
) 
  
  
  
  
  
  
  
R
T
 M
(S
D
) 
B
lo
ck
 1
  
  
  
 2
2
4
1
.3
6
(6
7
6
.0
3
) 
  
  
2
3
9
9
.1
0
(6
5
2
.0
1
) 
  
  
  
2
3
6
6
.0
8
(6
6
4
.0
6
) 
2
4
6
7
.7
0
(6
2
9
.0
7
) 
  
  
  
2
2
3
4
.1
4
(6
1
3
.0
3
) 
  
  
  
  
2
4
9
5
.8
4
(8
4
3
.9
2
) 
B
lo
ck
 2
  
  
  
 2
1
3
6
.7
1
(7
1
2
.5
4
) 
  
 2
3
3
5
.2
2
(8
9
6
.1
5
) 
 2
3
0
4
.9
9
(9
0
3
.9
4
) 
2
3
9
7
.9
9
(8
8
8
.0
9
) 
  
  
  
2
1
2
9
.7
6
(6
8
4
.2
4
) 
  
  
  
2
4
4
8
.3
4
(1
0
2
5
.0
2
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
  
  
  
  
 E
A
S
 H
C
  
  
  
  
  
  
  
  
  
E
A
S
 M
C
I 
  
  
  
  
  
  
  
E
A
S
 a
M
C
I 
  
  
  
  
  
  
  
E
A
S
 n
aM
C
I 
  
  
  
  
  
  
 A
C
 H
C
 
  
  
  
  
  
A
C
 M
C
I 
 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
  
 A
cc
u
ra
cy
 M
(S
D
) 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
B
lo
ck
 1
 
0
.9
6
7
(0
.0
4
) 
  
  
0
.9
6
2
(0
.0
4
) 
 
0
.9
6
1
(0
.0
4
) 
 
0
.9
6
4
(0
.0
4
) 
 
0
.9
6
8
(0
.0
4
) 
 
0
.9
5
7
(0
.0
5
) 
B
lo
ck
 2
 
0
.9
7
2
(0
.0
8
) 
  
  
0
.9
5
8
(0
.0
1
3
) 
0
.9
6
7
(0
.1
1
) 
 
0
.9
3
8
0
.1
6
) 
 
0
.9
6
9
(0
.9
0
) 
 
0
.9
6
2
(0
.1
1
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
129 
 
  
T
ab
le
 9
 
A
im
 I
 r
es
u
lt
s 
fo
r 
th
e 
p
ro
ce
ss
in
g
 s
p
ee
d
 d
o
m
ai
n
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
 
 
 
  
 N
M
 
 
  
N
M
 
 
  
N
M
 
 
  
N
M
 
 
  
  
  
  
 N
M
 
 
  
  
N
M
 
O
u
tc
o
m
e 
 
T
M
T
-A
 
R
T
 m
ea
n
 
R
T
 I
S
D
 
R
T
 I
C
V
  
  
  
 A
cc
u
ra
c
y
 m
ea
n
 
  
 A
cc
u
ra
c
y
 I
S
D
  
  
  
  
A
cc
u
ra
c
y
 I
C
V
 
E
A
S
 M
C
I 
M
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
A
C
 M
C
I 
M
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
E
A
S
 M
C
I3
 
n
aM
C
I 
v
s 
H
C
  
p
>
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
E
A
S
 M
C
I3
 
n
aM
C
I 
v
s 
aM
C
I 
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
E
A
S
 M
C
I3
 
aM
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 N
o
te
: 
S
ig
n
if
ic
an
t 
re
su
lt
s 
in
 b
o
ld
. 
T
M
T
-A
 =
 T
ra
il
 M
ak
in
g
 T
es
t 
P
ar
t 
A
; 
N
M
 =
 N
u
m
b
er
 M
at
ch
 T
as
k
; 
R
T
 =
 r
ea
ct
io
n
 t
im
e;
 I
S
D
 =
 
In
tr
ai
n
d
iv
id
u
al
 s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
; 
IC
V
 =
 I
n
tr
ai
n
d
iv
id
u
al
 c
o
ef
fi
ci
en
t 
o
f 
v
ar
ia
ti
o
n
. 
 
130 
 
  T
ab
le
 1
0
 
D
es
cr
ip
ti
v
e 
st
at
is
ti
cs
 f
o
r 
th
e 
ex
ec
u
ti
v
e 
fu
n
ct
io
n
 d
o
m
ai
n
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
 
 
E
A
S
 H
C
 
 
E
A
S
 M
C
I 
 
E
A
S
 n
aM
C
I 
 
A
C
 H
C
 
 
A
C
 M
C
I 
N
 
 
 
 
1
8
3
 
 
 
6
5
 
 
 
2
3
 
 
 
2
0
4
 
 
 
4
4
 
A
g
e 
M
(S
D
) 
 
 
7
9
.0
8
(4
.8
5
) 
 
8
1
.3
4
(4
.8
1
) 
 
8
0
.4
6
(4
.7
7
) 
 
7
9
.1
3
(4
.6
9
) 
 
8
2
.1
9
(5
.3
2
) 
M
al
es
 (
%
) 
 
 
4
3
.7
 
 
 
3
6
.9
 
 
 
3
0
.4
 
 
 
4
1
.7
 
 
 
4
3
.2
 
C
au
ca
si
an
 (
%
) 
 
 
7
8
.7
 
 
 
6
9
.2
 
 
 
6
5
.2
 
 
 
7
7
.5
 
 
 
7
0
.5
 
E
d
u
ca
ti
o
n
 H
S
 o
r 
h
ig
h
er
 (
%
) 
9
0
.7
 
 
 
9
2
.3
 
 
 
9
5
.7
 
 
 
9
1
.7
 
 
 
8
8
.6
 
G
D
S
 5
 o
r 
le
ss
 (
%
) 
 
9
6
.7
 
 
 
9
6
.9
 
 
 
1
0
0
 
 
 
9
6
.6
 
 
 
9
7
.7
 
B
IM
C
 M
(S
D
) 
 
 
0
.8
9
(0
.9
4
) 
 
1
.1
8
(0
.9
9
) 
 
1
.0
4
(0
.9
3
) 
 
0
.8
4
(0
.9
2
) 
 
1
.5
2
(0
.9
8
) 
T
M
T
-B
 M
(S
D
) 
 
1
1
1
.6
3
(5
2
.4
6
) 
 
1
3
4
.9
8
(6
7
.6
4
) 
 
1
4
6
.0
0
(6
9
.6
4
) 
 
1
1
4
.2
2
(5
5
.0
1
) 
 
1
3
4
.1
4
(6
6
.6
8
) 
N
B
2
 R
T
 M
(S
D
) 
  
  
  
  
2
0
7
1
.5
0
(9
1
4
.9
3
) 
  
  
  
  
 2
2
8
2
.8
7
(9
8
0
.7
8
) 
  
  
  
 2
1
9
5
.0
8
(9
9
9
.3
3
) 
  
  
  
  
2
0
6
2
.5
6
(8
8
9
.1
5
) 
  
  
  
  
2
4
2
5
.1
9
(1
0
8
7
.0
3
) 
N
B
2
 A
cc
u
ra
c
y
 M
(S
D
) 
0
.7
7
7
(0
.1
8
) 
 
0
.7
2
9
(0
.2
0
) 
 
0
.7
3
8
(0
.1
7
) 
 
0
.7
8
0
(0
.1
8
) 
 
0
.6
9
1
(0
.2
1
) 
N
B
2
 R
T
 I
S
D
 M
(S
D
) 
 
4
0
1
.7
5
(4
5
7
.9
6
) 
5
1
3
.9
1
(5
2
8
.9
7
) 
4
0
5
.1
2
(3
3
6
.3
4
) 
4
0
1
.2
0
(4
4
7
.6
2
) 
  
  
  
  
 5
7
0
.0
1
(5
9
0
.1
7
) 
N
B
2
 R
T
 I
C
V
 M
(S
D
) 
 
0
.1
7
0
(0
.1
1
) 
 
0
.2
0
5
(0
.1
3
) 
 
0
.1
8
0
(0
.1
0
) 
 
0
.1
7
2
(0
.1
1
) 
 
0
.2
1
5
(0
.1
5
) 
N
B
2
 A
cc
u
ra
c
y
 I
S
D
 M
(S
D
) 
0
.1
0
6
(0
.1
2
) 
 
0
.1
2
5
(0
.1
3
) 
 
0
.1
1
9
(0
.1
2
) 
 
0
.1
0
4
(0
.1
1
) 
 
0
.1
4
3
(0
.1
4
) 
N
B
2
 A
cc
u
ra
c
y
 I
C
V
 M
(S
D
) 
0
.2
2
5
(0
.4
4
) 
 
0
.2
8
8
(0
.5
0
) 
 
0
.2
5
3
(0
.4
7
) 
 
0
.2
1
9
(0
.4
3
) 
 
0
.3
5
0
(0
.5
4
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
131 
 
  
T
ab
le
 1
1
 
R
ea
ct
io
n
 t
im
e 
(i
n
 m
il
li
se
co
n
d
s)
 a
n
d
 a
cc
u
ra
c
y
 (
p
ro
p
o
rt
io
n
 c
o
rr
ec
t)
 b
lo
ck
 p
er
fo
rm
an
ce
 b
y
 g
ro
u
p
 f
o
r 
th
e 
ex
ec
u
ti
v
e 
fu
n
ct
io
n
 e
x
p
er
im
en
ta
l 
ta
sk
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
E
A
S
 H
C
 
  
  
  
  
E
A
S
 M
C
I 
  
  
  
 E
A
S
 a
M
C
I 
  
  
  
E
A
S
 n
aM
C
I 
  
  
 A
C
 H
C
 
 
A
C
 M
C
I 
 
 
R
T
 M
(S
D
) 
  
  
  
  
R
T
 M
(S
D
) 
  
  
  
 R
T
 M
(S
D
) 
  
  
  
R
T
 M
(S
D
) 
 
  
  
R
T
 M
(S
D
) 
  
  
 
R
T
 M
(S
D
) 
B
lo
ck
 1
  
  
  
 2
0
9
4
.1
2
(6
7
5
.0
6
) 
  
  
2
2
9
2
.0
4
(7
2
1
.2
0
) 
  
2
2
8
5
.3
9
(7
2
5
.4
5
) 
  
2
3
0
4
.1
9
(7
2
9
.4
5
) 
2
1
0
2
.1
2
(6
6
9
.4
4
) 
  
  
 2
3
4
9
.4
2
(7
6
1
.2
4
) 
B
lo
ck
 2
  
  
  
 2
1
0
0
.6
0
(1
1
2
0
.5
2
) 
  
 2
2
9
7
.5
0
(1
2
1
1
.3
7
) 
  
2
3
3
7
.3
9
(1
2
0
4
.7
0
) 
  
2
2
2
4
.6
7
(1
2
4
7
.2
4
) 
  
  
2
0
9
1
.2
6
(1
0
9
3
.1
4
) 
  
2
4
3
4
.7
6
(1
3
4
2
.0
2
) 
B
lo
ck
 3
  
  
  
 2
0
1
9
.7
9
(1
2
4
0
.9
7
) 
  
 2
2
5
9
.0
7
(1
4
1
1
.8
9
) 
  
2
3
7
0
.0
7
(1
5
1
6
.9
4
) 
  
2
0
5
6
.3
8
(1
2
0
1
.7
6
) 
1
9
9
4
.3
1
(1
2
0
2
.4
1
) 
  
2
4
9
1
.4
0
(1
5
8
6
.0
3
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
  
  
  
  
 E
A
S
 H
C
  
  
  
  
  
  
  
  
  
E
A
S
 M
C
I 
  
  
  
  
  
  
  
E
A
S
 a
M
C
I 
  
  
  
  
  
  
  
E
A
S
 n
aM
C
I 
  
  
  
  
  
  
 A
C
 H
C
 
  
  
  
  
  
A
C
 M
C
I 
 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
  
  
  
 A
cc
u
ra
cy
 M
(S
D
) 
  
  
 A
cc
u
ra
c
y
 M
(S
D
) 
B
lo
ck
 1
  
  
  
  
0
.8
1
6
(0
.1
1
) 
  
  
0
.7
7
9
(0
.1
3
) 
 
0
.7
7
9
(0
.1
4
) 
 
0
.7
8
0
(0
.1
2
) 
 
0
.8
1
6
(0
.1
2
) 
 
0
.7
6
5
(0
.1
2
) 
B
lo
ck
 2
  
  
  
  
0
.7
6
7
(0
.2
4
) 
  
  
0
.7
1
2
(0
.2
6
) 
 
0
.7
1
3
(0
.2
7
) 
 
0
.7
0
9
(0
.2
5
) 
 
0
.7
6
7
(0
.2
4
) 
 
0
.6
8
7
(0
.2
8
) 
B
lo
ck
 3
  
  
  
  
0
.7
4
6
0
.2
7
) 
  
  
0
.6
9
5
(0
.3
1
) 
 
0
.6
7
7
(0
.3
3
) 
 
0
.7
2
6
(0
.2
5
) 
 
0
.7
5
6
(0
.2
6
) 
 
0
.6
2
3
(0
.3
3
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
132 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
ab
le
 1
2
 
A
im
 I
 r
es
u
lt
s 
fo
r 
th
e 
ex
ec
u
ti
v
e 
fu
n
ct
io
n
 d
o
m
ai
n
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 
 
 
 
 
  
 N
B
2
  
 N
B
2
 
 
  
N
B
2
 
 
  
 N
B
2
  
  
  
  
  
 N
B
2
 
 
  
  
N
B
2
 
O
u
tc
o
m
e 
 
T
M
T
-B
 
R
T
 m
ea
n
 
R
T
 I
S
D
 
R
T
 I
C
V
  
  
  
 A
cc
u
ra
c
y
 m
ea
n
 
  
 A
cc
u
ra
c
y
 I
S
D
  
  
  
  
A
cc
u
ra
c
y
 I
C
V
 
E
A
S
 M
C
I 
M
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
A
C
 M
C
I 
M
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
<
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
<
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
E
A
S
 M
C
I3
 
n
aM
C
I 
v
s 
H
C
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
E
A
S
 M
C
I3
 
n
aM
C
I 
v
s 
aM
C
I 
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
E
A
S
 M
C
I3
 
aM
C
I 
v
s 
H
C
 
 
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
p
>
0
.0
5
  
  
  
p
>
0
.0
5
 
 
p
>
0
.0
5
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
 N
o
te
: 
S
ig
n
if
ic
an
t 
re
su
lt
s 
in
 b
o
ld
. 
T
M
T
-B
 =
 T
ra
il
 M
ak
in
g
 T
es
t 
P
ar
t 
B
; 
N
B
2
 =
 N
-B
ac
k
 2
 T
as
k
; 
R
T
 =
 r
ea
ct
io
n
 t
im
e;
 I
S
D
 =
 
In
tr
ai
n
d
iv
id
u
al
 s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
; 
IC
V
 =
 I
n
tr
ai
n
d
iv
id
u
al
 c
o
ef
fi
ci
en
t 
o
f 
v
ar
ia
ti
o
n
. 
133 
 
Table 13 
PCA correlations between variable and component across-domain 
______________________________________________________________________________ 
      Component 1      Component 2      Component 3 
FCSRT Rev   0.375   -0.310    0.190 
TMT-A   0.682   -0.312   -0.504 
TMT-B   0.768   -0.299   -0.366 
CRRST RT ISD  0.478   -0.269    0.528 
CRRST Accuracy ISD 0.290   -0.196    0.628 
NM RT ISD   0.115    0.066    0.174 
NM Accuracy ISD  0.188    0.021    0.421 
NB2 RT ISD   0.444    0.832    0.028 
NB2 Accuracy ISD  0.430    0.844    0.017 
______________________________________________________________________________ 
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Table 14 
PCA variable contributions to components across-domain 
______________________________________________________________________________ 
         Component 1      Component 2      Component 3 
FCSRT Rev   7.26%   5.32%   2.76% 
Trails A   23.98%  5.39%   19.45% 
Trails B   30.4%   4.96%   10.25% 
CRRST RT ISD  11.81%  4.03%   21.34% 
CRRST Accuracy ISD 4.33%   2.13%   30.23% 
NM RT ISD   0.68%   0.24%   2.31% 
NM Accuracy ISD  1.82%   0.02%   13.58% 
NB2 RT ISD   10.16%  38.38%  0.06% 
NB2 Accuracy ISD  9.56%   39.53%  0.02% 
______________________________________________________________________________ 
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Table 15 
Incidence of follow-up MCI by wave 
______________________________________________________________________________ 
Waves of Data           Total      Incidence of    Incidence of 
After Baseline       Participants (N)     EAS MCI (N)   AC MCI (N) 
 1  35   12   9 
 2  28   11   8 
 3  32   8   5 
 4  16   8   3 
 5  32   8   8 
 6  30   4   5 
 7  19   8   1 
 8  36   5   3 
 9  18   1   2 
 10  1   0   0 
______________________________________________________________________________ 
 Total  247   65   44 
______________________________________________________________________________ 
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Table 16 
Descriptive statistics for participants with/without four or more years of follow-up data 
______________________________________________________________________________ 
    3 or Fewer Waves  4 or More Waves 
N     95    152  
Age M(SD)    79.17(4.99)   79.94(4.87) 
Males (%)    44.2    40.1 
Caucasian (%)    76.8    75.7 
Education HS or higher (%)  90.5    91.4 
GDS 5 or less (%)   94.7    98.0 
EAS Baseline HC (%)  90.5    96.1 
EAS Follow-up MCI (%)  12.6    34.9 
AC Follow-up MCI (%)  4.2    26.3 
AC Follow-up pre-MCI (%)  20.0    32.9 
______________________________________________________________________________ 
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Figures 
 
 
 
 
 
Figure 1. Biomarker model adapted from Jack, C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M.,  
 
Aisen, P.S., Weiner, M.W., … Trojanowski, J.Q. (2010). 
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Figure 2. Updated biomarker model adapted from Jack, C.R., Knopman, D.S., Jagust, W.J.,  
 
Petersen, R.C., Weiner, M.W., Aisen, P.S., … Trojanowski, J.Q. (2013). 
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Figure 3. Visual display of learning and cued-recall stages of the computerized Cued-Recall 
Retrieval Speed Task adapted from Ramratan, W.S., Rabin, L.A., Wang, C., Zimmerman, M.E., 
Katz, M.J., Lipton, R.B., & Buschke, H. (2012). 
A: 16 category cues presented with two possible exemplars (one correct, one incorrect) for 10 
sec sequentially.  
B: 6 blocks of: 16-item cued-recall (5 sec) immediately followed by post-cue presentation (2 
sec). 
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Figure 4. Visual display of the computerized Number Match task. 
A: Rows of numbers are the same.  
B: Rows of numbers are different. 
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     First Number     Second Number      Question 1 Question 2  Question 3     …                  Question 20 
 
 
 
 
 
 
Figure 5. Visual display of the computerized N-Back 2 task.  
A: Question 1: Does this number match the first number presented?  
B: Question 2: Does this number match the second number presented?  
C: Question 3: Does this number match the number presented 2-back?  
D: Question 20: Does this number match the number presented 2-back?
5 8 5 3 8 2 
2 
8 3 
5 
8 
5 
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Number Presentation 
Single digit number presented on 
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______________________________________________________________________________ 
Figure 6. CRRST mean reaction time (ms) across blocks for the EAS MCI outcome.  The MCI  
group had significantly greater reaction times than HC at each block.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 7. CRRST mean accuracy (proportion correct) across blocks for the EAS MCI outcome. 
The MCI group had significantly poorer accuracy than HC at each block.  Standard errors  
(+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 8. CRRST mean reaction time (ms) across blocks for the AC MCI outcome.  The MCI  
group had significantly greater reaction times than HC at each block.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 9. CRRST mean accuracy (proportion correct) across blocks for the AC MCI outcome.   
The MCI group had significantly poorer accuracy than HC at each block, except at block 5.   
Standard errors (+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 10. CRRST mean reaction time (ms) across blocks for the EAS MCI3 outcome.  The 
aMCI group had significantly greater reaction times than HC at each block.  Standard errors 
(+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 11. CRRST mean accuracy (proportion correct) across blocks for the EAS MCI3  
outcome.  The aMCI group had significantly poorer accuracy than HC at each block.  Standard  
errors (+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 12. FCSRT mean (items recalled) for the EAS MCI outcome.  The MCI group recalled 
significantly fewer items than HC.  Standard errors (+2SE) of the mean are represented in the 
figure by the error bars attached at each box. 
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Figure 13. FCSRT mean (items recalled) for the AC MCI outcome.  The MCI and HC groups 
did not significantly differ in the number of items recalled.  Standard errors (+2SE) of the mean 
are represented in the figure by the error bars attached at each box. 
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Figure 14. FCSRT mean (items recalled) for the EAS MCI3 outcome.  The aMCI group recalled 
significantly fewer items than HC.  Standard errors (+2SE) of the mean are represented in the 
figure by the error bars attached at each box. 
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Figure 15. NM mean reaction time (ms) across blocks for the EAS MCI outcome.  The MCI  
group had significantly greater reaction times than HC at each block.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 16. NM mean accuracy (proportion correct) across blocks for the EAS MCI outcome.  
The MCI and HC groups did not significantly differ in accuracy at any block.  Standard errors 
(+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 17. NM mean reaction time (ms) across blocks for the AC MCI outcome.  The MCI  
group had significantly greater reaction times than HC at each block.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 18. NM mean accuracy (proportion correct) across blocks for the AC MCI outcome.  The  
MCI and HC groups did not significantly differ in accuracy at any block.  Standard errors (+2SE)  
of the mean are represented in the figure by error bars at each block. 
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Figure 19. NM mean reaction time (ms) across blocks for the EAS MCI3 outcome.  The naMCI  
group had significantly greater reaction times than HC at each block.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 20. NM mean accuracy (proportion correct) across blocks for the EAS MCI3 outcome.   
The naMCI group had significantly poorer accuracy than HC only at block 2.  Standard errors  
(+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 21. TMT-A mean (time in sec) for the EAS MCI outcome.  The MCI and HC groups did  
not significantly differ in the time it took to complete the task.  Standard errors (+2SE) of the  
mean are represented in the figure by error bars attached at each box. 
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Figure 22. TMT-A mean (time in sec) for the AC MCI outcome.  The MCI and HC groups did  
not significantly differ in the time it took to complete the task.  Standard errors (+2SE) of the  
mean are represented in the figure by error bars attached at each box. 
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Figure 23. TMT-A mean (time in sec) for the EAS MCI3 outcome.  Groups did not significantly  
differ in the time it took to complete the task.  Standard errors (+2SE) of the mean are 
represented in the figure by error bars attached at each box. 
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Figure 24. NB2 mean reaction time (ms) across blocks for the EAS MCI outcome.  The MCI  
group had significantly greater reaction time than HC only at block 1.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 25. NB2 mean accuracy (proportion correct) across blocks for the EAS MCI outcome.   
The MCI group had significantly poorer accuracy than HC only at block 1.  Standard errors  
(+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 26. NB2 mean reaction time (ms) across blocks for the AC MCI outcome.  The MCI  
group had significantly greater reaction time than HC only at block 1.  Standard errors (+2SE) of  
the mean are represented in the figure by error bars at each block. 
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Figure 27. NB2 mean accuracy (proportion correct) across blocks for the AC MCI outcome.  
The MCI group had significantly poorer accuracy than HC at block 1 and block 3.  Standard  
errors (+2SE) of the mean are represented in the figure by error bars at each block. 
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Figure 28. NB2 mean reaction time (ms) across blocks for the EAS MCI3 outcome.  Groups did  
not significantly differ in reaction time at any block.  Standard errors (+2SE) of the mean are  
represented in the figure by error bars at each block. 
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Figure 29. NB2 mean accuracy (proportion correct) across blocks for the EAS MCI3 outcome.   
Groups did not significantly differ in accuracy at any block.  Standard errors (+2SE) of the mean  
are represented in the figure by error bars at each block. 
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Figure 30. TMT-B mean (time in sec) for the EAS MCI outcome.  The MCI and HC groups did  
not significantly differ in the time it took to complete the task.  Standard errors (+2SE) of the  
mean are represented in the figure by error bars attached at each box. 
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Figure 31. TMT-B mean (time in sec) for the AC MCI outcome.  The MCI and HC groups did  
not significantly differ in the time it took to complete the task.  Standard errors (+2SE) of the  
mean are represented in the figure by error bars attached at each box. 
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Figure 32. TMT-B mean (time in sec) for the EAS MCI3 outcome.  Groups did not significantly  
differ in the time it took to complete the task.  Standard errors (+2SE) of the mean are  
represented in the figure by error bars attached at each box. 
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Figure 33. Across-domain PCA plot. 
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______________________________________________________________________________ 
 
Figure 34. PCA bootstrap ratio for component 1. 
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______________________________________________________________________________ 
 
Figure 35. PCA bootstrap ratio for component 2. 
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______________________________________________________________________________ 
 
Figure 36. PCA bootstrap ratio for component 3. 
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